import React, { useEffect } from 'react';
import * as SQLite from "expo-sqlite"

const db = SQLite.openDatabase('db.db')

const ExecuteQuery = (sql, params = []) => new Promise((resolve, reject) => {
      db.transaction((trans) => {
            trans.executeSql(sql, params, (trans, results) => {
                  resolve('Database Succesfully inserted into the database', results);
            },
                  (error) => {
                        reject('Failed to inserts Drugs into the database!', error);
                  });
      });
});

const insertDrugsToDatabaseAsync = async () => {

 

      let drugs = [
            {
                "id": 1,
                "guid": "1",
                "name": "Acarbose",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose",
                "teratogenicity": null,
                "contraindications": "Hypoglycemia\nHypersensitivity to the drug",
                "interactions": "Insulin: cumulative effects\nMay decrease bioavailability of digoxin, metformin by approximately 20%",
                "adverse_effects": "Diarrhea in 3/5 dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T15:44:59.000000Z",
                "updated_at": "2020-05-06T15:44:59.000000Z"
            },
            {
                "id": 2,
                "guid": "2",
                "name": "Acemannan",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "No adverse effects at 1 mg/kg IV repeated, or 10 mg/kg IV once, in healthy dogs \n 5 mg/kg IP or 10 mg/kg repeated doses IV causes abdominal discomfort and vomiting in dogs, no deaths \n No adverse effects at 1500 mg/kg/day PO for 90 days in healthy dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T15:45:56.000000Z",
                "updated_at": "2020-11-04T01:53:13.000000Z"
            },
            {
                "id": 3,
                "guid": "3",
                "name": "Acepromazine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "For hypotension: circulatory volume expansion (IV fluid therapy) if needed\n vasopressors (e.g., infusion of dopamine or phenylephrine)",
                "teratogenicity": "",
                "contraindications": "Organophosphate-induced tremors (acepromazine potentiates toxicity) \n hypotension \n systemic illness \n hypersensitivity to the drug",
                "interactions": "Potentiates effects of other CNS depressants",
                "adverse_effects": "Older patients may have excessively long duration of action (relative contraindication) \n Caution with liver disease (prolonged/excessive effect) \n Rare incidence of reverse sneezing \n Rare mania/aggression \n Mild hypotensive effects at 0.1 mg/kg SC, often accentuated if IV, older patients, or systemic illness",
                "deleted_at": null,
                "created_at": "2020-05-06T15:47:16.000000Z",
                "updated_at": "2020-11-04T01:57:44.000000Z"
            },
            {
                "id": 4,
                "guid": "4",
                "name": "Acetaminophen",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "s-adenosylmethionine, acetylcysteine",
                "teratogenicity": "",
                "contraindications": "",
                "interactions": "",
                "adverse_effects": "Methemoglobinemia  \n  Acute hepatic injury  \n  Hemolytic anemia",
                "deleted_at": null,
                "created_at": "2020-05-06T15:50:12.000000Z",
                "updated_at": "2020-11-04T16:58:29.000000Z"
            },
            {
                "id": 5,
                "guid": "5",
                "name": "Acetazolamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Teratogenic (limb deformities) in mice and rats\ndrug is shed in milk",
                "contraindications": "Hypokalemia \n Hyponatremia \n Hypotension/dehydration (may be potentiated by drug) \n Chronic hepatopathies (increased risk of hepatic encephalopathy) \n Renal disease (electrolyte and hypovolemic effects) \n Hypoadrenocorticism \n Hypersensitivity to the drug",
                "interactions": "Cisapride\n\r\nAnticonvulsants, digoxin, cyclosporine (altered hepatic metabolism)\n\r\nDiuretics (potentiate hypovolemia/dehydration, hyponatremia, hypokalemia)",
                "adverse_effects": "At 10-25 mg/kg, frequent adverse effects in cats (metabolic acidosis-induced panting, mentation changes) are prohibitive",
                "deleted_at": null,
                "created_at": "2020-05-06T15:51:59.000000Z",
                "updated_at": "2020-11-04T02:01:14.000000Z"
            },
            {
                "id": 6,
                "guid": "6",
                "name": "Acetylcysteine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "No teratogenicity/lactation restrictions reported",
                "contraindications": "Nebulization (400 mg/CAT nebulized via endotracheal tube) for mucolytic effect actually triggers bronchoconstriction in cats \n Hypersensitivity to the drug",
                "interactions": "Incompatible (do not mix) with ampicillin, amphotericin B",
                "adverse_effects": "500 mg/kg IV is lethal as single dose in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T15:52:57.000000Z",
                "updated_at": "2020-11-04T02:01:58.000000Z"
            },
            {
                "id": 7,
                "guid": "7",
                "name": "Acetylsalicylic acid",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "5-12 (cats and 12-18 (dogs) mg/dL\nnot clinically proven and rarely used",
                "reversal_agent": "",
                "teratogenicity": "No teratogenic effects at clinical dosages",
                "contraindications": "Hypersensitivity to the drug \n Anorexia \n Dehydration \n Platelet function disorder, thrombocytopenia, or coagulopathy \n Gastrointestinal disease (relative contraindication) \n For anti-inflammatory effects, many safer alternatives exist (same or greater anti-inflammatory effect with lower risk of adverse effects): carprofen, deracoxib, meloxicam, etc.",
                "interactions": "Corticosteroids (potentiate gastrointestinal ulceration), aminoglycoside antibiotics, diuretics, and potentially nephrotoxic drugs (aggravate renal injury)",
                "adverse_effects": "Gastrointestinal ulceration, especially if administered on an empty stomach or in a dehydrated animal \n Renal injury",
                "deleted_at": null,
                "created_at": "2020-05-06T15:54:31.000000Z",
                "updated_at": "2020-11-04T02:02:41.000000Z"
            },
            {
                "id": 8,
                "guid": "8",
                "name": "ACTH gel",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T15:56:27.000000Z",
                "updated_at": "2020-05-06T15:56:27.000000Z"
            },
            {
                "id": 9,
                "guid": "9",
                "name": "ACTH-like synthetic solution",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T15:57:15.000000Z",
                "updated_at": "2020-11-04T02:16:27.000000Z"
            },
            {
                "id": 10,
                "guid": "10",
                "name": "Actinomycin D",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Suspected teratogen, like many antineoplastic drugs",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Allopurinol, colchicine",
                "adverse_effects": "Vesicant/extravasation injury\nHigh (40%) rate of neurotoxicosis in dogs treated with actinomycin D-cyclophosphamide-5-fluorouracil combination\nThrombocytopenia common (45%) and reversible",
                "deleted_at": null,
                "created_at": "2020-05-06T15:58:17.000000Z",
                "updated_at": "2020-05-06T15:58:17.000000Z"
            },
            {
                "id": 11,
                "guid": "11",
                "name": "Activated charcoal",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Relative contraindication: ineffective for heavy metal intoxications",
                "interactions": "Limits absorption of most drugs",
                "adverse_effects": "Aspiration pneumonia can be devastating. As a result, this must only be administered to conscious animals with a patent airway and a positive swallowing reflex (or if unconscious, endotracheal intubation with inflated cuff and continuous supervision are mandatory)",
                "deleted_at": null,
                "created_at": "2020-05-06T15:58:51.000000Z",
                "updated_at": "2020-11-04T02:16:59.000000Z"
            },
            {
                "id": 12,
                "guid": "12",
                "name": "Acyclovir",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Lack of clinical efficacy in dogs with neonatal canine herpesvirus infection\nContraindication to oral administration in cats due to very low efficacy against feline herpesvirus and clinically significant myelotoxicosis and nephrotoxicosis",
                "interactions": null,
                "adverse_effects": "Renal, bone marrow",
                "deleted_at": null,
                "created_at": "2020-05-06T16:00:18.000000Z",
                "updated_at": "2020-05-06T16:00:18.000000Z"
            },
            {
                "id": 13,
                "guid": "13",
                "name": "Aglepristone",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Abortefacient - precautions necessary with humans (veterinary staff, clients) potentially exposed to drug",
                "contraindications": "Hypersensitivity to the drug \n Physical obstruction/risk factors for mechanical dystocia \n Closed pyometra risks sepsis and/or uterine rupture",
                "interactions": "",
                "adverse_effects": "Local inflammation at injection site (common in dogs) \n Cats: brief depression, anorexia in 10% \n Injection site pruritus in 4%",
                "deleted_at": null,
                "created_at": "2020-05-06T16:01:14.000000Z",
                "updated_at": "2020-11-04T02:19:08.000000Z"
            },
            {
                "id": 14,
                "guid": "14",
                "name": "Albendazole",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Has teratogenic potential",
                "contraindications": "Hypersensitivity to the drug   \n   Neutropenia   \n   Thrombocytopenia   \n   Nonregenerative anemia",
                "interactions": "",
                "adverse_effects": "Myelotoxicosis/bone marrow toxicosis described as dose-related (dog) or idiosyncratic (cat) in single case reports - appears to be rare",
                "deleted_at": null,
                "created_at": "2020-05-06T16:03:11.000000Z",
                "updated_at": "2020-11-04T02:22:41.000000Z"
            },
            {
                "id": 15,
                "guid": "15",
                "name": "Albuterol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Potassium repletion",
                "teratogenicity": "Drug does cross the placenta;rare cleft palate occurrence in mice",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Beta-blockers (generally less of a concern if beta-1 selective blockers such as atenolol, metoprolol, carvedilol)\nDiuretics and other agents that cause potassium excretion (monitor serum K)\nDigoxin (decreases digoxin serum concentration)",
                "adverse_effects": "Tachycardia, mild anxiety (which may subside after 7-10 days of treatment) possible\nOverdoses can cause potentially profound hypokalemia, paresis/paralysis",
                "deleted_at": null,
                "created_at": "2020-05-06T16:04:43.000000Z",
                "updated_at": "2020-05-06T16:04:43.000000Z"
            },
            {
                "id": 16,
                "guid": "16",
                "name": "Alendronate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug  \n  Hypocalcemia  \n  Esophagitis, Gastritis",
                "interactions": "Food interferes substantially with absorption\nAdminister on an empty stomach, follow with water to ensure passage through esophagus into stomach, and feed >30 minutes later.",
                "adverse_effects": "Experimental beagles treated with 0.25-1 mg/kg PO q 24h for 1 year showed no adverse effects  \n  Humans can develop esophagitis when taking this drug - caution in dogs and cats is warranted \n  Osteopetrosis and pathologic fractures (bilateral patellar fractures in 1 case report)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:06:21.000000Z",
                "updated_at": "2020-11-04T16:53:51.000000Z"
            },
            {
                "id": 17,
                "guid": "17",
                "name": "Alfaxalone",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Unregulated hypoxemia\nHypercapnia\nApnea",
                "interactions": "Cumulative effect with other induction agents or with sedatives/tranquilizers/anesthetics\nSafe with premedications (acepromazine, atropine, opiates)",
                "adverse_effects": "Apnea is common",
                "deleted_at": null,
                "created_at": "2020-05-06T16:07:30.000000Z",
                "updated_at": "2020-05-06T16:07:30.000000Z"
            },
            {
                "id": 18,
                "guid": "18",
                "name": "Allopurinol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Urinary acidifiers (ammonium chloride, ascorbic acid, etc.) may increase risk of xanthine urolith formation\nCyclosporine (allopurinol increases serum cyclosporine levels)\nDacarbazine (has similar, cumulative hypouricemic effects)\nMethylxanthines (aminophylline, theophylline), which may be displaced and therefore have lower concentrations",
                "adverse_effects": "Xanthine urolithiasis may develop in some treated dogs  \n  Bone marrow toxicosis is reported in humans (rare)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:08:28.000000Z",
                "updated_at": "2020-11-04T01:56:15.000000Z"
            },
            {
                "id": 19,
                "guid": "19",
                "name": "Alprazolam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic potential;should be avoided during pregnancy",
                "contraindications": "Hypersensitivity to the drug\nCaution if using additional/concurrent drugs with sedative or CNS depressive effects",
                "interactions": "Ketoconazole, itraconazole, cimetidine may increase alprazolam levels significantly (hepatic CYP3A enzyme inhibition)",
                "adverse_effects": "Drowsiness, hepatopathy possible but uncommon at this dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T16:09:38.000000Z",
                "updated_at": "2020-05-06T16:09:38.000000Z"
            },
            {
                "id": 20,
                "guid": "20",
                "name": "Aluminum hydroxide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Deferoxamine",
                "teratogenicity": null,
                "contraindications": "Hypophosphatemia\nHypersensitivity to the drug",
                "interactions": "In dogs, has interfered with absorption of other medications such as beta-blockers, tetracyclines, and fluoroquinolones",
                "adverse_effects": "In dogs, has caused aluminum toxicosis when given in doses of 145-200 mg/kg/day during chronic kidney disease",
                "deleted_at": null,
                "created_at": "2020-05-06T16:10:19.000000Z",
                "updated_at": "2020-05-06T16:10:19.000000Z"
            },
            {
                "id": 21,
                "guid": "21",
                "name": "Amantadine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dantrolene (anecdotal, unproven)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nCaution if using additional/concurrent drugs with sedative or CNS depressive effects",
                "interactions": "CNS stimulants, anticholinergics may be potentiated",
                "adverse_effects": "CNS and anticholinergic effects are reported infrequently in humans",
                "deleted_at": null,
                "created_at": "2020-05-06T16:11:45.000000Z",
                "updated_at": "2020-05-06T16:11:45.000000Z"
            },
            {
                "id": 22,
                "guid": "22",
                "name": "Amikacin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Desired peak > 40 µg/mL (to increase bactericidal effect), and desired trough < 10 µg/mL (to minimize nephrotoxic effect) (based on q 24h dosing)",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Kidney disease\n Vestibular disease \n Neuromuscular disease",
                "interactions": "Caution with drugs that can deplete intravascular volume (e.g., diuretics) or are directly nephrotoxic\r\nUnlike other aminoglycosides (e.g., gentamicin, tobramycin), amikacin is not inactivated in vitro by penicillins",
                "adverse_effects": "Neuromuscular paralysis \n Nephrotoxicosis, ototoxicosis, possible as with other aminoglycosides",
                "deleted_at": null,
                "created_at": "2020-05-06T16:12:26.000000Z",
                "updated_at": "2020-11-04T02:23:40.000000Z"
            },
            {
                "id": 23,
                "guid": "23",
                "name": "Aminocaproic acid",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Caution if using additional/concurrent drugs with sedative or CNS depressive effects",
                "interactions": "",
                "adverse_effects": "Poorly described in vet med",
                "deleted_at": null,
                "created_at": "2020-05-06T16:13:29.000000Z",
                "updated_at": "2020-11-04T02:26:49.000000Z"
            },
            {
                "id": 24,
                "guid": "24",
                "name": "Aminopentamide",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Gastrointestinal tract obstruction\nIleus\nUrethral obstruction\nGlaucoma\nGastrointestinal disease associated with sepsis",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:14:21.000000Z",
                "updated_at": "2020-05-06T16:14:21.000000Z"
            },
            {
                "id": 25,
                "guid": "25",
                "name": "Aminophylline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "10-20 µg/mL (as theophylline)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nCaution if using additional/concurrent drugs with sedative or CNS depressive effects",
                "interactions": "Central nervous system stimulants may trigger cumulative effects\nfluoroquinolones inhibit metabolism, potentially leading to toxic serum aminophylline levels",
                "adverse_effects": "Signs of toxicosis resemble chocolate intoxication -since theobromine is one of the toxic principles in chocolate- and caffeine: excitability, hyperesthesia, tremor, seizures",
                "deleted_at": null,
                "created_at": "2020-05-06T16:15:10.000000Z",
                "updated_at": "2020-05-06T16:15:10.000000Z"
            },
            {
                "id": 26,
                "guid": "26",
                "name": "Amiodarone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Bradycardia, including AV block \n Liver dysfunction \n Uncontrolled hypothyroidism \n Possibly pre-existing autoimmune disease \n Hypersensitivity to the drug",
                "interactions": "Drugs that alter cytochrome/CYP enzyme function, including cyclosporine, ketoconazole, cimetidine, and digoxin (increased serum concentration of amiodarone or of the co-drug)\r\nany potentially hepatotoxic drug (cumulative hepatotoxic effect)",
                "adverse_effects": "Numerous \n In dogs: hepatopathy (rising liver enzymes), autoimmunity (positive autoagglutination of red blood cells), hypothyroidism, and keratopathy (at least 16% prevalence, may be higher with sunlight, may be reversible)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:16:24.000000Z",
                "updated_at": "2020-11-04T02:27:43.000000Z"
            },
            {
                "id": 27,
                "guid": "27",
                "name": "Amitraz",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Atipamezole",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing signs resembling toxicosis\nDiabetes mellitus (amitraz application raises blood glucose levels for hours)",
                "interactions": "May potentiate/be potentiated by monoamine oxidase inhibitors (e.g., selegiline), alpha-2 agonists (e.g., dexmedetomidine), tramadol, risking serotonin syndrome",
                "adverse_effects": "Depression and lethargy (8-35% of cases), vomiting, diarrhea, hypothermia, ataxia with topical use\nRisk of adverse effects is greater if licked/ingested\nCan cause headaches, skin rashes, asthma attacks in humans\nAmitraz is flammable (prior to dilution)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:17:42.000000Z",
                "updated_at": "2020-05-06T16:17:42.000000Z"
            },
            {
                "id": 28,
                "guid": "28",
                "name": "Amitriptyline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "If given with anticholinergic drugs, may cause paralytic ileus\nMay potentiate/be potentiated by monoamine oxidase inhibitors (e.g., selegiline), tramadol, risking serotonin syndrome",
                "adverse_effects": "Lethargy (2/17 dogs [12%])\nSomnolence at start of treatment (15% of cats), weight gain (78% of cats), decreased grooming/decreased coat quality (89% of cats), transient cystic calculi (45% of cats)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:18:36.000000Z",
                "updated_at": "2020-05-06T16:18:36.000000Z"
            },
            {
                "id": 29,
                "guid": "29",
                "name": "Amlodipine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypotension\nHypersensitivity to the drug",
                "interactions": "Cumulative effect possible with other antihypertensives",
                "adverse_effects": "Gingival hyperplasia in 8.5% of treated dogs (reversible in 2 weeks with discontinuation of drug)\nIn cats, transdermal formulation is less effective or ineffective",
                "deleted_at": null,
                "created_at": "2020-05-06T16:19:35.000000Z",
                "updated_at": "2020-05-06T16:19:35.000000Z"
            },
            {
                "id": 30,
                "guid": "30",
                "name": "Ammonium chloride",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Acidemia/acidosis\nSystemic disease predisposing to acidosis, notably kidney disease\nHypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:21:22.000000Z",
                "updated_at": "2020-05-06T16:21:22.000000Z"
            },
            {
                "id": 31,
                "guid": "31",
                "name": "Amoxicillin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Rodent studies suggest amoxicillin is generally safe in pregnancy and lactation",
                "contraindications": "Hypersensitivity to the drug, both humans handling the drug (penicillin allergy) and animals receiving it\nResistant infections (common: 6% rate of single drug resistance and 28% rate of multidrug resistance including amoxicillin for E. coli infections in dogs)\nIneffective for borreliosis/Lyme disease\nLack of benefit in feline upper respiratory infection",
                "interactions": "Synergistic antibacterial effect with aminoglycosides (but not synergistic for adverse/toxic effects)\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Occasional anorexia, inappetence, vomiting, which resolve with discontinuation of the drug\nFanconi syndrome associated with amoxicillin treatment in a dog\nAmong the lowest reported rate of adverse effects (7.5%) for antibacterials according to owner surveys",
                "deleted_at": null,
                "created_at": "2020-05-06T16:22:25.000000Z",
                "updated_at": "2020-05-06T16:22:25.000000Z"
            },
            {
                "id": 32,
                "guid": "32",
                "name": "Amoxicillin + clavulanic acid",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Rodent studies suggest amoxicillin is generally safe in pregnancy and lactation",
                "contraindications": "Hypersensitivity to the drug, both humans handling the drug (penicillin allergy) and animals",
                "interactions": "Synergistic antibacterial effect with aminoglycosides (but not synergistic for adverse/toxic effects)\r\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Occasional anorexia, inappetence, vomiting, which resolve with discontinuation of the drug",
                "deleted_at": null,
                "created_at": "2020-05-06T16:25:05.000000Z",
                "updated_at": "2020-11-04T16:52:26.000000Z"
            },
            {
                "id": 33,
                "guid": "33",
                "name": "Amphotericin B",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Compatible with sterile water (for reconstitution) and 5% dextrose (for infusion) but not NaCl\nAvoid concurrent administration with other drugs that have nephrotoxic potential (e.g., aminoglycoside antibacterials) or that can foster prerenal azotemia (e.g., diuretics)\nRare hypokalemia",
                "adverse_effects": "Nephrotoxicosis is common\nIt is significantly reduced if the infusion is given slowly (5 hours) rather than quickly (25 minutes)\nOngoing monitoring is essential during administration (BUN, creatinine, urine specific gravity before each dose)\nVesicant\nAvoid extravasation to reduce risk of perivascular sloughing\nUncommon allergic/hyperthermic reactions\nDrug may play a role in the development of calcinosis cutis in rare cases",
                "deleted_at": null,
                "created_at": "2020-05-06T16:27:51.000000Z",
                "updated_at": "2020-05-06T16:27:51.000000Z"
            },
            {
                "id": 34,
                "guid": "34",
                "name": "Amphotericin B, liposomal encapsulated",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Compatible with sterile water (for reconstitution) and 5% dextrose (for infusion) - *incompatible* with 0.9% NaCl and others\nAvoid concurrent administration with other drugs that have nephrotoxic potential (e.g., aminoglycoside antibacterials) or that can foster prerenal azotemia (e.g., diuretics)\nRare hypokalemia",
                "adverse_effects": "Nephrotoxicosis is rare at 4 mg/kg q 24h and appears much less severe than with standard amphotericin B",
                "deleted_at": null,
                "created_at": "2020-05-06T16:28:49.000000Z",
                "updated_at": "2020-05-06T16:28:49.000000Z"
            },
            {
                "id": 35,
                "guid": "35",
                "name": "Amphotericin B lipid complex",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Compatible with 5% dextrose (for infusion) - do not use other fluid types\nAvoid concurrent administration with other drugs that have nephrotoxic potential (e.g., aminoglycoside antibacterials) or that can foster prerenal azotemia (e.g., diuretics)\nRare hypokalemia",
                "adverse_effects": "Nephrotoxicosis is rare at 4 mg/kg q 24h and appears much less severe than with standard amphotericin B",
                "deleted_at": null,
                "created_at": "2020-05-06T16:29:40.000000Z",
                "updated_at": "2020-05-06T16:29:40.000000Z"
            },
            {
                "id": 36,
                "guid": "36",
                "name": "Ampicillin sodium",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug, both humans handling the drug (penicillin allergy) and animals",
                "interactions": "Ampicillin inactivates gentamicin and other aminoglycosides in bottles/vials/joints (intra-articular injections), etc., so avoid combining in same syringe, fluid line, or any other compartment\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Rare autoimmune (pemphigus-like) adverse reaction",
                "deleted_at": null,
                "created_at": "2020-05-06T16:30:27.000000Z",
                "updated_at": "2020-05-06T16:30:27.000000Z"
            },
            {
                "id": 37,
                "guid": "37",
                "name": "Ampicillin + sulbactam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug, both humans handling the drug (penicillin allergy) and animals",
                "interactions": "Ampicillin inactivates gentamicin and other aminoglycosides in bottles/vials/joints (intra-articular injections), etc., so avoid combining in same syringe, fluid line, or any other compartment\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:32:17.000000Z",
                "updated_at": "2020-05-06T16:32:17.000000Z"
            },
            {
                "id": 38,
                "guid": "38",
                "name": "Amprolium",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Possibility of thiamin-induced central nervous system lesions in developing pups",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:32:55.000000Z",
                "updated_at": "2020-05-06T16:32:55.000000Z"
            },
            {
                "id": 39,
                "guid": "39",
                "name": "Apomorphine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Naloxone reverses central nervous system effects (but not emetic effects) - potentially attractive when patient has ingested a substance that is causing CNS depression, where exacerbation of the depression needs to be avoided (but emesis is desired)",
                "teratogenicity": null,
                "contraindications": "Ingestion of petroleum distillates, acids, or alkalis\nEsophageal obstruction\nUnconsciousness/loss of gag reflex\nHypersensitivity to the drug\nAvoid in cats (opiate)",
                "interactions": "Effects negated by antiemetics (e.g., maropitant, ondansetron)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:33:38.000000Z",
                "updated_at": "2020-05-06T16:33:38.000000Z"
            },
            {
                "id": 40,
                "guid": "40",
                "name": "Ascorbic acid",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:34:50.000000Z",
                "updated_at": "2020-05-06T16:34:50.000000Z"
            },
            {
                "id": 41,
                "guid": "41",
                "name": "L-asparaginase",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug is a relative contraindication\nPretreatment with antihistamine and further use of L-asparaginase may increase longevity",
                "interactions": null,
                "adverse_effects": "Recognized concern for hypersensitivity/anaphylaxis (8% of cases, despite diphenhydramine pretreatment - occurs within 24 hours of dosing)\nUncommon occurrence of severe acute tumor lysis syndrome\nRare single cases of pancreatitis, of hyperammonemia\nGenerally considered one of the safest anticancer drugs",
                "deleted_at": null,
                "created_at": "2020-05-06T16:35:37.000000Z",
                "updated_at": "2020-05-06T16:35:37.000000Z"
            },
            {
                "id": 42,
                "guid": "42",
                "name": "Atenolol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Isoproterenol",
                "teratogenicity": "",
                "contraindications": "Bradycardia \n Hypotension \n Active congestive heart failure \n Sinus tachycardia in a patient with systemic signs (atenolol is contraindicated as monotherapy), because sinus tachycardia in a patient with systemic signs can exists in response to a primary cause (hypovolemia, systemic inflammation, anemia, etc.) and suppression of sinus tachycardia with a beta-blocker, without correcting of the primary cause, can cause hemodynamic collapse and cardiac arrest \n No convincing long-term benefit for hypertrophic cardiomyopathy in cats",
                "interactions": "",
                "adverse_effects": "Generally very safe drug \n Inappetence, lethargy in marked overdoses or debilitated patients",
                "deleted_at": null,
                "created_at": "2020-05-06T16:37:28.000000Z",
                "updated_at": "2020-11-04T02:28:02.000000Z"
            },
            {
                "id": 43,
                "guid": "43",
                "name": "Atipamezole",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T16:39:12.000000Z",
                "updated_at": "2020-11-04T02:28:14.000000Z"
            },
            {
                "id": 44,
                "guid": "44",
                "name": "Atovaquone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Tetracycline, metoclopramide significantly decrease atovaquone plasma levels (avoid such cotreatments)",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T16:40:04.000000Z",
                "updated_at": "2020-11-04T02:28:22.000000Z"
            },
            {
                "id": 45,
                "guid": "45",
                "name": "Atracurium",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "To reverse neuromuscular blockade, administer atropine 0.02-0.04 mg/kg IV, then 1 minute later either neostigmine 0.06-0.1 mg/kg or edrophonium 2.5 mg/kg (can repeat atropine and either neostigmine or edrophonium if no visible effects of reversal after 5 minutes)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nDisorders requiring analgesia and/or general anesthesia (atracurium is incomplete treatment)",
                "interactions": "Compatible with 0.9% NaCl and 5% dextrose",
                "adverse_effects": "Respiratory muscle paralysis if excessive administration\nMonitor respiratory rate, jaw tone, capnometry, and nerve conduction velocity",
                "deleted_at": null,
                "created_at": "2020-05-06T16:41:09.000000Z",
                "updated_at": "2020-05-06T16:41:09.000000Z"
            },
            {
                "id": 46,
                "guid": "46",
                "name": "Atropine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Pre-existing tachycardia, especially ventricular or supraventricular tachyarrhythmias\nIleus\nGlaucoma",
                "interactions": null,
                "adverse_effects": "Tachycardia\nIleus\nXerostomia",
                "deleted_at": null,
                "created_at": "2020-05-06T16:41:57.000000Z",
                "updated_at": "2020-05-06T16:41:57.000000Z"
            },
            {
                "id": 47,
                "guid": "47",
                "name": "Attapulgite",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound\nGastrointestinal obstruction\nSigns of systemic illness (e.g., dehydration, weakness) suggesting that additional care is necessary",
                "interactions": "May nonspecifically decrease the absorption of other drugs",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:43:17.000000Z",
                "updated_at": "2020-05-06T16:43:17.000000Z"
            },
            {
                "id": 48,
                "guid": "48",
                "name": "Auranofin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Diarrhea may occur at 0.2 mg/kg q 12h\nReduction to 0.2 mg/kg q 24h resolved the diarrhea\nThrombocytopenia occurs with chronic, higher dosages (e.g., 1.2 mg/kg q 12h)\nNephrotoxicosis possible",
                "deleted_at": null,
                "created_at": "2020-05-06T16:44:12.000000Z",
                "updated_at": "2020-05-06T16:44:12.000000Z"
            },
            {
                "id": 49,
                "guid": "49",
                "name": "Aurothioglucose",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Thrombocytopenia and clinical bleeding in at least 1 dog\nonset of oral lesions has coincided with therapy\nAnecdotal reports of life-threatening adverse reactions in dogs\nNephrotoxicosis possible",
                "deleted_at": null,
                "created_at": "2020-05-06T16:44:45.000000Z",
                "updated_at": "2020-05-06T16:44:45.000000Z"
            },
            {
                "id": 50,
                "guid": "50",
                "name": "Azathioprine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Caution re. handling by humans (avoid splitting or crushing tablets)",
                "contraindications": "Hypersensitivity to the drug  \n  Pre-existing neutropenia, sepsis, or infection",
                "interactions": "Allopurinol increases serum azathioprine levels 3- to 4-fold (adjust accordingly)\r\nACE inhibitors increase risk of anemia in humans taking azathioprine",
                "adverse_effects": "Myelotoxicosis, especially neutropenia/opportunistic infections  \n  Cases reported in dogs including weight gain, hypotrichosis, hepatopathy (increased liver enzyme activity, diabetes mellitus, keratoconjunctivitis sicca, mammary gland adenoma, hepatic masses, lymphoma",
                "deleted_at": null,
                "created_at": "2020-05-06T16:45:27.000000Z",
                "updated_at": "2020-11-04T16:50:57.000000Z"
            },
            {
                "id": 51,
                "guid": "51",
                "name": "Azithromycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T16:46:45.000000Z",
                "updated_at": "2020-11-04T02:29:14.000000Z"
            },
            {
                "id": 52,
                "guid": "52",
                "name": "Benazepril",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug  \n  Hypotension/hypovolemia",
                "interactions": "Cumulative effect of hyperkalemia possible with spironolactone but uncommon at clinically normal dosages with adequate renal function",
                "adverse_effects": "Azotemia (minimal risk if animal eating well, euvolemic, and receiving standard dosage)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:49:00.000000Z",
                "updated_at": "2020-11-04T16:01:52.000000Z"
            },
            {
                "id": 53,
                "guid": "53",
                "name": "Bethanechol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Physical obstruction to urinary bladder outflow\nHypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Cholinergic (parasympathetic) signs: hypersalivation, miosis, diarrhea (may be dose-dependent)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:51:29.000000Z",
                "updated_at": "2020-05-06T16:51:29.000000Z"
            },
            {
                "id": 54,
                "guid": "54",
                "name": "Bisacodyl",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nIleus",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T16:52:49.000000Z",
                "updated_at": "2020-05-06T16:52:49.000000Z"
            },
            {
                "id": 55,
                "guid": "55",
                "name": "Bismuth subsalicylate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to salicylate compounds in general (e.g., aspirin)",
                "interactions": null,
                "adverse_effects": "Warn owners that greyish-black stools are expected when an animal is taking this medication\nNote that the tablet form is highly radiopaque and should not be mistaken for metal on radiographs (appearance is identical to a coin)\nPotential toxicity to cats due to salicylate component",
                "deleted_at": null,
                "created_at": "2020-05-06T16:54:09.000000Z",
                "updated_at": "2020-05-06T16:54:09.000000Z"
            },
            {
                "id": 56,
                "guid": "56",
                "name": "Bismuth subcarbonate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound\nGastrointestinal obstruction\nSigns of systemic illness (e.g., dehydration, weakness) suggesting that additional care is necessary",
                "interactions": "May nonspecifically decrease the absorption of other drugs",
                "adverse_effects": "Warn owners that greyish-black stools are expected when an animal is taking this medication",
                "deleted_at": null,
                "created_at": "2020-05-06T16:55:38.000000Z",
                "updated_at": "2020-05-06T16:55:38.000000Z"
            },
            {
                "id": 57,
                "guid": "57",
                "name": "Bleomycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Human teratogen - instructions for proper handing and precautions (clients, veterinary staff) are essential.   Carcinogenic and fetotoxic potential.",
                "contraindications": "Hypersensitivity to the drug \n Pregnancy",
                "interactions": "Avoid if patient is receiving nephrotoxic drugs (cisplatin, aminoglycoside antibacterials, etc.) because may compromise renal route of excretion",
                "adverse_effects": "Uncommon \n Wound formation/dehiscence (possibly with bone exposure) has been reported with intralesional use \n Mild tissue reactions, local swelling/infection possible \n Cutaneous erythema and pulmonary fibrosis (both can occur with systemic bleomycin use in humans, especially with cumulative dose >300 mg/m²) has not been reported in dogs or cats",
                "deleted_at": null,
                "created_at": "2020-05-06T16:56:29.000000Z",
                "updated_at": "2020-11-04T16:07:57.000000Z"
            },
            {
                "id": 58,
                "guid": "58",
                "name": "Bromide, potassium",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "1.8 +/- 0.6 mg/mL (lower may be acceptable if cotreatment with other anticonvulsants is in effect)",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Higher dietary chloride enhances bromide elimination, predisposing to subtherapeutic concentrations",
                "adverse_effects": "Dogs: bromism (bromide toxicosis) manifests as ataxia, altered consciousness, and upper or motor neuron para-or tetraparesis   \n   Excessively high dosage, typically associated with failure to monitor serum levels, is a major predisposing cause   \n   Full resolution of clinical signs takes weeks because of long half-life   \n   Cats: mild to severe (has been fatal), chronic (may occur after months of therapy) airway disease, characterized by asthma-like signs, lipid pneumonia, and requiring discontinuation of therapy and treatment with glucocorticoids  \n  Bromide-associated panniculitis suspected in 2 canine cases",
                "deleted_at": null,
                "created_at": "2020-05-06T16:57:47.000000Z",
                "updated_at": "2020-11-04T16:49:01.000000Z"
            },
            {
                "id": 59,
                "guid": "59",
                "name": "Bromocriptine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Abortefacient;also inhibits lactation",
                "contraindications": "Desired pregnancy\nNormally-lactating dams\nHypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Vomiting (20% of treated dogs)",
                "deleted_at": null,
                "created_at": "2020-05-06T16:58:50.000000Z",
                "updated_at": "2020-05-06T16:58:50.000000Z"
            },
            {
                "id": 60,
                "guid": "60",
                "name": "Budesonide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n May exacerbate pre-existing hypercortisol states, e.g., hyperadrenocorticism",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T17:00:35.000000Z",
                "updated_at": "2020-11-04T17:23:32.000000Z"
            },
            {
                "id": 61,
                "guid": "61",
                "name": "Bunamidine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing cardiac arrhythmias and/or structural heart disease",
                "interactions": null,
                "adverse_effects": "Sudden death (suspected due to life-threatening cardiac arrhythmias) described in several dogs receiving the drug",
                "deleted_at": null,
                "created_at": "2020-05-06T17:01:30.000000Z",
                "updated_at": "2020-05-06T17:01:30.000000Z"
            },
            {
                "id": 62,
                "guid": "62",
                "name": "Bupivacaine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Do not use solutions that contain preservatives (e.g., most multi-dose vials) for epidural or intrathecal infusion",
                "interactions": "",
                "adverse_effects": "Intraarticular use apperars to be cytotoxic to chondrocytes and use is controversial \n In cats, there are reports of severe but reversible neurologic deficits following retrobulbar or mandibular block in this species",
                "deleted_at": null,
                "created_at": "2020-05-06T17:02:05.000000Z",
                "updated_at": "2020-11-04T18:19:22.000000Z"
            },
            {
                "id": 63,
                "guid": "63",
                "name": "Buprenorphine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Peak plasma concentration of 14.8 ng/mL observed 30 minutes after buccal administration in cats, and is associated with oral analgesia",
                "reversal_agent": "Naloxone is less effective at reversing effects of buprenorphine than effects of other opiates\n therefore, treatment of severe overdoses (causing apnea) may need to include mechanical ventilation",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Slower metabolism (and therefore higher serum levels) if concurrent administration of ketoconazole, erythromycin, or other inhibitors of hepatic CYP3A4 enzyme activity",
                "adverse_effects": "Wide margin of safety \n Severe overdoses may be life-threatening via apnea",
                "deleted_at": null,
                "created_at": "2020-05-06T17:05:36.000000Z",
                "updated_at": "2020-11-04T20:17:15.000000Z"
            },
            {
                "id": 64,
                "guid": "64",
                "name": "Buspirone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cotreatment with monoamine oxidase (MAO) inhibitors like selegiline may cause systemic hypertension",
                "adverse_effects": "Renal insufficiency and/or hepatic insufficiency may increase serum levels",
                "deleted_at": null,
                "created_at": "2020-05-06T17:08:04.000000Z",
                "updated_at": "2020-05-06T17:08:04.000000Z"
            },
            {
                "id": 65,
                "guid": "65",
                "name": "Butorphanol",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Naloxone may partially reverse butorphanol",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Sedation is rarely observed with antitussive dosages",
                "deleted_at": null,
                "created_at": "2020-05-06T17:08:57.000000Z",
                "updated_at": "2020-11-04T20:18:42.000000Z"
            },
            {
                "id": 66,
                "guid": "66",
                "name": "Cabergoline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Abortefacient\ncontraindicated in pregnant animals when the pregnancy is intended to go to term",
                "contraindications": "Hypersensitivity to the drug \n Pregnancy (intended)",
                "interactions": "",
                "adverse_effects": "Acute, mild vomiting, diarrhea, tenesmus, and weakness may occur, especially within 60 minutes of treatment, but some or all of these signs may also be caused by cotreatment (especially prostaglandin) \n No alterations in serum drug levels with mild or moderate renal or hepatic insufficiency (humans) \n Humans treated chronically may develop heart valve fibrosis, but the shorter duration clinical applications in dogs and cats has not been reported to trigger or worsens valve disease",
                "deleted_at": null,
                "created_at": "2020-05-06T17:11:58.000000Z",
                "updated_at": "2020-11-04T20:22:04.000000Z"
            },
            {
                "id": 67,
                "guid": "67",
                "name": "Calcitonin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypocalcemia",
                "interactions": null,
                "adverse_effects": "Uncommon local tissue inflammation, vomiting",
                "deleted_at": null,
                "created_at": "2020-05-06T17:14:13.000000Z",
                "updated_at": "2020-05-06T17:14:13.000000Z"
            },
            {
                "id": 68,
                "guid": "68",
                "name": "Calcitriol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Hypercalcemia",
                "interactions": "Coadministration of thiazide diuretics may increase serum calcium levels\r\nFurosemide may lower serum calcium levels\r\nKetoconazole may alter (raise or lower) endogenous calcitriol levels",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T17:15:09.000000Z",
                "updated_at": "2020-11-04T20:40:43.000000Z"
            },
            {
                "id": 69,
                "guid": "69",
                "name": "Calcium carbonate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation\nHypercalcemia",
                "interactions": null,
                "adverse_effects": "Caution: treatment of hypocalcemia with calcium carbonate plus vitamin D has caused hypercalcemia in dogs\nMonitoring of serum calcium during treatment is essential",
                "deleted_at": null,
                "created_at": "2020-05-06T17:16:06.000000Z",
                "updated_at": "2020-05-06T17:16:06.000000Z"
            },
            {
                "id": 70,
                "guid": "70",
                "name": "Calcium chloride",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the preparation \n Hypercalcemia",
                "interactions": "",
                "adverse_effects": "No observable discomfort on intratesticular injections compared to placebo \n Possible vesicant (avoid extravasation)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:18:41.000000Z",
                "updated_at": "2020-11-04T20:44:24.000000Z"
            },
            {
                "id": 71,
                "guid": "71",
                "name": "Calcium disodium EDTA",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation\nAnuria\nRenal and/or hepatic dysfunction",
                "interactions": null,
                "adverse_effects": "Nephrotoxicosis may rival lead-induced renal damage, so euvolemia/normal hydration, and fluid diuresis, are essential leading up to and during treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T17:20:16.000000Z",
                "updated_at": "2020-05-06T17:20:16.000000Z"
            },
            {
                "id": 72,
                "guid": "72",
                "name": "Calcium gluconate",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation\nHypercalcemia",
                "interactions": null,
                "adverse_effects": "SC administration, once very common, is recognized to cause unpredictable dermal necrosis and calcinosis cutis",
                "deleted_at": null,
                "created_at": "2020-05-06T17:20:59.000000Z",
                "updated_at": "2020-05-06T17:20:59.000000Z"
            },
            {
                "id": 73,
                "guid": "73",
                "name": "Captopril",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Like all ACE inhibitors, this drug is strictly contraindicated in pregnancy (fetal renal dysfunction, fetal lung hypoplasia, fetal skeletal malformations, and fetal death)",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": "Cumulative effect possible with potassium-sparing diuretics (e.g., spironolactone), leading to hyperkalemia - appears rare",
                "adverse_effects": "Rare cases of angioedema",
                "deleted_at": null,
                "created_at": "2020-05-06T17:23:07.000000Z",
                "updated_at": "2020-05-06T17:23:07.000000Z"
            },
            {
                "id": 74,
                "guid": "74",
                "name": "Carbenicillin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Avoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Unconfirmed/rare reports of induced platelet dysfunction",
                "deleted_at": null,
                "created_at": "2020-05-06T17:24:07.000000Z",
                "updated_at": "2020-05-06T17:24:07.000000Z"
            },
            {
                "id": 75,
                "guid": "75",
                "name": "Carbimazole",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "May cross placenta, secreted in milk (risk of fetal, neonatal hypothyroidism respectively)",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Vomiting, inappetence, lethargy reported in a minority of treated cats \n Worsening renal function is common due to comorbid chronic kidney disease and regular monitoring is recommended, with dosage adjustments if necessary \n Hematological adverse effects have been documented in treated cats, including fatal outcomes\na case report of vasculitis associated with treatment also exists",
                "deleted_at": null,
                "created_at": "2020-05-06T17:24:34.000000Z",
                "updated_at": "2020-11-04T20:47:21.000000Z"
            },
            {
                "id": 76,
                "guid": "76",
                "name": "Carboplatin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Lithium (thought to reduce/prevent thrombocytopenia) instead has been shown to fail to do so[1]",
                "teratogenicity": "Human teratogen - instructions for proper handing and precautions (clients, veterinary staff) are essential.  Fetotoxic and carcinogenic potential.",
                "contraindications": "Hypersensitivity to the drug    \n    Pre-existing neutropenia    \n    Thrombocytopenia    \n    Severe gastrointestinal disease (other than neoplastic if treatment is intended to improve GI tract infiltration)",
                "interactions": "Nephrotoxic drugs may compound a similar effect in carboplatin and should be avoided if possible",
                "adverse_effects": "Neutropenia (8.6% of dogs, 27.2% of cats), which forces a rescheduling of planned treatment to 1 week later and self-resolves in majority of cases during that time    \n    GI toxicosis (19% of dogs, especially smaller breeds)    \n    Moderate toxicosis (in the form of neutropenia, thrombocytopenia) is expected in 50% of dogs receiving 340 mg/m², and severe toxicosis in 5% of dogs receiving 278 mg/m²    \n    The nadirs in neutrophil and platelet counts are expected 14 days after treatment in dogs and cats    \n    No evidence of pulmonary or renal toxicity in cats (vs. cisplatin)   \n   Hemorrhagic cystitis reported rarely in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T17:25:48.000000Z",
                "updated_at": "2020-11-04T21:23:48.000000Z"
            },
            {
                "id": 77,
                "guid": "77",
                "name": "Carmustine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Human teratogen and carcinogen - instructions for proper handing and precautions (clients, veterinary staff) are essential.  Fetotoxic potential.",
                "contraindications": "Hypersensitivity to the drug\nPre-existing neutropenia",
                "interactions": "Caution if combining with other drugs that affect the bone marrow (risk of cumulative neutropenic effect)",
                "adverse_effects": "Neutropenia occurs in virtually all cases and is likely dose-limiting",
                "deleted_at": null,
                "created_at": "2020-05-06T17:28:31.000000Z",
                "updated_at": "2020-05-06T17:28:31.000000Z"
            },
            {
                "id": 78,
                "guid": "78",
                "name": "Carnitine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T17:29:01.000000Z",
                "updated_at": "2020-11-04T21:33:51.000000Z"
            },
            {
                "id": 79,
                "guid": "79",
                "name": "Carprofen",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Avoid concurrent use of other nonsteroidal anti-inflammatories and/or glucocorticoids",
                "adverse_effects": "Hepatotoxicosis in some dogs given normal therapeutic doses \n Fecal occult blood documented in dogs but overall produces the least adverse GI effects of the NSAIDs \n Long-term administration may delay bone healing (similar to other NSAIDs) \n Prolongs coagulation times but not to a clinically-relevant effect in otherwise healthy dogs\nCoprophagia has been implicated in relay toxicosis in one canine case",
                "deleted_at": null,
                "created_at": "2020-05-06T17:29:51.000000Z",
                "updated_at": "2020-11-04T21:44:43.000000Z"
            },
            {
                "id": 80,
                "guid": "80",
                "name": "Carvedilol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Isoproterenol",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nAsthma/airway disease\nBradycardia (sinus, 3rd or advanced 2nd degree AV block, sick sinus syndrome, atrial standstill)\nHypotension/hypovolemic shock\nSevere liver dysfunction\nSinus tachycardia in a patient with systemic signs (carvedilol is contraindicated as monotherapy), because sinus tachycardia in a patient with systemic signs can exists in response to a primary cause (hypovolemia, systemic inflammation, anemia, etc.) and suppression of sinus tachycardia with a beta-blocker, without correcting of the primary cause, can cause hemodynamic collapse and cardiac arrest",
                "interactions": "May raise serum concentrations of calcium-channel blockers, cyclosporine, digoxin",
                "adverse_effects": "Hypotension, bradycardia, iatrogenic congestive heart failure/triggering of cardiac decompensation can occur if treatment is initiated with a dosage that is too high, notably in patients with moderate to advanced structural valvular or myocardial disease",
                "deleted_at": null,
                "created_at": "2020-05-06T17:32:05.000000Z",
                "updated_at": "2020-05-06T17:32:05.000000Z"
            },
            {
                "id": 81,
                "guid": "81",
                "name": "Caspofungin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Use only sterile 0.9% NaCl or sterile water for reconstitution\nDo NOT reconstitute with dextrose (drug is unstable in dextrose-containing solutions)\nCotreatment with cyclosporine increases plasma caspofungin levels (by 35%) but not vice-versa\nMay require slightly higher dose if coadministration with drugs that induce clearance (e.g., dexamethasone, phenobarbital, etc.)",
                "adverse_effects": "Possibility of liver enzyme elevation, and vomiting during administration (extrapolation from humans, as veterinary data is very sparse)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:33:12.000000Z",
                "updated_at": "2020-05-06T17:33:12.000000Z"
            },
            {
                "id": 82,
                "guid": "82",
                "name": "Cefaclor",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "Possibility of GI bacterial overgrowth and superinfection (as with many antibacterials)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:33:41.000000Z",
                "updated_at": "2020-05-06T17:33:41.000000Z"
            },
            {
                "id": 83,
                "guid": "83",
                "name": "Cefadroxil",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": "",
                "adverse_effects": "Vomiting (13% of dogs) that may or may not recur when restarting the medication after a pause in treatment \n Possibility of GI bacterial overgrowth and superinfection (as with any antibacterial)\nRare instance of severe dermatologic adverse reaction in one feline case report (Sgevens-Johnson syndrome)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:34:27.000000Z",
                "updated_at": "2020-11-04T21:46:11.000000Z"
            },
            {
                "id": 84,
                "guid": "84",
                "name": "Cefamandole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:36:02.000000Z",
                "updated_at": "2020-05-06T17:36:02.000000Z"
            },
            {
                "id": 85,
                "guid": "85",
                "name": "Cefazolin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": "",
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation) \n Possibility of GI bacterial overgrowth and superinfection, as with many antibacterial\nInadvertent intrathecal injection caused status epilepticus in 1 canine case report (recovery and discharge from hospital after 4 days of intensive care, no recurrence for >9 months)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:36:32.000000Z",
                "updated_at": "2020-11-04T21:48:53.000000Z"
            },
            {
                "id": 86,
                "guid": "86",
                "name": "Cefepime",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:37:43.000000Z",
                "updated_at": "2020-05-06T17:37:43.000000Z"
            },
            {
                "id": 87,
                "guid": "87",
                "name": "Cefixime",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "Possibility of GI bacterial overgrowth and superinfection (as with many antibacterials)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:38:13.000000Z",
                "updated_at": "2020-05-06T17:38:13.000000Z"
            },
            {
                "id": 88,
                "guid": "88",
                "name": "Cefoperazone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:39:07.000000Z",
                "updated_at": "2020-05-06T17:39:07.000000Z"
            },
            {
                "id": 89,
                "guid": "89",
                "name": "Cefotaxime",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:39:43.000000Z",
                "updated_at": "2020-05-06T17:39:43.000000Z"
            },
            {
                "id": 90,
                "guid": "90",
                "name": "Cefotetan",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:40:17.000000Z",
                "updated_at": "2020-05-06T17:40:17.000000Z"
            },
            {
                "id": 91,
                "guid": "91",
                "name": "Cefovecin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": "Coadministration with carprofen, doxycycline, furosemide, or ketoconazole causes increased circulating levels of these drugs",
                "adverse_effects": "Possibility of GI bacterial overgrowth and superinfection (as with many antibacterials)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:41:03.000000Z",
                "updated_at": "2020-11-05T19:46:43.000000Z"
            },
            {
                "id": 92,
                "guid": "92",
                "name": "Cefoxitin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": "",
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation) \n Possibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:42:12.000000Z",
                "updated_at": "2020-11-05T19:53:23.000000Z"
            },
            {
                "id": 93,
                "guid": "93",
                "name": "Cefpodoxime",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": "",
                "adverse_effects": "Possibility of GI bacterial overgrowth and superinfection (as with many antibacterials)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:42:46.000000Z",
                "updated_at": "2020-11-05T20:30:51.000000Z"
            },
            {
                "id": 94,
                "guid": "94",
                "name": "Ceftazidime",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:43:26.000000Z",
                "updated_at": "2020-05-06T17:43:26.000000Z"
            },
            {
                "id": 95,
                "guid": "95",
                "name": "Ceftiofur",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "Possibility of GI bacterial overgrowth and superinfection (as with many antibacterials)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:44:46.000000Z",
                "updated_at": "2020-05-06T17:44:46.000000Z"
            },
            {
                "id": 96,
                "guid": "96",
                "name": "Ceftriaxone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)\nHyperbilirubinemia (ceftriaxone displaces bilirubin from its plasma binding site, increasing serum free bilirubin concentration)",
                "interactions": "Do not administer with calcium-containing fluids (e.g., lactated Ringer's solution), as crystallization in vivo has been identified, as well as crystallization in the IV set",
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:45:21.000000Z",
                "updated_at": "2020-05-06T17:45:21.000000Z"
            },
            {
                "id": 97,
                "guid": "97",
                "name": "Cefuroxime",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "May cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:46:20.000000Z",
                "updated_at": "2020-05-06T17:46:20.000000Z"
            },
            {
                "id": 98,
                "guid": "98",
                "name": "Cephalexin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": "",
                "adverse_effects": "Frequent reports of mild vomiting, inappetence, diarrhea, warranting discontinuation or pause in treatment \n Possibility of GI bacterial overgrowth and superinfection (as with any antibacterial)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:47:11.000000Z",
                "updated_at": "2020-11-05T20:32:27.000000Z"
            },
            {
                "id": 99,
                "guid": "99",
                "name": "Cephalothin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cephalosporins (and/or hypersensitivity to penicillins)",
                "interactions": null,
                "adverse_effects": "Decreases platelet function, increasing bleeding time (questionable clinical significance)\nMay cause pain and sterile abscesses when injected SC\nMay cause vomiting if injected IV too rapidly (central - chemoreceptor trigger zone stimulation)\nPossibility of GI bacterial overgrowth and superinfection, as with many antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T17:48:27.000000Z",
                "updated_at": "2020-05-06T17:48:27.000000Z"
            },
            {
                "id": 100,
                "guid": "100",
                "name": "Cetirizine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to hydroxyzine",
                "interactions": "",
                "adverse_effects": "Acute vomiting (may or may not require termination of treatment) in 9% of dogs that receive the drug",
                "deleted_at": null,
                "created_at": "2020-05-06T17:49:03.000000Z",
                "updated_at": "2020-11-05T20:33:35.000000Z"
            },
            {
                "id": 101,
                "guid": "101",
                "name": "Chitosan-based phosphate binder",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation\nHypercalcemia",
                "interactions": null,
                "adverse_effects": "Anecdotal reports of treatment-induced hypercalcemia",
                "deleted_at": null,
                "created_at": "2020-05-06T17:50:17.000000Z",
                "updated_at": "2020-05-06T17:50:17.000000Z"
            },
            {
                "id": 102,
                "guid": "102",
                "name": "Chlorambucil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Contraindicated in pregnancy, with fetal harm (notably renal agenesis) documented in several species.  Human teratogen and carcinogen - instructions for proper handing and precautions (clients, veterinary staff) are essential.",
                "contraindications": "Hypersensitivity to the drug \n History of resistance to the drug",
                "interactions": "",
                "adverse_effects": "Myelotoxicosis (neutropenia, thrombocytopenia, anemia), neurotoxicosis (myoclonus)\nIn dogs receiving metronomic therapy, 4 mg/m2 is the preferred dosage: thrombocytopenia occurs significantly earlier with 8 mg/m2 compared to 4 mg/m2, and adverse GI effects occur significantly more often with 6 mg/m2 compared to 4 mg/m2, without any therapeutic benefit of the higher dosage\nIn cats, nephrotoxicosis in the form of acquired and potentially reversible Fanconi's syndrome has been documented in association with chlorambucil treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T17:50:47.000000Z",
                "updated_at": "2020-11-07T18:24:13.000000Z"
            },
            {
                "id": 103,
                "guid": "103",
                "name": "Chloramphenicol",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHuman exposure",
                "interactions": "Administration of chloramphenicol increases phenobarbital half-life extensively and may produce signs of toxicosis",
                "adverse_effects": "Siderocytes, sideroblasts (peripheral blood, bone marrow respectively)\nReports of dose-dependent erythroid hypoplasia in dogs and cats",
                "deleted_at": null,
                "created_at": "2020-05-06T17:51:57.000000Z",
                "updated_at": "2020-05-06T17:51:57.000000Z"
            },
            {
                "id": 104,
                "guid": "104",
                "name": "Chlorothiazide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypercalcemia\nHypovolemia\nHypersensitivity to the drug",
                "interactions": "Nonsteroidal anti-inflammatories may decrease efficacy of chlorothiazide\nMay exacerbate digoxin toxicosis (especially if hypokalemia)",
                "adverse_effects": "Hypokalemia\nDecreases renal blood flow at 5 mg/kg IV in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T17:53:48.000000Z",
                "updated_at": "2020-05-06T17:53:48.000000Z"
            },
            {
                "id": 105,
                "guid": "105",
                "name": "Chlorpheniramine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the compound",
                "interactions": "",
                "adverse_effects": "Drowsiness, lethargy",
                "deleted_at": null,
                "created_at": "2020-05-06T17:54:59.000000Z",
                "updated_at": "2020-11-07T18:33:07.000000Z"
            },
            {
                "id": 106,
                "guid": "106",
                "name": "Chlorpromazine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Gastrointestinal tract obstruction\nHypersensitivity to the drug\nHypotension\nWeakness/lethargy",
                "interactions": "Can potentiate other CNS depressants",
                "adverse_effects": "Like all phenothiazine drugs, chlorpromazine may reduce blood pressure and cause sedation/weakness (which some consider to be advantageous if the patient is agitated and the medical causes of agitation such as pain are all being addressed already)",
                "deleted_at": null,
                "created_at": "2020-05-06T17:56:47.000000Z",
                "updated_at": "2020-05-06T17:56:47.000000Z"
            },
            {
                "id": 107,
                "guid": "107",
                "name": "Chlorpropamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose for hypoglycemic crisis",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoglycemia",
                "interactions": "Can potentiate other antihyperglycemic drugs (e.g., insulin)",
                "adverse_effects": "Hypoglycemia",
                "deleted_at": null,
                "created_at": "2020-05-06T17:57:27.000000Z",
                "updated_at": "2020-05-06T17:57:27.000000Z"
            },
            {
                "id": 108,
                "guid": "108",
                "name": "Chorionic gonadotropin, human (hCG)",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T17:58:09.000000Z",
                "updated_at": "2020-11-07T18:45:08.000000Z"
            },
            {
                "id": 109,
                "guid": "109",
                "name": "Cimetidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cytochrome P450 inhibitor. As a result, may raise plasma concentrations of many drugs, including calcium-channel blockers, tricyclic antidepressants, metoprolol, aminophylline, etc.\nCompetition for renal tubular secretion may increase plasma levels of cyclosporine, procainamide, tacrolimus, etc.\nIncrease in gastric pH may alter availability of drugs (e.g., ketoconazole, ampicillin-class antibacterials, digoxin) - extrapolated from human medicine\nSucralfate needs an acidic environment to disperse, so it should be given >30 minutes before cimetidine",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T17:59:39.000000Z",
                "updated_at": "2020-05-06T17:59:39.000000Z"
            },
            {
                "id": 110,
                "guid": "110",
                "name": "Ciprofloxacin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Fluoroquinolones are generally not recommended in pregnancy (cartilage effects)",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Coadministration with tizanidine is contraindicated, due to resultant toxic circulating levels of tizanidine\r\nCoadministration with theophylline increases circulating theophylline concentrations\r\nPossibility of class effects (e.g., enrofloxacin): reduction in elimination of cyclosporine and flunixin, potentially increasing the serum levels of these drugs to clinically significant (toxic) levels\r\nIon-containing gastric protectants (e.g., calcium carbonate) or gastric protectants (e.g., sucralfate) may reduce absorption",
                "adverse_effects": "Cartilage malformation if given at higher doses (≥ 30 mg/kg) to growing dogs \n Caution in epileptic patients because of possible CNS stimulatory effects of fluoroquinolone antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T18:00:47.000000Z",
                "updated_at": "2020-11-07T18:48:00.000000Z"
            },
            {
                "id": 111,
                "guid": "111",
                "name": "Cisapride",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Physical obstruction of any part of the gastrointestinal tract",
                "interactions": "Prokinetic effect of cisapride may increase absorption of many drugs\r\nAtropine decreases or eliminates the effect of cisapride on the GI tract of dogs\r\nCytochrome P450 inhibitors (e.g., clarithromycin, azole antifungals, etc.) can increase cisapride concentrations",
                "adverse_effects": "Removed from human pharmaceutical market due to increased risk of sudden death (prolongation of QT interval on electrocardiogram), but such effects are not observed in dogs receiving therapeutic dosages",
                "deleted_at": null,
                "created_at": "2020-05-06T18:01:32.000000Z",
                "updated_at": "2020-11-07T18:50:01.000000Z"
            },
            {
                "id": 112,
                "guid": "112",
                "name": "Cisplatin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Human teratogen and carcinogen - instructions for proper handing and precautions (clients, veterinary staff) are essential.  Fetotoxic potential.",
                "contraindications": "Hypersensitivity to the drug \n Kidney disease/renal failure \n Absolute contraindication in the cat due to fatal pulmonary edema",
                "interactions": "Not to be administered with other potentially nephrotoxic drugs (e.g., aminoglycoside antibacterials, amphotericin B, etc.)",
                "adverse_effects": "Nephrotoxicosis (often irreversible, generally peaks approximately 5 days after administration) \n Nausea (up to 54% of cases - maropitant significantly reduces cisplatin-induced vomiting in dogs) \n Severe/fatal pulmonary edema in cats at standard dosages (40-60 mg/m²) \n Myelosuppression",
                "deleted_at": null,
                "created_at": "2020-05-06T18:02:27.000000Z",
                "updated_at": "2020-11-07T18:52:34.000000Z"
            },
            {
                "id": 113,
                "guid": "113",
                "name": "Cisplatin, liposome encapsulated",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Human teratogen and carcinogen - instructions for proper handing and precautions (clients, veterinary staff) are essential.  Fetotoxic potential.",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Anaphylaxis is common but \"clinically manageable\" (according to one study)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:04:42.000000Z",
                "updated_at": "2020-05-06T18:04:42.000000Z"
            },
            {
                "id": 114,
                "guid": "114",
                "name": "Clarithromycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Inhibits metabolism of cisapride, enhancing cisapride toxicosis",
                "adverse_effects": "Hepatotoxicosis possible at therapeutic dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T18:05:16.000000Z",
                "updated_at": "2020-11-07T18:56:54.000000Z"
            },
            {
                "id": 115,
                "guid": "115",
                "name": "Clemastine fumarate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Diarrhea",
                "deleted_at": null,
                "created_at": "2020-05-06T18:06:36.000000Z",
                "updated_at": "2020-05-06T18:06:36.000000Z"
            },
            {
                "id": 116,
                "guid": "116",
                "name": "Clindamycin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other lincosamides (e.g., lincomycin)",
                "interactions": null,
                "adverse_effects": "Diarrhea\nEsophageal injury documented in cats, and thought to be more likely if dose is not followed by bolus of food or water\nStill considered the treatment of choice for toxoplasmosis in cats, but paradoxically may accelerate dissemination of acute Toxoplasma in cats if treatment is begun 7 days after exposure/inoculation",
                "deleted_at": null,
                "created_at": "2020-05-06T18:07:28.000000Z",
                "updated_at": "2020-05-06T18:07:28.000000Z"
            },
            {
                "id": 117,
                "guid": "117",
                "name": "Clofazimine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Causes hyperpigmentation of skin of fetus in humans",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Vomiting after dosing, photosensitization, inappetence - all reversible with discontinuation of drug",
                "deleted_at": null,
                "created_at": "2020-05-06T18:10:16.000000Z",
                "updated_at": "2020-05-06T18:10:16.000000Z"
            },
            {
                "id": 118,
                "guid": "118",
                "name": "Clomipramine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing liver disease",
                "interactions": "Serotonin syndrome may occur if combined with monoamine oxidase inhibitors (MAOs, like selegiline, amitraz), selective serotonin reuptake inhibitors (SSRIs), or certain opiates (e.g., tramadol)",
                "adverse_effects": "Mild transient vomiting\nLiver enzyme elevation/hepatopathy\nSedation in some cats\nAnecdotal report of recurrent pancreatitis in 1 dog and urinary retention in 1 cat",
                "deleted_at": null,
                "created_at": "2020-05-06T18:10:59.000000Z",
                "updated_at": "2020-05-06T18:10:59.000000Z"
            },
            {
                "id": 119,
                "guid": "119",
                "name": "Clonazepam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other benzodiazepines\nLiver disease",
                "interactions": null,
                "adverse_effects": "Tolerance develops after 1-2 weeks\nWell-recognized risk of physical dependence (dog)\nAbuse potential (human)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:13:19.000000Z",
                "updated_at": "2020-05-06T18:13:19.000000Z"
            },
            {
                "id": 120,
                "guid": "120",
                "name": "Clopidogrel",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug  \n  Liver disease",
                "interactions": "",
                "adverse_effects": "Nausea  \n  Rare hepatopathy  \n  Increased bleeding tendency",
                "deleted_at": null,
                "created_at": "2020-05-06T18:13:52.000000Z",
                "updated_at": "2020-11-07T19:09:46.000000Z"
            },
            {
                "id": 121,
                "guid": "121",
                "name": "Cloprostenol",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Abortefacient;contraindicated in pregnant animals when the pregnancy is intended to go to term",
                "contraindications": "Hypersensitivity to the drug\nClosed pyometra (potential for uterine rupture)\nPregnancy intended to continue to term",
                "interactions": null,
                "adverse_effects": "Acute, mild vomiting, diarrhea, tenesmus, and weakness may occur, especially within 60 minutes of treatment\nAvoid contact with human skin or mucous membranes",
                "deleted_at": null,
                "created_at": "2020-05-06T18:14:45.000000Z",
                "updated_at": "2020-05-06T18:14:45.000000Z"
            },
            {
                "id": 122,
                "guid": "122",
                "name": "Clorazepate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other benzodiazepines",
                "interactions": "",
                "adverse_effects": "Sedation \n Very rare hepatic adverse effects in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T18:15:43.000000Z",
                "updated_at": "2020-11-07T19:12:24.000000Z"
            },
            {
                "id": 123,
                "guid": "123",
                "name": "Clotrimazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Incomplete cribriform plate (if infusing intranasally)",
                "interactions": "",
                "adverse_effects": "Swelling of nasal mucosa may produce increased respiratory stertor that should self-resolve in 24-72 hours",
                "deleted_at": null,
                "created_at": "2020-05-06T18:16:12.000000Z",
                "updated_at": "2020-11-07T19:17:21.000000Z"
            },
            {
                "id": 124,
                "guid": "124",
                "name": "Cobalamin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the compound",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T18:17:47.000000Z",
                "updated_at": "2020-11-08T14:15:21.000000Z"
            },
            {
                "id": 125,
                "guid": "125",
                "name": "Codeine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Cough that is beneficial (e.g., pneumonia, foreign body, or other instances of purposeful cough where the cough should not be suppressed)",
                "interactions": "Additive effects with other opiates, sedatives, antitussives",
                "adverse_effects": "Lethargy \n Somnolence \n Drowsiness \n Constipation possible (typically at higher dosages than those that produce lethargy)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:19:26.000000Z",
                "updated_at": "2020-11-08T14:17:16.000000Z"
            },
            {
                "id": 126,
                "guid": "126",
                "name": "Colchicine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Teratogen: should be avoided in all pregnant animals",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Severe hepatopathy, skeletal myopathy, and gastrointestinal adverse effect suspected in one dog receiving both colchicine and ketoconazole",
                "adverse_effects": "Cytochrome P450 substrate, i.e., coadministration of cyclosporine, clarithromycin, or other P450 inhibitors can produce toxic levels of colchicine  \n  Vomiting, diarrhea, lethargy, hypothermia, bradycardia occurred in a healthy dogs that ate its owner's colchicine tablets equaling a 10 to 100-fold overdose  \n  Myopathy associated with colchicine in humans, especially if co-treatment with cyclosporine",
                "deleted_at": null,
                "created_at": "2020-05-06T18:20:14.000000Z",
                "updated_at": "2020-11-08T14:20:06.000000Z"
            },
            {
                "id": 127,
                "guid": "127",
                "name": "Cyclophosphamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Human teratogen and carcinogen - instructions for proper handing and precautions (clients, veterinary staff) are essential.  Fetotoxic potential.",
                "contraindications": "Hypersensitivity to the drug  \n  Neutropenia",
                "interactions": "Is metabolized to active cytotoxic product\r\nMay be enhanced (e.g., chronic phenobarbital) or inhibited (e.g., cimetidine, chloramphenicol) by drugs that alter cytochrome P450 enzyme systems",
                "adverse_effects": "Well-recognized propensity for causing hemorrhagic cystitis (risk is reduced from 9% to 1.2% by giving furosemide [e.g., 2 mg/kg PO or SC or IV] immediately before cyclophosphamide dose)  \nAdd this new adverse effect item after the current first Adverse Side Effect item\n  Myelosuppression  \n  Cardiotoxicosis and carcinogenesis are reported in humans but not convincingly in dogs or cats\n30% rate of grade IV neutropenia in canine lymphoma protocol using cyclophosphamide 250 mg/m2 PO divided over days 0 through 4, lomustine 60 mg/m2 on day 0, and prophylactic antibiotics\nIn cats receiving low-dose metronomic cyclophosphamide (6-27 mg/m2 PO q 24-72h), the incidence of adverse effects in the first 30 days of treatment is low: 8% rate of hematologic toxicosis and 4% rate of nephrotoxicosis\nIn a dog, a marked overdose of 1750 mg (2303 mg/m2) divided over 21 days was treated successfully with no permanent sequelae",
                "deleted_at": null,
                "created_at": "2020-05-06T18:21:34.000000Z",
                "updated_at": "2020-11-08T14:57:59.000000Z"
            },
            {
                "id": 128,
                "guid": "128",
                "name": "Cyclosporine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "General: 800-1400 ng/mL (peak), 400-600 ng/mL (trough), typically evaluated q 3-6 months once stable. Allergic disease: recommended minimum trough concentration (measured immediately pre-dose, I.e., 12 hours post-dose) = 250 ng/mL\nperianal fistula minimum trough = 600 ng/mL (induction), 100 ng/mL (maintenance)\nrenal transplantation minimum trough = 750 ng/mL (induction, i.e., first month), minimum trough = 350-400 ng/mL thereafter.  (Auburn University College of Veterinary Medicine - Clinical Pharmacology Laboratory)",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Several drugs can raise serum cyclosporine concentrations, including azole antifungals (e.g., ketoconazole, fluconazole, itraconazole), calcium-channel blockers (e.g., diltiazem, verapamil), macrolide antibacterials (e.g., azithromycin, clarithromycin, erythromycin), amiodarone, and metoclopramide\nClarithromycin coadministered with cyclosporine in dogs increases peak cyclosporine levels by 46%, whereas fluconazole coadministration with cyclosporin alters neither cyclosporine nor fluconazole concentrations, nor other pharmacokinetic parameters\nCyclosporine may raise the serum levels of methotrexate and digoxin",
                "adverse_effects": "Vomiting (31% of dogs, 22% of cats) and diarrhea (20% of dogs) are common and self-limiting, and generally do not require a change in cyclosporine treatment \n Persistent otitis externa (7%), urinary tract infection (4%), anorexia and lethargy (2-3%), gingival hyperplasia, lymphadenopathy, systemic hypertension, and/or protein-losing nephropathy/nephrotoxicosis can occur, requiring dosage decrease or discontinuation \nOpportunistic infections such as cutaneous nocardiosis,Burkholderia pyoderma,and cutaneous and systemic fungal infections , have been noted in dogs receiving cyclosporin\r\n Hyperglycemia (increasing serum fructosamine by 10% after 6 weeks of treatment)\nOverall, a small number of often-reversible adverse effects has been reported in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T18:23:53.000000Z",
                "updated_at": "2020-11-08T15:19:11.000000Z"
            },
            {
                "id": 129,
                "guid": "129",
                "name": "Cyproheptadine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Monoamine oxidase inhibitors (e.g., selegiline) may intensify the anticholinergic effects of cyproheptadine (e.g., tachycardia, mydriasis, etc.)\nSedative effects can be potentiated by opiates, phenothiazines, and other sedatives and tranquilizers",
                "adverse_effects": "Polyphagia (25% of dogs, some cats)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:27:24.000000Z",
                "updated_at": "2020-05-06T18:27:24.000000Z"
            },
            {
                "id": 130,
                "guid": "130",
                "name": "Cytosine arabinoside",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Contraindicated in pregnancy due to fetal myelotoxicosis",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cumulative effects possible if coadministered with other potentially myelotoxic drugs",
                "adverse_effects": "Myelotoxicosis: 300 mg/m² IV CRI q 24h for 2 days is myelotoxic to >50% of dogs and does not induce remission of lymphoma (as monotherapy in dogs)\n1 case of acute, fatal, suspected drug-induced interstitial lung disease in a dog",
                "deleted_at": null,
                "created_at": "2020-05-06T18:28:54.000000Z",
                "updated_at": "2020-11-08T18:41:40.000000Z"
            },
            {
                "id": 131,
                "guid": "131",
                "name": "Dacarbazine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cumulative myelotoxic effects with other antineoplastic drugs",
                "adverse_effects": "Thrombocytopenia (62-67% of dogs, occurring 7-14 days after treatment and requiring postponement of treatment)  \n  Neutropenia  \n  Gastrointestinal signs (5% of dogs, 3% requiring supportive care)  \n  Hepatotoxicosis  \n  Vesicant (can cause extravasation injury)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:31:15.000000Z",
                "updated_at": "2020-11-08T19:00:53.000000Z"
            },
            {
                "id": 132,
                "guid": "132",
                "name": "Danazol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Known teratogen (has caused genitourinary malformations in the fetus)",
                "contraindications": "Hypersensitivity to the drug \n Pregnancy",
                "interactions": "May cause insulin resistance\r\nMay increase plasma levels of cyclosporine and tacrolimus",
                "adverse_effects": "Potential hepatotoxin",
                "deleted_at": null,
                "created_at": "2020-05-06T18:32:03.000000Z",
                "updated_at": "2020-11-08T19:02:15.000000Z"
            },
            {
                "id": 133,
                "guid": "133",
                "name": "Dantrolene",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Hypoventilation (causing hypercapnia), mild hyperkalemia have been recorded in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T18:32:44.000000Z",
                "updated_at": "2020-05-06T18:32:44.000000Z"
            },
            {
                "id": 134,
                "guid": "134",
                "name": "Dapsone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Fatal thrombocytopenic hemorrhagic diathesis in 1 dog\nVomiting has been associated with dapsone treatment in dogs and may require discontinuation of the drug\nMild liver enzyme elevations, marked neutrophilia",
                "deleted_at": null,
                "created_at": "2020-05-06T18:33:49.000000Z",
                "updated_at": "2020-05-06T18:33:49.000000Z"
            },
            {
                "id": 135,
                "guid": "135",
                "name": "Darbepoetin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "In dogs and cats, formation of anti-darbepoietin antibodies is thought to be less common with darbepoietin treatment than anti-erythropoietin antibodies with erythropoietin treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T18:34:16.000000Z",
                "updated_at": "2020-11-08T19:04:13.000000Z"
            },
            {
                "id": 136,
                "guid": "136",
                "name": "Decoquinate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T18:34:57.000000Z",
                "updated_at": "2020-05-06T18:34:57.000000Z"
            },
            {
                "id": 137,
                "guid": "137",
                "name": "Deferoxamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nOliguric/anuric renal failure",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T18:35:22.000000Z",
                "updated_at": "2020-05-06T18:35:22.000000Z"
            },
            {
                "id": 138,
                "guid": "138",
                "name": "Delmadinone ",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nBreeding male\nDiabetic animals",
                "interactions": "Markedly suppresses serum cortisol concentration and ACTH stimulation testing: 2 injections 1 week apart in dogs produce 4- to 10-fold reductions in serum cortisol by week 2, both resting and after ACTH stimulation",
                "adverse_effects": "May alter color of haircoat at site of injection - inject in inconspicuous location (e.g., medial thigh)\nHas caused mammary hyperplasia in treated cats (male and female)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:36:05.000000Z",
                "updated_at": "2020-05-06T18:36:05.000000Z"
            },
            {
                "id": 139,
                "guid": "139",
                "name": "Deracoxib",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other NSAIDs \n Gastrointestinal ulceration \n Anorexia \n Dehydration",
                "interactions": "Avoid concurrently administering glucocorticoids and/or other nonsteroidal anti-inflammatories (cumulative gastric toxicity)",
                "adverse_effects": "Gastrointestinal irritation and even perforation is well-recognized in a small minority of dogs, especially those receiving (contrary-to-label) excessively high dosages and/or recent administration/coadministration of glucocorticoids or another NSAID \n Altered platelet function",
                "deleted_at": null,
                "created_at": "2020-05-06T18:37:10.000000Z",
                "updated_at": "2020-11-08T19:25:25.000000Z"
            },
            {
                "id": 140,
                "guid": "140",
                "name": "Desmopressin acetate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Conjunctivitis or other ocular disease (for topical formulation instilled in conjunctival sac) \n Causes of polyuria/polydipsia other than diabetes insipidus",
                "interactions": "",
                "adverse_effects": "Conjunctival irritation (topical application to eye) in some dogs and many cats",
                "deleted_at": null,
                "created_at": "2020-05-06T18:38:13.000000Z",
                "updated_at": "2020-11-08T19:51:30.000000Z"
            },
            {
                "id": 141,
                "guid": "141",
                "name": "Desoxycorticosterone pivalate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the compound \n Hyperaldosteronism",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T18:41:00.000000Z",
                "updated_at": "2020-11-08T19:52:34.000000Z"
            },
            {
                "id": 142,
                "guid": "142",
                "name": "Dexamethasone",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "Normal serum cortisol concentration = 0.5-5.5 µg/dL (13.8-151.7 nmol/L)",
                "reversal_agent": "",
                "teratogenicity": "Abortefacient - do not use in pregnant animals if pregnancy is intended to reach term",
                "contraindications": "Hypersensitivity to the preparation \n Pregnancy \n Chronic use is contraindicated in animals with uncontrolled hyperadrenocorticism or other signs of untreated glucocorticoid excess \n Seizure disorders (may lower seizure threshold) unless corticosteroid-responsive disease",
                "interactions": "Avoid nonsteroidal anti-inflammatories and/or other glucocorticoids concurrently (markedly increased risk of gastrointestinal ulceration/perforation)",
                "adverse_effects": "Gastrointestinal ulceration (especially with acute, high-dosage use in compromised patients) \n Polyphagia leading to weight gain \n Polyuria/polydipsia \n Immunosuppression \n Liver enzyme elevation/steroid hepatopathy \n Soft tissue fragility/delayed healing possible with chronic usage \n Insulin antagonism in cats, causing persistent glucosuria (to a significantly greater degree than prednisolone treatment)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:41:49.000000Z",
                "updated_at": "2020-11-08T19:55:15.000000Z"
            },
            {
                "id": 143,
                "guid": "143",
                "name": "Dexmedetomidine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Atipamezole 150 µg/kg IM",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other alpha-2 agonists \n Systemic hypertension \n Bradycardia",
                "interactions": "Atropine coadministration is associated with cardiac arrhythmias",
                "adverse_effects": "Majority of treated cats, and some dogs, vomit within minutes of administration (but before sedative effects, so the risk of aspiration in otherwise healthy animals is minimal)",
                "deleted_at": null,
                "created_at": "2020-05-06T18:46:31.000000Z",
                "updated_at": "2020-11-08T20:06:29.000000Z"
            },
            {
                "id": 144,
                "guid": "144",
                "name": "Dexrazoxane",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T18:48:29.000000Z",
                "updated_at": "2020-05-06T18:48:29.000000Z"
            },
            {
                "id": 145,
                "guid": "145",
                "name": "Dextroamphetamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Chlorpromazine (antagonizes dopamine and norepinephrine reuptake, reducing the central nervous system stimulant effects of dextroamphetamine)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHuman misappropriation/abuse\nSystemic hypertension",
                "interactions": "Interaction with monoamine oxidase inhibitors (e.g., selegiline, many behavior-modifying drugs) may cause hypertensive crises\nDecreases efficacy of beta-adrenergic blockers\nincreased serum levels of dextroamphetamine if concurrent treatment with alkalinizing agents (e.g., diets for promoting an alkaline urine, sodium bicarbonate) and/or diuretics that cause alkalinization of urine (e.g., acetazolamide, some thiazides)\nMay delay intestinal uptake of phenobarbital",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T18:49:22.000000Z",
                "updated_at": "2020-05-06T18:49:22.000000Z"
            },
            {
                "id": 146,
                "guid": "146",
                "name": "Dextromethorphan",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPurposeful cough (e.g., pneumonia)",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T18:50:10.000000Z",
                "updated_at": "2020-05-06T18:50:10.000000Z"
            },
            {
                "id": 147,
                "guid": "147",
                "name": "Dextrose 50%",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "Normal blood glucose reference interval: 50-120 mg/dL (2.78-6.7 mmol/L)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to preparation\nHyperglycemia",
                "interactions": null,
                "adverse_effects": "In patients with insulinoma, higher dosages and/or unnecessarily persistent treatment may trigger further insulin release, aggravating the problem",
                "deleted_at": null,
                "created_at": "2020-05-06T18:53:52.000000Z",
                "updated_at": "2020-05-06T18:53:52.000000Z"
            },
            {
                "id": 148,
                "guid": "148",
                "name": "Diazepam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Flumazenil",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other benzodiazepines \n Hepatic encephalopathy \n Seizures when a reversible cause is at fault (e.g., hypoglycemia, hypocalcemia)",
                "interactions": "Cytochrome P450 enzyme inducer, causing reductions in serum/plasma levels of many other drugs when given chronically\r\nConversely, chronic phenobarbital treatment increases requirement of diazepam to achieve same therapeutic effect (presumably via hepatic cytochrome enzyme induction)",
                "adverse_effects": "Hepatotoxicosis (severe) in minority of cats receiving diazepam orally, characterized by overt signs of liver failure within 4-11 days after start of treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T18:55:33.000000Z",
                "updated_at": "2020-11-08T20:12:51.000000Z"
            },
            {
                "id": 149,
                "guid": "149",
                "name": "Diazoxide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic (atrophy of fetal pancreatic beta cells) - not for use in pregnancy",
                "contraindications": "Hypersensitivity to the drug\nHyperglycemia",
                "interactions": "Opposes effects of antidiabetic drugs (insulin, acarbose, etc.)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T18:59:10.000000Z",
                "updated_at": "2020-05-06T18:59:10.000000Z"
            },
            {
                "id": 150,
                "guid": "150",
                "name": "Dichlorphenamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T18:59:40.000000Z",
                "updated_at": "2020-05-06T18:59:40.000000Z"
            },
            {
                "id": 151,
                "guid": "151",
                "name": "Dichlorvos",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Several reports express concern over possible carcinogenicity",
                "deleted_at": null,
                "created_at": "2020-05-06T19:00:14.000000Z",
                "updated_at": "2020-05-06T19:00:14.000000Z"
            },
            {
                "id": 152,
                "guid": "152",
                "name": "Diethylcarbamazine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Dirofilaria microfilaremia (potentially fatal anaphylaxis)",
                "interactions": "",
                "adverse_effects": "Recognized hepatotoxicosis in some dogs \n Daily administration is considered a drawback (although not a contraindication) because the opportunity for missing a treatment is likely greater than if clients administer prophylaxis just once a month, as is the case with most modern heartworm preventives",
                "deleted_at": null,
                "created_at": "2020-05-06T19:00:41.000000Z",
                "updated_at": "2020-11-08T20:14:10.000000Z"
            },
            {
                "id": 153,
                "guid": "153",
                "name": "Diethylstilbestrol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogen in humans (causes fetal predisposition to vaginal or cervical cancer)",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cytochrome P450 induction agents (phenobarbital, rifampin, etc.) may decrease serum concentrations",
                "adverse_effects": "Sporadic reports of feminizing syndrome\nRare/no myelotoxicosis at this dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T19:02:17.000000Z",
                "updated_at": "2020-05-06T19:02:17.000000Z"
            },
            {
                "id": 154,
                "guid": "154",
                "name": "Difloxacin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nCaution/relative contraindication in patients with seizure disorders, since fluoroquinolones may lower the seizure threshold",
                "interactions": "Concurrent antacids or gastric protectants (e.g., sucralfate) may decrease absorption, and dosing should be staggered to prevent this interaction",
                "adverse_effects": "Caution re. cartilage in growing dogs, retinal damage in cats (fluoroquinolone class effect), because specific information for difloxacin is lacking",
                "deleted_at": null,
                "created_at": "2020-05-06T19:03:07.000000Z",
                "updated_at": "2020-05-06T19:03:07.000000Z"
            },
            {
                "id": 155,
                "guid": "155",
                "name": "Digoxin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "0.6-1.9 ng/mL (1.2-2.6 nmol/L)",
                "reversal_agent": "Anti-digoxin antibodies for parenteral injection (Digibind)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other cardiac glycosides\nOliguria/anuria\nAnorexia",
                "interactions": "Phenobarbital cotreatment significantly increases digoxin concentrations in dogs\nSeveral other drug interactions demonstrated in humans may increase digoxin levels in dogs and cats, including alprazolam, azithromycin, clarithromycin, cyclosporine, diphenoxylate, erythromycin, esomeprazole, itraconazole, ketoconazole, omeprazole, propantheline, quinidine, spironolactone, and tetracycline",
                "adverse_effects": "Well-recognized, dosage-dependent occurrence of inappetence, lethargy, vomiting, diarrhea which can occur immediately after onset of therapy, or weeks/months later. Cardiac arrhythmias may occur with digoxin therapy, less commonly in the absence of other systemic signs as just described.  Standard treatment consists of withholding digoxin administration for 48h and restarting at half dose, or finding alternative treatment (e.g., calcium-channel blocker, beta-blocker for atrial fibrillation)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:03:35.000000Z",
                "updated_at": "2020-05-06T19:03:35.000000Z"
            },
            {
                "id": 156,
                "guid": "156",
                "name": "Dihydrotachysterol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypercalcemia",
                "interactions": "Enhances absorption of calcium-containing compounds (e.g., calcium carbonate)",
                "adverse_effects": "Uncontrolled/unmonitored supplementation may lead to an excess of vitamin D effects, including irreversible soft tissue mineralization",
                "deleted_at": null,
                "created_at": "2020-05-06T19:04:57.000000Z",
                "updated_at": "2020-05-06T19:04:57.000000Z"
            },
            {
                "id": 157,
                "guid": "157",
                "name": "Diltiazem, regular",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "50-200 ng/mL recommended in humans\nequivalent not known for dogs or cats with clinical heart disease and not routinely measured",
                "reversal_agent": "Epinephrine 0.2-0.4 µg/kg/min IV CRI for 60 minutes or glucagon 2 µg/kg/min IV CRI for 15 minutes\n calcium chloride is ineffective",
                "teratogenicity": "Fetotoxic (fetal death) in pregnant mice, rats, and rabbits",
                "contraindications": "Hypersensitivity to the drug \n Bradycardia",
                "interactions": "Cumulative effects with other calcium-channel blockers, with beta-blockers, and with digoxin\r\nIn humans, raises serum levels of cyclosporine, digoxin, midazolam, and others",
                "adverse_effects": "Generally well-tolerated (far better than sustained-release formulations)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:06:04.000000Z",
                "updated_at": "2020-11-08T20:17:12.000000Z"
            },
            {
                "id": 158,
                "guid": "158",
                "name": "Diltiazem, sustained release",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Epinephrine 0.2-0.4 µg/kg/min IV CRI for 60 minutes or glucagon 2 µg/kg/min IV CRI for 15 minutes; calcium chloride is ineffective",
                "teratogenicity": "Fetotoxic (fetal death) in pregnant mice, rats, and rabbits",
                "contraindications": "Hypersensitivity to the drug\nBradycardia",
                "interactions": "Cumulative effects with other calcium-channel blockers, with beta-blockers, and with digoxin\nIn humans, raises serum levels of cyclosporine, digoxin, midazolam, and others",
                "adverse_effects": "30 mg/CAT produces serum drug concentrations that are subtherapeutic (by extrapolation from human medicine) in several cats, whereas 60 mg/CAT produces lethargy, vomiting, and weight loss in 36% of treated cats",
                "deleted_at": null,
                "created_at": "2020-05-06T19:08:06.000000Z",
                "updated_at": "2020-05-06T19:08:06.000000Z"
            },
            {
                "id": 159,
                "guid": "159",
                "name": "Dimenhydrinate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Sedation, drowsiness",
                "deleted_at": null,
                "created_at": "2020-05-06T19:08:52.000000Z",
                "updated_at": "2020-05-06T19:08:52.000000Z"
            },
            {
                "id": 160,
                "guid": "160",
                "name": "Dimercaprol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Nephrotoxic\nVomiting and/or neurologic adverse effects are common and reversible with decrease in dosage\nDrug is painful on administration and must be given deep IM",
                "deleted_at": null,
                "created_at": "2020-05-06T19:09:58.000000Z",
                "updated_at": "2020-05-06T19:09:58.000000Z"
            },
            {
                "id": 161,
                "guid": "161",
                "name": "Dimethyl sulfoxide",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "LD50 in cats (single dose) = 12.8 - 28.3 g/kg",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Signs of pain, lethargy, anorexia, nausea/excessive lip licking 24-48h after dosing\nIn humans inadvertently exposed through contact, headache and a garlic odor to the breath are commonly reported",
                "deleted_at": null,
                "created_at": "2020-05-06T19:10:35.000000Z",
                "updated_at": "2020-05-06T19:10:35.000000Z"
            },
            {
                "id": 162,
                "guid": "162",
                "name": "Diminazene",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Vomiting, urination, central nervous system deficits, and anaphylactic shock (dogs), and hypersalivation, nausea, monoparesis in the injected limb, proteinuria, and possible hepatotoxicosis (cats) reported in animals receiving clinical doses",
                "deleted_at": null,
                "created_at": "2020-05-06T19:11:24.000000Z",
                "updated_at": "2020-11-08T20:23:39.000000Z"
            },
            {
                "id": 163,
                "guid": "163",
                "name": "Diphenhydramine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cumulative side-effects (e.g., somnolence) if combined with other antihistamines, central nervous system depressants (e.g., tranquilizers, sedatives, anesthetics)",
                "adverse_effects": "Accidental ingestions by dogs are common\n median ingested doses are 9.5-19.0 mg/kg (older to younger dogs respectively)\n and 23% of dogs show clinical signs (lethargy/somnolence [40% of cases with clinical signs, typically @ mean ingested dose of 9.2 mg/kg], hyperactivity/agitation [26%, typically @ mean ingested dose of 33 mg/kg], tachycardia [16%, typically @ mean ingested dose of 39 mg/kg], ataxia [12%, typically @ mean ingested dose of 26 mg/kg], hyperthermia [11%, typically @ mean ingested dose of 47 mg/kg], tremors [11%, typically @ mean ingested dose of 74 mg/kg]) and 2% of ingestions are fatal (330 mg/kg oral or 20-110 mg/kg injection).",
                "deleted_at": null,
                "created_at": "2020-05-06T19:12:35.000000Z",
                "updated_at": "2020-11-08T20:27:05.000000Z"
            },
            {
                "id": 164,
                "guid": "164",
                "name": "Dirlotapide",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nNot for use in cats (hepatic lipidosis)",
                "interactions": null,
                "adverse_effects": "Vomiting (48% of treated dogs, vs. 20% of placebo-treated dogs, in 7 months)\nIncreased alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) in 10% of treated dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T19:17:04.000000Z",
                "updated_at": "2020-05-06T19:17:04.000000Z"
            },
            {
                "id": 165,
                "guid": "165",
                "name": "Dobutamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "None needed (plasma half-life: 2 minutes)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nIncreased afterload (outflow tract obstruction, systemic hypertension, other)\nVentricular arrhythmia",
                "interactions": "Cumulative effects with other positive inotropes (e.g., epinephrine, pimobendan), and may increase blood pressure disproportionately if given with vasoconstrictors (e.g., phenylephrine, norepinephrine)",
                "adverse_effects": "Ongoing use may promote ventricular arrhythmia, but duration and dose are widely variable depending on severity of underlying cardiac disease",
                "deleted_at": null,
                "created_at": "2020-05-06T19:17:38.000000Z",
                "updated_at": "2020-05-06T19:17:38.000000Z"
            },
            {
                "id": 166,
                "guid": "166",
                "name": "Dolasetron",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Prolongation of QT interval on the electrocardiogram in humans\nLimited if any clinical significance in veterinary medicine",
                "deleted_at": null,
                "created_at": "2020-05-06T19:18:27.000000Z",
                "updated_at": "2020-05-06T19:18:27.000000Z"
            },
            {
                "id": 167,
                "guid": "167",
                "name": "Dopamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "May be detrimental to dam, based on high-dose toxicology studies in rats that produce increased mortality and decreased weight gain\nlittle evidence of toxicosis in fetuses",
                "contraindications": "Hypersensitivity to the drug and/or preparation \n Systemic hypertension and/or evidence of hypertensive target organ damage",
                "interactions": "",
                "adverse_effects": "Acute bradycardia has occurred in dogs at the start of IV infusion",
                "deleted_at": null,
                "created_at": "2020-05-06T19:19:04.000000Z",
                "updated_at": "2020-11-08T20:30:23.000000Z"
            },
            {
                "id": 168,
                "guid": "168",
                "name": "Doramectin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Although not reported, ABCB1 gene mutations can be expected to make dogs highly sensitive to doramectin, like other avermectins",
                "interactions": "",
                "adverse_effects": "Well-tolerated in dogs, both as biweekly injections and oral daily dosing, and in cats as a single SC injection",
                "deleted_at": null,
                "created_at": "2020-05-06T19:20:01.000000Z",
                "updated_at": "2020-11-08T20:32:59.000000Z"
            },
            {
                "id": 169,
                "guid": "169",
                "name": "Doxapram",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Neonatal apnea",
                "interactions": "",
                "adverse_effects": "Potential side effects include systemic hypertension, tachycardia, cardiac arrhythmias, muscle rigidity, hyperthermia, and seizures, and doxapram treatment should be avoided in animals predisposed to these disorders",
                "deleted_at": null,
                "created_at": "2020-05-06T19:20:41.000000Z",
                "updated_at": "2020-11-08T20:35:57.000000Z"
            },
            {
                "id": 170,
                "guid": "170",
                "name": "Doxorubicin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dexrazoxane (for systemic adverse effects and/or extravasation injury)",
                "teratogenicity": "Teratogenic",
                "contraindications": "Neutropenia\nDilated cardiomyopathy or any advanced heart disease\nInability to establish venous access\nHypersensitivity to the drug is common, especially on repeated dosing, and is a contraindication to retreatment without premedication (but ongoing treatment is possible if preceded by diphenhydramine, dexamethasone, or both, prior to each dose)",
                "interactions": "Cumulative effects with other drugs, particularly chemotherapeutics, that cause myelotoxicosis and/or gastrointestinal toxicosis",
                "adverse_effects": "Neutropenia/myelotoxicosis, gastrointestinal toxicosis, and extravasation injury are potentially serious (may be fatal) complications\nA cumulative lifetime dose >180 mg/m² (and in rare cases as low as 90 mg/m²) is associated with irreversible myocardial toxicosis manifesting as ventricular arrhythmias initially and ultimately myocardial systolic dysfunction and congestive heart failure",
                "deleted_at": null,
                "created_at": "2020-05-06T19:21:30.000000Z",
                "updated_at": "2020-05-06T19:21:30.000000Z"
            },
            {
                "id": 171,
                "guid": "171",
                "name": "Doxycycline",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Contraindicated in all pregnant dams and queens due to dental (discoloration) and osseous (altered bone growth) effects on the fetus, unless indication is life-threatening disorder in the dam",
                "contraindications": "Hypersensitivity to the drug or to tetracyclines in general",
                "interactions": "Absorption is impaired by calcium-, aluminum-, and bismuth-containing compounds (e.g., several laxative and antacid solutions)\r\nIn general, it is preferable to avoid coadministration with penicillins, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Gastrointestinal signs (vomiting, inappetence, diarrhea) occur in some in dogs and cats \n Well-recognized risk of esophagitis (tablet is retained in esophagus) in cats and small dogs, so each oral dose should be followed by several mL of water or a morsel of food",
                "deleted_at": null,
                "created_at": "2020-05-06T19:23:50.000000Z",
                "updated_at": "2020-11-08T20:50:02.000000Z"
            },
            {
                "id": 172,
                "guid": "172",
                "name": "Edrophonium",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Atropine if cholinergic crisis",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Overdose may produce cholinergic crisis (diarrhea, dyspnea due to bronchoconstriction, bradycardia)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:28:42.000000Z",
                "updated_at": "2020-05-06T19:28:42.000000Z"
            },
            {
                "id": 173,
                "guid": "173",
                "name": "Enalapril",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Fetotoxic (renal effects on fetus, including fetal death) and therefore contraindicated in pregnancy",
                "contraindications": "Hypersensitivity to the drug and/or ACE inhibitors in general",
                "interactions": "Concurrent furosemide administration can increase risk of azotemia/oliguria (in which case the furosemide dosage should be reduced and/or the dietary salt intake reduced without impacting diet palatability)\r\nConcurrent spironolactone administration may predispose to hyperkalemia (low risk at therapeutic dosages with normal renal function)\r\nConcurrent administration of amlodipine or other antihypertensive may predispose to hypotension (low risk at therapeutic dosages)",
                "adverse_effects": "Adverse renal effects were of great concern when the drug was first introduced, but are now recognized to be uncommon and mild in animals that have an adequate appetite, are adequately hydrated, and are receiving standard dosages of ACE inhibitor\nClinically significant hypotension occurs under general anesthesia in dogs that receive enalapril the day of surgery, suggesting this medication should be withheld in the immdiate preoperative period\nAdministration of enalapril at standard herapeutic dosages, even in conjunction with spironolactone, does not typically produce clinically significant electrolyte or renal abnormalities",
                "deleted_at": null,
                "created_at": "2020-05-06T19:29:16.000000Z",
                "updated_at": "2020-11-09T20:20:37.000000Z"
            },
            {
                "id": 174,
                "guid": "174",
                "name": "Enilconazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Contraindicated in pregnancy (cartilage damage in fetus if given to dam)",
                "contraindications": "Hypersensitivity to the drug and/or azole antifungal drugs in general",
                "interactions": null,
                "adverse_effects": "Inappetence (mild)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:30:46.000000Z",
                "updated_at": "2020-05-06T19:30:46.000000Z"
            },
            {
                "id": 175,
                "guid": "175",
                "name": "Enrofloxacin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fluoroquinolones are generally not recommended in pregnancy (cartilage effects)",
                "contraindications": "Hypersensitivity to the drug and/or to other fluoroquinolones\nImpaired vision (cats)\nGrowing puppies\nCaution/relative contraindication in patients with seizure disorders, since fluoroquinolones may lower the seizure threshold",
                "interactions": "Enrofloxacin reduces theophylline elimination by 43% in dogs, increasing serum theophylline concentrations to potentially toxic levels\nCoadministration of flunixin and enrofloxacin increases elimination half-life of flunixin by 29% and of enrofloxacin by 50%\nEnrofloxacin reduces elimination of cyclosporine, raising serum cyclosporine levels\nConcurrent administration of ion-containing antacids (e.g., calcium carbonate) or gastric protectants (e.g., sucralfate) reduces enrofloxacin absorption\nHowever, Enrofloxacin causes no significant alteration of serum digoxin concentrations in dogs",
                "adverse_effects": "Retinal toxicosis (causing permanent blindness) in cats receiving >5 mg/kg/day, with incidence estimated at 1:125 000 cats treated (higher with older cats and/or higher dosages)\nCartilage damage to growing puppies\nVomiting with high dosage given IV\nHigh increase in free radical concentrations in treated dogs, suggesting this as the mechanism of toxicity\nCaution in epileptic patients because of possible CNS stimulatory effects of fluoroquinolone antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T19:31:38.000000Z",
                "updated_at": "2020-05-06T19:31:38.000000Z"
            },
            {
                "id": 176,
                "guid": "176",
                "name": "Enteric probiotic supplement",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T19:36:03.000000Z",
                "updated_at": "2020-05-06T19:36:03.000000Z"
            },
            {
                "id": 177,
                "guid": "177",
                "name": "Epinephrine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Beta-adrenergic blocker (e.g., atenolol, propranolol)",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the compound \n Stable patient",
                "interactions": "Potentiates effects other catecholamines (e.g., dobutamine)\r\n“Epinephrine reversal”: concurrent administration with an alpha-1 adrenergic antagonist (e.g., phenothiazine tranquilizer) could lead to marked hypotension due to unopposed stimulation of vasodilatory beta receptors)",
                "adverse_effects": "Tachycardia, cardiac arrhythmias \n Caution with any patient with pre-existing heart disease (preferable to administer small doses and repeat, rather than a large dose that triggers tachycardia)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:36:46.000000Z",
                "updated_at": "2020-11-09T20:26:31.000000Z"
            },
            {
                "id": 178,
                "guid": "178",
                "name": "Epirubicin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Dexrazoxane",
                "teratogenicity": "Teratogenic and embryotoxic",
                "contraindications": "Hypersensitivity to the drug  \n  Bone marrow suppression (unless caused by neoplastic bone marrow infiltration)  \n  Dilated cardiomyopathy",
                "interactions": "Cumulative effect with other myelotoxic compounds is possible\r\nCotreatment with cimetidine increases serum epirubicin concentrations",
                "adverse_effects": "315 doses led to 116 instances of adverse effects (37%): lethargy (16%), vomiting (16%), anorexia (12%), hypersensitivity (<2%), and suspected extravasation (<1%) (percentages add up to more than 37% because some patients had more than one adverse effect) \n Dilated cardiomyopathy documented in a cocker spaniel that received a cumulative epirubicin dose of 168 mg/m2, although causality was not proven and the breed is recognized to be overrepresented in cases of dilated cardiomyopathy.",
                "deleted_at": null,
                "created_at": "2020-05-06T19:38:26.000000Z",
                "updated_at": "2020-11-09T20:45:09.000000Z"
            },
            {
                "id": 179,
                "guid": "179",
                "name": "Erythromycin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to any macrolide antibacterials",
                "interactions": "Decreases the elimination of hepatically-metabolized compounds, notably cyclosporine (which can be used advantageously to reduce the amount of cyclosporine needed to maintain therapeutic serum levels) and cisapride (which has been associated with prolongation of the QT interval on the electrocardiogram of human patients but is of unproven significance in veterinary medicine)\nPotentially fatal interaction if given with disopyramide 3 mg/kg IV",
                "adverse_effects": "Vomiting/hypersalivation/nausea (common: estimated to occur in 50% of dogs given antibacterial dosages of 10-15 mg/kg)\nOne suspected case of immune-mediated hemolytic anemia in a cat beginning 24-48 hours after start of erythromycin treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T19:39:27.000000Z",
                "updated_at": "2020-05-06T19:39:27.000000Z"
            },
            {
                "id": 180,
                "guid": "180",
                "name": "Erythropoietin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nLong-term use of human recombinant erythropoietin in dogs and cats is almost invariably associated with eventual iatrogenic pure red-cell aplasia",
                "interactions": null,
                "adverse_effects": "Erythroid hypoplasia (leading to intractable anemia via anti-erythropoietin antibodies) occurs in 67% of dogs after 4 weeks of treatment with recombinant human erythropoietin, a further 17% of dogs at 8 weeks, and 16% of dogs at 16 weeks (overall >99% incidence) but in 0% of dogs treated with recombinant canine erythropoietin\nIn cats, 71% of cats treated for >180 days using recombinant human erythropoietin develop anti-erythropoietin antibodies and concomitant refractory anemia\nRecombinant human erythropoietin is associated with vomiting in 36% of cats [concurrent uremia as possible confounder], and acute cutaneous hypersensitivity reactions in 9% of cats and 17% of dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T19:41:47.000000Z",
                "updated_at": "2020-05-06T19:41:47.000000Z"
            },
            {
                "id": 181,
                "guid": "181",
                "name": "Esmolol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Dobutamine",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Bradycardia \n Hypotension \n Could increase bronchoconstriction in asthmatic patients at higher dosages",
                "interactions": "Additive effects with other beta-blockers (e.g., atenolol, metoprolol, carvedilol, propranolol), calcium-channel blockers (diltiazem, verapamil), and potentially certain sodium-channel blockers (ivabradine)\r\ncountereffects/negation by catecholamines (e.g., dobutamine, epinephrine)",
                "adverse_effects": "Increase in left ventricular end-diastolic pressure may trigger congestive heart failure in patients with pre-existing structural heart disease",
                "deleted_at": null,
                "created_at": "2020-05-06T19:43:18.000000Z",
                "updated_at": "2020-11-09T21:09:11.000000Z"
            },
            {
                "id": 182,
                "guid": "182",
                "name": "Ethanol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Serum ethanol concentration of 35 mg/dL reduces urinary oxalic acid excretion to baseline (control) levels in dogs, indicating treatment efficacy\nno greater benefit if serum ethanol level = 140 mg/dL",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the compound",
                "interactions": "",
                "adverse_effects": "Somnolence, coma possible with high doses, and such signs may be used for titrating treatment (caution: high-dose exposure to ethylene glycol may produce similar signs)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:44:19.000000Z",
                "updated_at": "2020-11-11T18:49:44.000000Z"
            },
            {
                "id": 183,
                "guid": "183",
                "name": "Etodolac",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing keratoconjunctivitis sicca\nPre-existing gastrointestinal disorders",
                "interactions": "Should not be given concurrently with other nonsteroidal anti-inflammatories or with glucocorticoids (gastric ulceration risk may be severe)",
                "adverse_effects": "Keratoconjunctivitis sicca occurs in a small but significant proportion of cases (may be reversible with discontinuation of treatment, or permanent)\nCauses a significant decrease in thyroxine levels, with 21% of pre-treatment normal values falling below the reference interval during treatment, and may increase thyrotropin (TSH) concentration, mimicking hypothyroidism\nLimited significant gastrointestinal adverse effects (endoscopically-apparent gastric lesions) with long-term treatment (up to 90 days), worse at inappropriately high dosages of ≥ 25 mg/kg\nAdverse renal effects may occur in dogs that are dehydrated during treatment (e.g., due to concurrent illness, medication)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:45:28.000000Z",
                "updated_at": "2020-05-06T19:45:28.000000Z"
            },
            {
                "id": 184,
                "guid": "184",
                "name": "Etretinate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Powerful teratogen, both in animals receiving the medication and in humans touching the medication (cannot be handled by pregnant women): meningomyelocele, absence of distal phalanges, cardiac malformations, facial dysmorphia, etc.",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": "Fatty meal increases drug absorption\nHepatotoxicosis may be increased with other potentially hepatotoxic drugs (e.g., methotrexate)\nCumulative effect with other retinoids (e.g., isotretinoin)",
                "adverse_effects": "Teratogenicity\nHepatotoxicity\nPhotosensitization",
                "deleted_at": null,
                "created_at": "2020-05-06T19:46:20.000000Z",
                "updated_at": "2020-05-06T19:46:20.000000Z"
            },
            {
                "id": 185,
                "guid": "185",
                "name": "Famotidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "May alter absorption of drugs for which gastric pH is important regarding bioavailability (e.g., ketoconazole, ampicillin-class antibacterials, digoxin) - extrapolated from human medicine\r\nSucralfate needs an acidic environment to disperse, so it should be given >30 minutes before famotidine",
                "adverse_effects": "Extremely wide range of safety in dogs (1000-fold overdosages given daily for 2 years were not lethal) \n Anecdotal suspicion of risk of hemolysis in cats receiving injectable famotidine",
                "deleted_at": null,
                "created_at": "2020-05-06T19:47:00.000000Z",
                "updated_at": "2020-11-11T18:54:32.000000Z"
            },
            {
                "id": 186,
                "guid": "186",
                "name": "Fatty acid supplement",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Fish odor to pet's breath can be unpleasant to some owners\nOther potential adverse effects can involve platelet function, the GI tract, altered wound healing, and weight gain",
                "deleted_at": null,
                "created_at": "2020-05-06T19:48:49.000000Z",
                "updated_at": "2020-11-11T18:58:33.000000Z"
            },
            {
                "id": 187,
                "guid": "187",
                "name": "Febantel",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Contraindicated in pregnancy (combination of febantel and praziquantel is associated with increased rates of abortion, fetal deformities);effective and grossly safe (no overt adverse effects) in 2 week-old puppies",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T19:49:54.000000Z",
                "updated_at": "2020-05-06T19:49:54.000000Z"
            },
            {
                "id": 188,
                "guid": "188",
                "name": "Felbamate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "13-55 mg/L reported in dogs, in conjunction with good clinical results",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "May increase serum phenobarbital concentrations if being administered concurrently",
                "adverse_effects": "Mild, drug-associated neutropenia and/or thrombocytopenia are common and may require ending felbamate treatment of affected dogs\nSingle case report of keratoconjunctivitis sicca (unclear if drug related or spontaneous)",
                "deleted_at": null,
                "created_at": "2020-05-06T19:52:46.000000Z",
                "updated_at": "2020-05-06T19:52:46.000000Z"
            },
            {
                "id": 189,
                "guid": "189",
                "name": "Fenbendazole",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Demonstrated to be safe to administer during pregnancy and to puppies 6 weeks of age or older",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Myelotoxicosis seen with other benzimidazole antiparasitics (e.g., albendazole) appears to be far less common with fenbendazole",
                "deleted_at": null,
                "created_at": "2020-05-06T19:53:17.000000Z",
                "updated_at": "2020-11-11T19:38:13.000000Z"
            },
            {
                "id": 190,
                "guid": "190",
                "name": "Fentanyl",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "Plasma level for analgesia = 0.23 ng/mL (dog), 1.07 ng/mL (cat)",
                "reversal_agent": "Naloxone (IV/IM/SC use antagonizes all fentanyl formulations, including transdermal)",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other opiate drugs  \n  Respiratory depression",
                "interactions": "Has additive effects with other central nervous system depressants (e.g., other opiates, tranquilizers, sedatives)",
                "adverse_effects": "Bradycardia, hypoventilation may occur but are less common with fentanyl than with many other opiates\n High dosages may stimulate physical activity briefly in cats but \"opioid mania\" is not a common occurrence in cats or dogs \n Dysphoria occurs in 24% of dogs receiving fentanyl after orthopedic surgery\nDysphoria occurs in 24% of dogs receiving fentanyl after orthopedic surgery  \n Marked cardiovascular vagal effects have caused asystole even with therapeutic fentanyl doses (3 μg/kg IV single bolus), which has responded to atropine 0.04 mg/kg IV and closed chest compressions\nMarked cardiovascular vagal effects have caused asystole even with therapeutic fentanyl doses (3 μg/kg IV single bolus), which has responded to atropine 0.04 mg/kg IV and closed chest compressions",
                "deleted_at": null,
                "created_at": "2020-05-06T19:56:46.000000Z",
                "updated_at": "2020-11-11T20:06:38.000000Z"
            },
            {
                "id": 191,
                "guid": "191",
                "name": "Ferrous sulfate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Deferoxamine",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound",
                "interactions": null,
                "adverse_effects": "Inappetence, nausea can occur, especially at higher dosages",
                "deleted_at": null,
                "created_at": "2020-05-06T20:01:23.000000Z",
                "updated_at": "2020-05-06T20:01:23.000000Z"
            },
            {
                "id": 192,
                "guid": "192",
                "name": "Filgrastim",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Benefit is short-lived (with q 12h treatment in cats, leukocyte counts decrease significantly by day 19 of treatment), likely due to autoantibody formation\nBleeding, decreased platelet count, and signs of bone pain associated with high-dose treatment in 1 case report",
                "deleted_at": null,
                "created_at": "2020-05-06T20:02:25.000000Z",
                "updated_at": "2020-11-11T20:10:32.000000Z"
            },
            {
                "id": 193,
                "guid": "193",
                "name": "Finasteride",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Contraindicated in pregnancy - teratogenic",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Increased risk of developing prostate cancer\nMinor sexual side effects\nDecrease in sperm volume but not quality",
                "deleted_at": null,
                "created_at": "2020-05-06T20:03:56.000000Z",
                "updated_at": "2020-05-06T20:03:56.000000Z"
            },
            {
                "id": 194,
                "guid": "194",
                "name": "Firocoxib",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Maternotoxic and fetotoxic - not for use in pregnant or lactating bitches",
                "contraindications": "Hypersensitivity to the drug \n Dogs less than 7 months old \n Gastrointestinal bleeding \n Blood dyscrasias or hemorrhagic disorders",
                "interactions": "Concomitant use with corticosteroids or other NSAIDs is contraindicated due to possibility of severe (life-threatening)  gastrointestinal ulceration, bleeding, and/or perforation, and risk of renal and hepatic adverse effects",
                "adverse_effects": "Hepatotoxicosis (hepatic lipidosis and other changes) in dogs 6 months of age or younger \n Inappetence, vomiting, diarrhea possible (5.1% of adult dogs treated for osteoarthritis for 1 year)",
                "deleted_at": null,
                "created_at": "2020-05-06T20:04:36.000000Z",
                "updated_at": "2020-11-11T20:30:28.000000Z"
            },
            {
                "id": 195,
                "guid": "195",
                "name": "Fluconazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Measured serum levels in treated cats (50 mg/CAT PO q 12h) = 15-80 mg/L, but correlation to a therapeutic threshold is not defined",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other azole antifungals",
                "interactions": "Increases serum levels of several coadministered drugs including aminophylline/theophylline, antihistamines, nonsteroidal anti-inflammatory drugs, cyclosporine, voriconazole, and fentanyl\nCoadministration of cimetidine may alter absorption\nDiscontinuation of fluconazole can produce an increase in hepatic enzyme activity, lowering serum levels of coadministered drugs via increased elimination\nCoadministration with cyclosporin alters neither cyclosporine nor fluconazole concentrations, nor other pharmacokinetic parameters",
                "adverse_effects": "Azole antifungals may cause hepatotoxicosis (monitoring and change in treatment if signs of liver dysfunction arise) but this appears to be uncommon with fluconazole in dogs and cats",
                "deleted_at": null,
                "created_at": "2020-05-06T20:05:11.000000Z",
                "updated_at": "2020-11-11T20:42:59.000000Z"
            },
            {
                "id": 196,
                "guid": "196",
                "name": "Fludrocortisone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Hyperadrenocorticism",
                "interactions": "May have cumulative effects with other drugs that predispose to hypokalemia (e.g., such loop diuretics as furosemide) or disorders that predispose to hypokalemia (e.g., chronic kidney disease) and individuals with such predisposing causes should have clinical signs and serum electrolytes monitored more closely",
                "adverse_effects": "Hypernatermia and hypokalemia are possible but not clinically important except in overdoses\nHypokalemia in 37% of cats undergoing fludrocortisone response test, but without induction or exacerbation of arterial hypertension",
                "deleted_at": null,
                "created_at": "2020-05-06T20:08:31.000000Z",
                "updated_at": "2020-11-11T20:57:48.000000Z"
            },
            {
                "id": 197,
                "guid": "197",
                "name": "Flumazenil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to benzodiazepines",
                "interactions": "",
                "adverse_effects": "Administration to individuals having received chronic, high-dose benzodiazepines may trigger benzodiazepine withdrawal signs, including seizures",
                "deleted_at": null,
                "created_at": "2020-05-06T20:09:28.000000Z",
                "updated_at": "2020-11-11T21:00:58.000000Z"
            },
            {
                "id": 198,
                "guid": "198",
                "name": "Flunixin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing gastrointestinal erosion/ulceration/bleeding\nRenal disease",
                "interactions": "Additive gastrointestinal ulcerogenic effects with other nonsteroidal anti-inflammatory drugs and/or corticosteroids",
                "adverse_effects": "Gastrointestinal ulceration/bleeding occurs commonly, including with single doses in compromised patients (hypovolemia, kidney disease, etc.)\nAdverse kidney and hepatic effects are well-recognized in small animals",
                "deleted_at": null,
                "created_at": "2020-05-06T20:10:14.000000Z",
                "updated_at": "2020-05-06T20:10:14.000000Z"
            },
            {
                "id": 199,
                "guid": "199",
                "name": "Fluorouracil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Teratogen\ncontraindicated in pregnancy",
                "contraindications": "Hypersensitivity to the drug \n Absolute contraindication in cats (neurotoxicosis) \n Pre-existing myelosuppression \n Pre-existing neurologic dysfunction \n Pre-existing serious infection",
                "interactions": "Leucovorin may enhance the toxicity of fluorouracil",
                "adverse_effects": "Neurotoxicosis occurs in up to 40% of dogs treated with fluorouracil as part of antineoplastic chemotherapeutic protocols \n Toxic ingestions also are well-recognized in dogs, especially from licking/chewing human fluorouracil preparations (e.g., tubes of fluorouracil skin cream) \n Minimum lethal ingested dosage in dogs: 20 mg/kg (i.e., only 0.4 g/kg of human fluorouracil cream) \n Clinical signs in dogs are biphasic - the most severe intoxications produce seizures (77% of cases), vomiting (73% of cases), and sudden death (61%), typically occurring within 60 minutes of ingestion (vomiting, seizures) and <24h after ingestion (death) \n Dogs that survive may experience profound neutropenia and thrombocytopenia from myelosuppression 5-7 days later\nMassive overdose (10 g fluorouracil cream in 30 kg dog\n 330 mg/kg) has been treated successfully: immediate spontaneous vomiting and then decontamination with activated charcoal produced a clinically normal dog 4 hours ingestion\n refractory seizures began 6 hours after ingestion and were managed with heavy sedation (phenobarbital, benzodiazepines, ketamine, and propofol) and 48 hours of mechanical ventilation, then IV levetiracetam due to persistent seizure activity, leading to discharge after 6 days and no lasting deficits in 1 case report",
                "deleted_at": null,
                "created_at": "2020-05-06T20:10:55.000000Z",
                "updated_at": "2020-11-11T21:01:57.000000Z"
            },
            {
                "id": 200,
                "guid": "200",
                "name": "Fluoxetine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Should not be coadministered with serotonergic drugs (e.g., other SSRIs, or monoamine oxidase inhibitors [selegiline, amitraz, etc.]), which carry the potential for serotonin syndrome\r\nHepatically-metabolized drugs (CYP2D6 enzyme-associated effects)\r\nBenzodiazepines (e.g., diazepam, midazolam, because the half-life of these drugs is increased)\r\nAlprazolam (increased alprazolam plasma levels may impair psychomotor function)",
                "adverse_effects": "Owner-reported lethargy and inappetence occur in 39% and 23% of treated dogs, respectively, vs. 0% of placebo-treated controls",
                "deleted_at": null,
                "created_at": "2020-05-06T20:12:09.000000Z",
                "updated_at": "2020-11-11T21:06:29.000000Z"
            },
            {
                "id": 201,
                "guid": "201",
                "name": "Fluticasone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug  \n  Intolerance to administration despite practice and careful handling if act of treating creates respiratory difficulty in the patient",
                "interactions": "Minimal, due to non-systemic route of administration",
                "adverse_effects": "Suppression of adrenal glucocorticoid production (blunted ACTH stimulation test results) after 1-3 weeks of treatment in dogs (250 µg/dose q 12h)  \n  No appreciable suppression of adrenal function in cats receiving 44-220 µg/CAT q 12h for 3 weeks \n Localized facial demodicosis due to Demodex cati has occurred in cats in association with inhaled fluticasone",
                "deleted_at": null,
                "created_at": "2020-05-06T20:14:04.000000Z",
                "updated_at": "2020-11-11T21:21:10.000000Z"
            },
            {
                "id": 202,
                "guid": "202",
                "name": "Folate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Extensively tested in pregnant women and considered safe",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Certain antineoplastic chemotherapeutics (e.g., methotrexate) and antibacterials (e.g., sulfa drugs) function through antagonism of folate",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T20:15:30.000000Z",
                "updated_at": "2020-11-11T21:15:05.000000Z"
            },
            {
                "id": 203,
                "guid": "203",
                "name": "Fomepizole",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Sporadic reports of anaphylactoid reactions",
                "deleted_at": null,
                "created_at": "2020-05-06T20:16:24.000000Z",
                "updated_at": "2020-05-06T20:16:24.000000Z"
            },
            {
                "id": 204,
                "guid": "204",
                "name": "Fondaparinux",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "0.1-0.4 mg/L (trough-peak) and 0.1-1.2 mg/L (trough-peak) plasma fondaparinux levels for prophylaxis against thromboembolism and treatment of existing thrombosis, respectively, in cats",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nBleeding disorders\nActive blood loss",
                "interactions": "Cumulative effect (and risk of hemorrhage) with other anticoagulants (e.g., warfarin, heparin) or with antiplatelet drugs (e.g., aspirin, clopidogrel)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T20:17:22.000000Z",
                "updated_at": "2020-05-06T20:17:22.000000Z"
            },
            {
                "id": 205,
                "guid": "205",
                "name": "Furosemide",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Intravenous fluid therapy",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug  \n  Hypovolemia",
                "interactions": "Cumulative effect with other diuretics (reducing circulating plasma volume)\r\nMay potentiate potassium and magnesium wasting if cotreatment with certain additional diuretics (e.g., thiazides) or this effect may be offset by potassium-sparing diuretics (e.g., spironolactone)\r\nHypokalemia caused by furosemide can potentiate digoxin toxicosis\r\nMay enhance nephrotoxicosis and/or ototoxicosis of aminoglycoside antibacterials, platinum-based antineoplastics, or both",
                "adverse_effects": "Mild azotemia is common and expected during treatment, whereas overtreatment can cause profound dehydration, hypovolemia, and hypotension, leading to intrinsic renal failure  \n  Hypokalemia, hypomagnesemia, and metabolic alkalosis are common and should be adjusted by assessing whether the severity of fluid retention (past or present) requires the current dosage of furosemide, and decreasing the dosage if it is not",
                "deleted_at": null,
                "created_at": "2020-05-06T20:17:47.000000Z",
                "updated_at": "2020-11-11T21:24:29.000000Z"
            },
            {
                "id": 206,
                "guid": "206",
                "name": "Gabapentin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "2.2-20 mg/L (trough) measured in dogs receiving 10 mg/kg PO q 8h, but correlation to seizure frequency, presence of a threshold level, and comparison to human serum levels (2-61.2 mg/L\ntoo broad to be clinically useful) limits this finding\nmainly used in vet med to confirm whether bioavailability of drug (which is highly variable from dog to dog) is adequate for producing serum levels that approximate the mid-range of human therapeutic levels",
                "reversal_agent": "",
                "teratogenicity": "Fetotoxic (hydroureter, delayed ossification of skull, vertebrae, and limbs in rats)",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Ataxia, sedation reported in some epileptic dogs (unclear if due to gabapentin or other concurrent anticonvulsants) \n Renally excreted, requiring dosage adjustment in patients with kidney disease",
                "deleted_at": null,
                "created_at": "2020-05-06T20:21:34.000000Z",
                "updated_at": "2020-11-12T19:10:29.000000Z"
            },
            {
                "id": 207,
                "guid": "207",
                "name": "Gemcitabine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fetotoxic (cleft palate, incomplete ossification) when given to pregnant dam",
                "contraindications": "Hypersensitivity to the drug\nPre-existing neutropenia\nThrombocytopenia",
                "interactions": "Potential for cumulative effect with other myelosuppressant and/or nausea-triggering drugs, notably other antineoplastic chemotherapeutics",
                "adverse_effects": "Vomiting, anorexia, diarrhea, and/or neutropenia can occur in approximately 1/3 of dogs at some point during treatment\nNeutropenia (33%), thrombocytopenia (17%) and gastrointestinal toxicosis (17%) occur in cats cotreated with gemcitabine and carboplatin",
                "deleted_at": null,
                "created_at": "2020-05-06T20:22:58.000000Z",
                "updated_at": "2020-05-06T20:22:58.000000Z"
            },
            {
                "id": 208,
                "guid": "208",
                "name": "Gentamicin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "Peak: 20 µg/mL (11-18 µmol/L);Trough [i.e., lower limit of detection]: 0.27 µg/mL (<1.1 µmol/L);Toxic range: peak >30-35 µg/mL [>27-33 µmol/L], trough >2 µg/mL [>2.7 µmol/L];(all data for dogs)",
                "reversal_agent": "Sylimarin and vitamin E combination lessens nephrotoxicosis in the dog[1]; ticarcillin at standard dosages binds gentamicin and reduces nephrotoxicosis (and reduces therapeutic effect), which is mainly useful in cases of overdosage",
                "teratogenicity": "Fetotoxic (nephrotoxic to fetus)",
                "contraindications": "Hypersensitivity to the drug\nPre-existing renal injury or failure (may not be absolute contraindication, but requires consideration of alternatives and judicious administration/monitoring if used)\nUntreated hypovolemia/hypotension",
                "interactions": "Caution: may cause precipitation of drug if administered directly in IV catheter with certain other drugs (e.g., Na penicillin), causing occlusion of the catheter and lack of drug delivery\nAll catheters must be flushed with sterile saline prior to, and after, IV administration of gentamicin\nEven in the absence of visible precipitation, gentamicin (and all aminoglycosides) binds in vitro to beta-lactam antibacterials (all penicillin-class antibacterials, all cephalosporins, etc.), inhibiting the antibacterial effect of both drugs",
                "adverse_effects": "Nephrotoxicosis is common in patients with pre-existing kidney disease and/or hypovolemia\nOtotoxicosis is reported in small animals with systemic or topical administration\nDose-dependent neuromuscular blockade",
                "deleted_at": null,
                "created_at": "2020-05-06T20:24:39.000000Z",
                "updated_at": "2020-05-06T20:24:39.000000Z"
            },
            {
                "id": 209,
                "guid": "209",
                "name": "Glipizide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose 50%",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing disorders causing signs that could be confused with adverse reactions",
                "interactions": "Additive effects when cotreatment with glipizide and other oral antihypertensive drugs or with insulin",
                "adverse_effects": "Transient anorexia (16% of cats) and transient icterus with normal liver enzyme activity (8%) occurs with treatment in diabetic cats\nThis is a sulfa-derived drug (sulfonylurea), therefore idiosyncratic reactions recorded in dogs and cats receiving sulfa-based antibacterials also should be cause for vigilance with glipizide: hepatic, dermatologic, and hematologic systems are typically more vulnerable",
                "deleted_at": null,
                "created_at": "2020-05-06T20:26:48.000000Z",
                "updated_at": "2020-05-06T20:26:48.000000Z"
            },
            {
                "id": 210,
                "guid": "210",
                "name": "Glucagon",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Pheochromocytoma \n Persistent hyperglycemia \n Disorders of reduced GI motility",
                "interactions": "",
                "adverse_effects": "Somnolence with SC administration in some dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T20:27:34.000000Z",
                "updated_at": "2020-11-12T19:25:52.000000Z"
            },
            {
                "id": 211,
                "guid": "211",
                "name": "Glucosamine + chondroitin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T20:29:07.000000Z",
                "updated_at": "2020-11-12T20:39:03.000000Z"
            },
            {
                "id": 212,
                "guid": "212",
                "name": "Glycopyrrolate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Minimal fetal effect expected because does not cross the placenta in appreciable concentrations",
                "contraindications": "Hypersensitivity to the drug\nPre-existing tachycardia",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T20:29:48.000000Z",
                "updated_at": "2020-05-06T20:29:48.000000Z"
            },
            {
                "id": 213,
                "guid": "213",
                "name": "Glycosaminoglycan, polysulfated",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T20:30:54.000000Z",
                "updated_at": "2020-05-06T20:30:54.000000Z"
            },
            {
                "id": 214,
                "guid": "214",
                "name": "Gonadotropin-releasing hormone (GnRH)",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fetotoxic both to animals and to people;should not be given to pregnant animals nor handled by pregnant women",
                "contraindications": "Hypersensitivity to the drug\nPlanned conception/mating",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T20:31:38.000000Z",
                "updated_at": "2020-05-06T20:31:38.000000Z"
            },
            {
                "id": 215,
                "guid": "215",
                "name": "Granisetron",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T20:34:09.000000Z",
                "updated_at": "2020-05-06T20:34:09.000000Z"
            },
            {
                "id": 216,
                "guid": "216",
                "name": "Griseofulvin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Cerebellar hypoplasia in kittens whose dams were treated with griseofulvin 500-1000 mg/CAT PO q 1 week during pregnancy\ncraniofacial defects (e.g., cleft palate) in kittens also",
                "contraindications": "Hypersensitivity to the drug \n Pregnancy \n Neutropenia/myelosuppression",
                "interactions": "",
                "adverse_effects": "Myelotoxicosis, especially in cat with feline immunodeficiency virus infection \n Neurotoxicosis, especially if overdose \n Cutaneous drug eruptions reported \n No adverse effect on semen quality in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T20:34:55.000000Z",
                "updated_at": "2020-11-12T20:41:04.000000Z"
            },
            {
                "id": 217,
                "guid": "217",
                "name": "Hemoglobin polymer",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": null,
                "adverse_effects": "Orange discoloration of mucous membranes, skin, and plasma is expected and should not be confused with icterus\nIn cats, volume overload (as with any intravenous fluid) can cause iatrogenic congestive heart failure: pleural effusion (18% of cats), pulmonary (8% of cats), or both, typically responding to benign neglect (no intervention needed) or rarely requiring furosemide and/or oxygen supplementation for hours-days",
                "deleted_at": null,
                "created_at": "2020-05-06T20:36:19.000000Z",
                "updated_at": "2020-05-06T20:36:19.000000Z"
            },
            {
                "id": 218,
                "guid": "218",
                "name": "Heparin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Therapeutic range for anti-factor-Xa activity is 0.35-0.7 U/mL (extrapolated from human medicine)",
                "reversal_agent": "Protamine",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Active bleeding \n Deficiency/absence of antithrombin",
                "interactions": "Cumulative effects (and risk of bleeding) with other anticoagulants and/or with antiplatelet drugs",
                "adverse_effects": "Excess may cause bleeding, but in clinical cases, undertreatment (allowing thromboembolism) is generally more common than overtreatment",
                "deleted_at": null,
                "created_at": "2020-05-06T20:37:27.000000Z",
                "updated_at": "2020-11-12T20:50:11.000000Z"
            },
            {
                "id": 219,
                "guid": "219",
                "name": "Heparin, low-molecular-weight",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Therapeutic range for anti-factor-Xa activity is 0.5-1 U/mL (extrapolated from human medicine)",
                "reversal_agent": "Protamine",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nActive bleeding\nDeficiency/absence of antithrombin",
                "interactions": "Cumulative effects (and risk of bleeding) with other anticoagulants and/or with antiplatelet drugs",
                "adverse_effects": "Excess may cause bleeding, but in clinical cases, undertreatment (allowing thromboembolism) is generally more common than overtreatment",
                "deleted_at": null,
                "created_at": "2020-05-06T20:39:26.000000Z",
                "updated_at": "2020-05-06T20:39:26.000000Z"
            },
            {
                "id": 220,
                "guid": "220",
                "name": "Hetacillin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to any beta-lactam (e.g., penicillin-class, cephalosporin, etc.) antibacterial drugs",
                "interactions": "Avoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T20:40:49.000000Z",
                "updated_at": "2020-05-06T20:40:49.000000Z"
            },
            {
                "id": 221,
                "guid": "221",
                "name": "Hydralazine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Vasopressors (e.g., dopamine, phenylephrine)",
                "teratogenicity": "Cleft palate and fetal craniofacial malformations have occurred in laboratory animals",
                "contraindications": "Hypersensitivity to the drug \n Pre-existing hypotension",
                "interactions": "Cumulative effects with other antihypertensives (e.g., amlodipine, prazosin, phenoxybenzamine) or other drugs that lower systemic blood pressure (e.g., inhalant anesthetics)",
                "adverse_effects": "Hypotension (decreased activity, inappetence, collapse)",
                "deleted_at": null,
                "created_at": "2020-05-06T20:41:14.000000Z",
                "updated_at": "2020-11-12T20:59:49.000000Z"
            },
            {
                "id": 222,
                "guid": "222",
                "name": "Hydrochlorothiazide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Intravenous fluids, hemodialysis (anuria)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to other sulfa-derived drugs\nOliguria/anuria",
                "interactions": "Additive effects (hypotension, electrolyte depletion) with other diuretics",
                "adverse_effects": "Decreases serum potassium concentration",
                "deleted_at": null,
                "created_at": "2020-05-06T20:42:54.000000Z",
                "updated_at": "2020-05-06T20:42:54.000000Z"
            },
            {
                "id": 223,
                "guid": "223",
                "name": "Hydrocodone",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "In healthy greyhounds, administration of 0.5 mg/kg PO (tablet) produces serum hydrocodone levels ≥ 2 ng/mL for 0.5-8h after administration[1]",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other opiates\nPurposeful/productive cough (e.g., pneumonia, airway foreign body) or systemic/\"warning\" cough (pulmonary hemorrhage, pulmonary edema, etc.)",
                "interactions": null,
                "adverse_effects": "Cumulative sedative effects are possible with other opiates and/or sedatives, but this would usually require dosages well above therapeutic range, and/or significant debility or illness",
                "deleted_at": null,
                "created_at": "2020-05-06T20:44:20.000000Z",
                "updated_at": "2020-05-06T20:44:20.000000Z"
            },
            {
                "id": 224,
                "guid": "224",
                "name": "Hydrocortisone sodium succinate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Corticosteroids are contraindicated in pregnancy both for fetotoxic effects and abortefacient effects",
                "contraindications": "Hypersensitivity to the product\nActive gastrointestinal bleeding",
                "interactions": "Avoid nonsteroidal anti-inflammatories and/or other glucocorticoids concurrently (markedly increased risk of gastrointestinal ulceration/perforation)",
                "adverse_effects": "Gastrointestinal ulceration (especially with acute, high-dosage use in compromised patients)",
                "deleted_at": null,
                "created_at": "2020-05-06T20:45:00.000000Z",
                "updated_at": "2020-05-06T20:45:00.000000Z"
            },
            {
                "id": 225,
                "guid": "225",
                "name": "Hydrogen peroxide 3%",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Ingestion of substances that could cause caustic chemical injury during vomiting (e.g., acids, alkalis) or which could easily be inhaled during vomiting and cause aspiration pneumonia (oils, solvents)\nPatient unconsciousness or mental depression/abnormal mentation\nSeizure disorders",
                "interactions": null,
                "adverse_effects": "Aspiration (of hydrogen peroxide, of vomited ingesta)",
                "deleted_at": null,
                "created_at": "2020-05-06T20:46:17.000000Z",
                "updated_at": "2020-05-06T20:46:17.000000Z"
            },
            {
                "id": 226,
                "guid": "226",
                "name": "Hydromorphone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Naloxone; partial reversal with butorphanol administration",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other opiates\nPre-existing vomiting/disorders causing nausea\nPre-exisiting dysphoria or disorders where dysphoria may be detrimental (central nervous system disorders, disorders requiring the animal to remain immobilized) if evidence of dysphoria has emerged during previous hydromorphone treatment\nPre-existing hyperthermia (cats)\nIntolerance to common adverse effects (e.g., panting, hyperresponsiveness to sound)\nRespiratory depression",
                "interactions": "Repeated cotreatment with anticholinergics may cause ileus, constipation\nCoadministration with butorphanol may partially reverse effects of hydromorphone\nAdditive effects possible if given with other central nervous system depressants (sedatives, tranquilizers)",
                "adverse_effects": "Hyperthermia (up to 40.3°C [104.5°F], with panting, and lasting 6h) in 17% of cats given 0.1 mg/kg IV\nPanting in 55% of treated dogs (and many cats)\nVomiting (22% of dogs and cats receiving 0.05 mg/kg IV doses)\nHigh vagal tone causes transient second-degree atrioventricular block in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T20:46:44.000000Z",
                "updated_at": "2020-05-06T20:46:44.000000Z"
            },
            {
                "id": 227,
                "guid": "227",
                "name": "Hydroxyethyl starch",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product\nActive bleeding",
                "interactions": "Increased risk of bleeding if cotreatment with other drugs that induce platelet dysfunction (e.g., aspirin, clopidogrel)",
                "adverse_effects": "Vomiting, hypotension in cats if given as a rapid bolus\nHemodilution\nAltered (reduced) platelet function potentially predisposing to bleeding (in dogs, platelet closure time doubles for 12 hours after administration, then returns to normal in most but not all dogs by 24h)",
                "deleted_at": null,
                "created_at": "2020-05-06T20:48:39.000000Z",
                "updated_at": "2020-05-06T20:48:39.000000Z"
            },
            {
                "id": 228,
                "guid": "228",
                "name": "Hydroxyurea",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Methylene blue 1-10 mg/kg slow IV, using the lowest effective dosage[1] for methemoglobinemia associated with hydroxyurea toxicosis",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing leukopenia or thrombocytopenia",
                "interactions": "Additive bone marrow effects and/or gastrointestinal effects possible with other antineoplastic chemotherapeutic drugs",
                "adverse_effects": "Leukopenia, thrombocytopenia possible and reversible with dosage adjustment\nMethemoglobinemia in dogs receiving 80-400 mg/kg\nOnychomadesis (sloughing of the nails) has occurred in dogs receiving hydroxyurea at clinical dosages",
                "deleted_at": null,
                "created_at": "2020-05-06T20:50:12.000000Z",
                "updated_at": "2020-05-06T20:50:12.000000Z"
            },
            {
                "id": 229,
                "guid": "229",
                "name": "Hydroxyzine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Potentiates opiates, barbiturates",
                "adverse_effects": "Massive overdoses can cause coma that can be reversible with intensive care",
                "deleted_at": null,
                "created_at": "2020-05-06T20:52:37.000000Z",
                "updated_at": "2020-05-06T20:52:37.000000Z"
            },
            {
                "id": 230,
                "guid": "230",
                "name": "Ibafloxacin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Labeled as safe for pregnant dogs",
                "contraindications": "Hypersensitivity to the drug and/or to other fluoroquinolones\nSeizure disorders, particularly in patients also receiving nonsteroidal anti-inflammatory drugs\nGrowing puppy (cartilage damage possible in dogs <8 months old, <18 months if giant breeds)",
                "interactions": "Interaction with nonsteroidal anti-inflammatory drugs, especially with respect to lowering seizure threshold",
                "adverse_effects": "Lowers seizure threshold, notably in dogs receiving cotreatment with nonsteroidal anti-inflammatory drugs\nChondrotoxicosis in growing animals\nDrug class effect of retinal toxicosis in cats at higher dosages",
                "deleted_at": null,
                "created_at": "2020-05-06T20:53:35.000000Z",
                "updated_at": "2020-05-06T20:53:35.000000Z"
            },
            {
                "id": 231,
                "guid": "231",
                "name": "Ibuprofen",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "In dogs, serum ibuprofen levels < 31 µg/mL are associated with absence of toxicosis",
                "reversal_agent": "Lipid emulsion IV infusion effective in 1 case report",
                "teratogenicity": "",
                "contraindications": "",
                "interactions": "",
                "adverse_effects": "Gastrointestinal ulceration",
                "deleted_at": null,
                "created_at": "2020-05-06T20:54:15.000000Z",
                "updated_at": "2020-11-16T00:44:22.000000Z"
            },
            {
                "id": 232,
                "guid": "232",
                "name": "Ifosfamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Fetotoxic - not for use in pregnancy",
                "contraindications": "Hypersensitivity to the drug \n Myelosuppression",
                "interactions": "Cumulative myelotoxic and/or gastrointestinal effects with many other antineoplastic chemotherapeutic drugs\n Cumulative nephrotoxic effects with aminoglycoside antibacterials (gentamicin, amikacin, etc.) and other nephrotoxic drugs",
                "adverse_effects": "Neutropenia, severe gastrointestinal effects, nephrotoxicity",
                "deleted_at": null,
                "created_at": "2020-05-06T20:56:15.000000Z",
                "updated_at": "2020-11-16T01:35:01.000000Z"
            },
            {
                "id": 233,
                "guid": "233",
                "name": "Imatinib",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Potent teratogen/fetotoxin",
                "contraindications": "Hypersensitivity to the drug \n Pregnancy",
                "interactions": "Inhibits hepatic microenzyme systems, which can increase serum levels of hepatically-metabolized drugs",
                "adverse_effects": "Relevant human adverse effects (extrapolation to vet med unknown) include congestive heart failure in patients with previously-compensated heart disease, hepatotoxicosis, and myelotoxicosis",
                "deleted_at": null,
                "created_at": "2020-05-06T20:57:09.000000Z",
                "updated_at": "2020-11-16T01:38:02.000000Z"
            },
            {
                "id": 234,
                "guid": "234",
                "name": "Imidapril",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic - not for use in pregnancy",
                "contraindications": "Hypersensitivity to the drug\nSystemic hypotension\nVentricular outflow tract obstructions (e.g., pulmonic or subaortic stenosis)\nHypertrophic cardiomyopathy",
                "interactions": "Coadministration with diuretics is appropriate, but excessive amounts of either drug may cause hypotension, dehydration, and renal adverse effects",
                "adverse_effects": "Nonspecific adverse effects in 26% of treated dogs (lethargy, inappetence) that may be due to the underlying disease process or to coadministered diuretics\nAs a class, ACE inhibitors in dogs and cats uncommonly cause adverse effects if renal function is adequate and the animal is alert and eating ",
                "deleted_at": null,
                "created_at": "2020-05-06T20:57:38.000000Z",
                "updated_at": "2020-05-06T20:57:38.000000Z"
            },
            {
                "id": 235,
                "guid": "235",
                "name": "Imidocarb",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Atropine",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Concurrent cholinergic agonists/anticholinesterases may accentuate toxicity",
                "adverse_effects": "Cholinergic signs possible (hypersalivation, vomiting, diarrhea, etc.) \n Discomfort at the site of injection for a few minutes after administration in cats \n 10-fold overdose in a dog was acutely fatal, due to massive hepatic necrosis",
                "deleted_at": null,
                "created_at": "2020-05-06T20:58:21.000000Z",
                "updated_at": "2020-11-16T01:48:10.000000Z"
            },
            {
                "id": 236,
                "guid": "236",
                "name": "Imipenem + cilastatin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other carbipenem or penicillin antibacterials\nSeizures are a possible contraindication, since this drug lowers the seizure threshold in humans (GABA-receptor antagonist)",
                "interactions": "Cilastatin is an inhibitor of renal tubular cell metabolism of imipenem and is added by the manufacturer (in 1:1 amounts in mg) to prolong the drug's effect and reduce nephrotoxicity",
                "adverse_effects": "Central nervous system effects (e.g., seizures) possible during drug administration, warranting immediate discontinuation",
                "deleted_at": null,
                "created_at": "2020-05-06T20:59:56.000000Z",
                "updated_at": "2020-05-06T20:59:56.000000Z"
            },
            {
                "id": 237,
                "guid": "237",
                "name": "Imipramine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "200-300 ng/mL (extrapolated from human medicine)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nCotreatment with monoamine oxidase inhibitor",
                "interactions": "Monoamine oxidase inhibitors are contraindicated during imipramine treatment (risk of hyperpyretic crises, seizures), and a minimum 14-day washout period is recommended if switching from imipramine to an MAO inhibitor (or vice-versa)",
                "adverse_effects": "Anxiety, undesirable behavior changes\nHigh dosages may cause decrease in gastrointestinal motility",
                "deleted_at": null,
                "created_at": "2020-05-06T21:00:51.000000Z",
                "updated_at": "2020-05-06T21:00:51.000000Z"
            },
            {
                "id": 238,
                "guid": "238",
                "name": "Immunoglobulin G, human",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product",
                "interactions": "",
                "adverse_effects": "Hypersensitivity reactions are very common, especially with repeated dosing, and require termination of treatment \n Transient leukopenia, circulating thrombin-antithrombin complexes, and increased fibrin(ogen) degradation products occur in dogs shortly after receiving a human immunoglobulin infusion",
                "deleted_at": null,
                "created_at": "2020-05-06T21:01:55.000000Z",
                "updated_at": "2020-11-16T01:50:27.000000Z"
            },
            {
                "id": 239,
                "guid": "239",
                "name": "Insulin, detemir",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoglycemia",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Mild, moderate or severe hypoglycemia can occur with excessive insulin effect (due to insulin sensitivity [e.g., transient resolution of diabetes mellitus/\"honeymoon period\"], excessively high dosage, or removal of insulin antagonism [e.g., reduction of endogenous [hyperadrenocorticism] or exogenous [injections, tablets] corticosteroids)\nRebound hyperglycemia (Somogyi effect) also possible with excessively high dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T21:04:03.000000Z",
                "updated_at": "2020-05-06T21:04:03.000000Z"
            },
            {
                "id": 240,
                "guid": "240",
                "name": "Insulin, glargine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Dextrose",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Hypoglycemia",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\r\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Mild, moderate or severe hypoglycemia can occur with excessive insulin effect (due to insulin sensitivity [e.g., transient resolution of diabetes mellitus/\"honeymoon period\"], excessively high dosage, or removal of insulin antagonism [e.g., reduction of endogenous [hyperadrenocorticism] or exogenous [injections, tablets] corticosteroids) \n Hypersensitivity has been recorded in 1 cat\nRebound hyperglycemia (Somogyi effect) also possible with excessively high dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T21:05:06.000000Z",
                "updated_at": "2020-11-16T02:02:13.000000Z"
            },
            {
                "id": 241,
                "guid": "241",
                "name": "Insulin, lente",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Dextrose",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Hypoglycemia",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\r\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Mild, moderate or severe hypoglycemia can occur with excessive insulin effect (due to insulin sensitivity [e.g., transient resolution of diabetes mellitus/\"honeymoon period\"], excessively high dosage, or removal of insulin antagonism [e.g., reduction of endogenous [hyperadrenocorticism] or exogenous [injections, tablets] corticosteroids) \n Rebound hyperglycemia (Somogyi effect) also possible with excessively high dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T21:05:54.000000Z",
                "updated_at": "2020-11-16T02:05:57.000000Z"
            },
            {
                "id": 242,
                "guid": "242",
                "name": "Insulin, lispro",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoglycemia",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Caution when decreasing blood glucose concentration too quickly hour-by-hour (severe/life-threatening central nervous system effects possible when hyperglycemia is severe and has been chronic) - blood glucose reduction should not exceed 50-75 mg/dL/h\nMonitor for hypoglycemia",
                "deleted_at": null,
                "created_at": "2020-05-06T21:06:43.000000Z",
                "updated_at": "2020-05-06T21:06:43.000000Z"
            },
            {
                "id": 243,
                "guid": "243",
                "name": "Insulin, NPH",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoglycemia",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Mild, moderate or severe hypoglycemia can occur with excessive insulin effect (due to insulin sensitivity [e.g., transient resolution of diabetes mellitus/\"honeymoon period\"], excessively high dosage, or removal of insulin antagonism [e.g., reduction of endogenous [hyperadrenocorticism] or exogenous [injections, tablets] corticosteroids)\nRebound hyperglycemia (Somogyi effect) also possible with excessively high dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T21:07:14.000000Z",
                "updated_at": "2020-05-06T21:07:14.000000Z"
            },
            {
                "id": 244,
                "guid": "244",
                "name": "Insulin, PZI",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoglycemia",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Mild, moderate or severe hypoglycemia can occur with excessive insulin effect (due to insulin sensitivity [e.g., transient resolution of diabetes mellitus/\"honeymoon period\"], excessively high dosage, or removal of insulin antagonism [e.g., reduction of endogenous [hyperadrenocorticism] or exogenous [injections, tablets] corticosteroids)\nRebound hyperglycemia (Somogyi effect) also possible with excessively high dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T21:08:12.000000Z",
                "updated_at": "2020-05-06T21:08:12.000000Z"
            },
            {
                "id": 245,
                "guid": "245",
                "name": "Insulin, regular/crystalline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Dextrose",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Hypoglycemia (14% incidence in the first 24h of treating diabetic ketoacidosis in dogs using the IV CRI protocol)",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\r\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Caution when decreasing blood glucose concentration too quickly hour-by-hour (severe/life-threatening central nervous system effects possible when hyperglycemia is severe and has been chronic) - blood glucose reduction should not exceed 50-75 mg/dL/hour \n Monitor for hypoglycemia",
                "deleted_at": null,
                "created_at": "2020-05-06T21:09:04.000000Z",
                "updated_at": "2020-11-16T02:09:17.000000Z"
            },
            {
                "id": 246,
                "guid": "246",
                "name": "Insulin, ultralente",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dextrose",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoglycemia",
                "interactions": "Additive effects with other insulins and/or with oral antihyperglycemic drugs\nInsulin's effects are countered by dextrose, corticosteroids",
                "adverse_effects": "Mild, moderate or severe hypoglycemia can occur with excessive insulin effect (due to insulin sensitivity [e.g., transient resolution of diabetes mellitus/\"honeymoon period\"], excessively high dosage, or removal of insulin antagonism [e.g., reduction of endogenous [hyperadrenocorticism] or exogenous [injections, tablets] corticosteroids)\nRebound hyperglycemia (Somogyi effect) also possible with excessively high dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T21:10:50.000000Z",
                "updated_at": "2020-05-06T21:10:50.000000Z"
            },
            {
                "id": 247,
                "guid": "247",
                "name": "Interferon-alpha",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Possibly abortefacient at very high dosages (1 million - 25 million IU/kg) based on primate studies",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Decreases elimination of theophylline",
                "adverse_effects": "Increased liver enzymes, behavioral changes possible (extrapolation from human medicine) but essentially no adverse reactions reported in clinical dogs and cats",
                "deleted_at": null,
                "created_at": "2020-05-06T21:11:19.000000Z",
                "updated_at": "2020-11-16T02:13:07.000000Z"
            },
            {
                "id": 248,
                "guid": "248",
                "name": "Interferon-omega",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Seemingly very rare (none recorded of significant clinical importance)",
                "deleted_at": null,
                "created_at": "2020-05-06T21:13:32.000000Z",
                "updated_at": "2020-11-16T02:26:49.000000Z"
            },
            {
                "id": 249,
                "guid": "249",
                "name": "Iodide (Na, K)",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the compound",
                "interactions": "Can increase production of thyroid hormone, which would be antagonist to methimazole and other antithyroid treatments\r\nDisplaces radioiodine and should not be coadministered during radioiodine treatment (extraordinarily unlikely circumstance of coincident sporotrichosis and radioiodine therapy for hyperthyroidism)",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T21:15:52.000000Z",
                "updated_at": "2020-11-16T02:35:27.000000Z"
            },
            {
                "id": 250,
                "guid": "250",
                "name": "Ipecac syrup",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Emetine (a metabolite of ipecac) can be detected in serum to confirm malicious exposure (Munchausen's syndrome by proxy)",
                "reversal_agent": "Activated charcoal",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound\nRisk of aspiration (e.g., unconsciousness)\nActive vomiting\nPharyngeal/esophageal obstruction",
                "interactions": "Reduces absorption of all coadministered compounds, but re-dosing is never recommended after vomiting even if the tablet or capsule is convincingly in the vomitus (risk of partial absorption of first dose and therefore double-dosing)",
                "adverse_effects": "Cardiotoxicosis is possible if vomiting does not occur",
                "deleted_at": null,
                "created_at": "2020-05-06T21:16:45.000000Z",
                "updated_at": "2020-05-06T21:16:45.000000Z"
            },
            {
                "id": 251,
                "guid": "251",
                "name": "Iron dextran",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Hepatotoxicosis possible",
                "deleted_at": null,
                "created_at": "2020-05-06T21:17:23.000000Z",
                "updated_at": "2020-05-06T21:17:23.000000Z"
            },
            {
                "id": 252,
                "guid": "252",
                "name": "Isoproterenol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Propranolol 0.05-0.1 mg IV boluses repeated to effect",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Supraventricular or ventricular tachycardia",
                "interactions": "Additive effects with epinephrine, possibly with aminophylline",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-05-06T22:02:22.000000Z",
                "updated_at": "2020-11-16T02:38:26.000000Z"
            },
            {
                "id": 253,
                "guid": "253",
                "name": "Isosorbide mononitrate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": ">100 ng/mL",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension\nHypovolemia",
                "interactions": "Additive effects with other vasodilators (e.g., ACE inhibitors, hydralazine, sildenafil) and volume-depleting drugs (e.g., diuretics), potentially causing hypotension",
                "adverse_effects": "Hypotension in patients predisposed to it naturally (low resting blood pressure) or pharmacologically (see Drug Interactions)",
                "deleted_at": null,
                "created_at": "2020-05-06T22:03:03.000000Z",
                "updated_at": "2020-05-06T22:03:03.000000Z"
            },
            {
                "id": 254,
                "guid": "254",
                "name": "Isotretinoin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Severely fetotoxic (central nervous system, craniofacial, ocular, cardiovascular malformations) in humans (public health concern);may cause abortion/stillbirth",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": null,
                "adverse_effects": "Teratogenicity\nOccasional keratoconjunctivitis, increased liver enzymes/cholesterol, vomiting, diarrhea reported\nMucocutaneous lesions",
                "deleted_at": null,
                "created_at": "2020-05-06T22:03:29.000000Z",
                "updated_at": "2020-05-06T22:03:29.000000Z"
            },
            {
                "id": 255,
                "guid": "255",
                "name": "Itraconazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "3.55 +/- 2.81 µg/mL (range: 0.67-10.8 µg/mL) associated with 74% survival and stable disease or cure in dogs with blastomycosis",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Liver disease",
                "interactions": "",
                "adverse_effects": "Hepatotoxicosis: increase in liver enzymes at some point during chronic treatment (months) in 26% of dogs, moderate or marked in 8% of dogs, often not producing any clinical signs of liver dysfunction nor requiring any treatment change (anorexia most common in those that do show signs: 15% of dogs treated with 10 mg/kg/day) \n Rare skin ulceration at high (5 mg/kg q 12h) dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T22:04:56.000000Z",
                "updated_at": "2020-11-16T02:56:04.000000Z"
            },
            {
                "id": 256,
                "guid": "256",
                "name": "Ivermectin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Lipid emulsion IV may reduce severity and duration of toxicosi",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n ABCB1 (MDR-1) mutation is a relative contraindication (higher dosages should be avoided and an alternative drug used)",
                "interactions": "Not a drug interaction as such, but a susceptibility to ivermectin toxicosis should suggest the ABCB1 mutation, which also means susceptibility to opiates (e.g., loperamide), antineoplastic chemotherapeutics (e.g., doxorubicin), and digoxin (and possibly decreased ability to mount a cortisol response during stress of illness)",
                "adverse_effects": "Seizures, coma, death possible, especially under 2 circumstances: decimal error in dosage calculation (common and catastrophic), and MDR-1 mutation (common in certain breeds and avoidable through screening) \n Pain is common at injection site and oral administration is preferred \n in the general population, 10% of dogs treated with high-dosage (0.3-0.6 mg/kg) ivermectin show mild signs such as lethargy and ataxia, and 2% of dogs show severe signs (e.g., seizures), and any of these signs warrant discontinuation of treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T22:08:01.000000Z",
                "updated_at": "2020-11-16T03:01:08.000000Z"
            },
            {
                "id": 257,
                "guid": "257",
                "name": "Kaolin + pectin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product\nDiarrhea associated with systemic signs of illness (e.g., lethargy, dehydration)\nGastrointestinal tract obstruction",
                "interactions": "May decrease absorption of virtually all coadministered drugs, so other medications should be given at least 30 minutes before or after kaolin + pectin",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T22:14:50.000000Z",
                "updated_at": "2020-05-06T22:14:50.000000Z"
            },
            {
                "id": 258,
                "guid": "258",
                "name": "Ketamine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nSituations where consciousness is required (e.g., preservation of gag/swallowing reflexes)\nRelative contraindication for disorders where tachycardia and/or sympathetic stimulation are detrimental, although ketamine may be used IV at low dosages with little risk in cardiac patients (vs. high-dose IM administration, for example)",
                "interactions": null,
                "adverse_effects": "Excesses may cause profound obtundation and severe tachycardia\nLoss of blink reflex can cause corneal dessication and ulceration",
                "deleted_at": null,
                "created_at": "2020-05-06T22:15:24.000000Z",
                "updated_at": "2020-05-06T22:15:24.000000Z"
            },
            {
                "id": 259,
                "guid": "259",
                "name": "Ketoconazole",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fetotoxic (mummified fetuses in dogs, adrenal effects)",
                "contraindications": "Hypersensitivity to the drug\nPregnancy\nLiver disease",
                "interactions": "Inhibits hepatic microsomal P450 enzyme function and reduces catabolism of other drugs - this can be used to beneficial effect (prolong action, allowing a lower dosage of an expensive drug like cyclosporine still achieves therapeutic serum levels) or harm (inadvertent coadministration of a drug like ivermectin, theophylline, or cisapride at standard dosages causes toxicosis)",
                "adverse_effects": "Anorexia, weight loss, vomiting, and/ or diarrhea occur sporadically, especially at higher dosages (>10 mg/kg/day), potentially hepatotoxic (warrants follow-up including serum liver enzyme levels)",
                "deleted_at": null,
                "created_at": "2020-05-06T22:18:31.000000Z",
                "updated_at": "2020-05-06T22:18:31.000000Z"
            },
            {
                "id": 260,
                "guid": "260",
                "name": "Ketoprofen",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nActive gastrointestinal ulceration",
                "interactions": "Additive adverse gastrointestinal +/- renal effects with other nonsteroidal anti-inflammatories and with glucocorticoids - reduce risk by avoiding coadministration/overlap with these drugs, and ensuring animal is well-hydrated and not anorexic",
                "adverse_effects": "Gastrointestinal ulcerative effects and nephrotoxicosis uncommon, but more likely in dehydrated, hypovolemic, anorectic, or otherwise systemically debilitated animals\nBleeding time (in vitro, and possibly in vivo) is prolonged during treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T22:21:25.000000Z",
                "updated_at": "2020-05-06T22:21:25.000000Z"
            },
            {
                "id": 261,
                "guid": "261",
                "name": "Lactoferrin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product\nIron deficiency",
                "interactions": "Iron binding function negates value of administration with iron products (e.g., iron dextran)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T22:23:15.000000Z",
                "updated_at": "2020-05-06T22:23:15.000000Z"
            },
            {
                "id": 262,
                "guid": "262",
                "name": "Lactulose",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product\nDiarrhea",
                "interactions": "Additive effects if given with other laxatives",
                "adverse_effects": "Diarrhea is common and can be avoided by lowering the dosage",
                "deleted_at": null,
                "created_at": "2020-05-06T22:24:14.000000Z",
                "updated_at": "2020-05-06T22:24:14.000000Z"
            },
            {
                "id": 263,
                "guid": "263",
                "name": "Leflunomide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "20 µg/mL (of A77 1726 - the active metabolite of lufenuron responsible for its immunosuppressant activity) in dogs showing clinical effects associated with the drug",
                "reversal_agent": null,
                "teratogenicity": "Known teratogen - fetotoxic (microphthalmia, hydrocephalus)",
                "contraindications": "Hypersensitivity to the drug\nPregnancy\nFulminant infection",
                "interactions": "May inhibit hepatic P450 enzyme systems, increasing half-life of such drugs as warfarin and several nonsteroidal anti-inflammatories",
                "adverse_effects": "Hematochezia/hematemesis (12% of treated dogs), inappetence (8% of treated dogs), and lethargy (4% of treated dogs) reported, without placebo control for comparison (i.e., cannot be attributed necessarily to drug effect)\nHepatotoxicosis reported in humans but appears very uncommon in dogs/cats",
                "deleted_at": null,
                "created_at": "2020-05-06T22:26:36.000000Z",
                "updated_at": "2020-05-06T22:26:36.000000Z"
            },
            {
                "id": 264,
                "guid": "264",
                "name": "Leucovorin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "In humans, dosages of 15, 30, and 100 mg/m² leucovorin have been recommended for plasma methotrexate concentrations of < 1.5, 1.5-5, and > 5 µmol/L, respectively (plasma methotrexate assay may be available from local human hospital)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "No adverse reactions",
                "deleted_at": null,
                "created_at": "2020-05-06T22:28:16.000000Z",
                "updated_at": "2020-05-06T22:28:16.000000Z"
            },
            {
                "id": 265,
                "guid": "265",
                "name": "Levamisole",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Atropine",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing neurologic dysfunction",
                "interactions": "Corticosteroids may antagonize levamisole's effects (human reports - undetermined impact in small animal medicine)\nParasympathomimetic effects may be heightened by cholinergic agonists, organophosphates",
                "adverse_effects": "Neurological signs, acute liver injury, and gastric hemorrhage in dogs receiving 25 mg/kg q 24h for 3 days (66% fatal without treatment)\nNeurologic signs (4%) and neutropenia (4%) in dogs receiving therapeutic dosages\nMuscarinic signs (e.g., salivation, defecation, bronchoconstriction/dyspnea) expected with overdose",
                "deleted_at": null,
                "created_at": "2020-05-06T22:29:24.000000Z",
                "updated_at": "2020-05-06T22:29:24.000000Z"
            },
            {
                "id": 266,
                "guid": "266",
                "name": "Levetiracetam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "5-45 µg/mL",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Transient lethargy, inappetence in 17% of treated cats",
                "deleted_at": null,
                "created_at": "2020-05-06T22:31:12.000000Z",
                "updated_at": "2020-05-06T22:31:12.000000Z"
            },
            {
                "id": 267,
                "guid": "267",
                "name": "Levothyroxine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "2.5-4.5 µg/dL, with blood collected 6h after levothyroxine dose;level should be > 1.5 µg/dL regardless of time of sampling (otherwise, the dosage needs to be increased) and a level > 6 µg/dL 6h post-dose warrants dosage reduction",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHyperthyroidism\nEuthyroid sick syndrome",
                "interactions": "Phenobarbital and glucocorticoids depress total T4 without affecting physiologic T4 (i.e., they cause the sick euthyroid syndrome), which means serum TSH levels should be normal or low, and no T4 supplementation is necessary (or an increase in T4 dosage is not justified, for phenobarbital/glucocorticoid-receiving patients with low T4s who are already receiving levothyroxine)\nSucralfate, high-fiber diets may reduce absorption (stagger administration)",
                "adverse_effects": "Extreme overdosages (intoxication) have caused short-lived vomiting and neurologic disturbances",
                "deleted_at": null,
                "created_at": "2020-05-06T22:32:13.000000Z",
                "updated_at": "2020-05-06T22:32:13.000000Z"
            },
            {
                "id": 268,
                "guid": "268",
                "name": "Lidocaine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "40 and 120 µg/kg/min lidocaine infusions in healthy dogs produce plasma lidocaine concentrations of 2.7 and 5.27 µg/mL, respectively (not clinically relevant because not routinely measured nor correlated to long-term benefit in canine or feline patients)",
                "reversal_agent": "Intravenous lipid, e.g., 20% lipid emulsion (1.5 mL/kg [0.68 mL/lb], IV) delivered over a 30-minute period, was associated with marked improvement in clinical signs of toxicosis in a feline case report",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypokalemia\nVentricular escape rhythm",
                "interactions": "Hypokalemia causes refractoriness to the drug's therapeutic (but not toxic) effects",
                "adverse_effects": "Transient neurotoxicosis (ataxia, progressing to seizures) if overdose and/or inability to metabolize adequately (e.g., due to poor hemodynamics)\nLiver disease may delay metabolism, increasing likelihood of toxic effects",
                "deleted_at": null,
                "created_at": "2020-05-06T22:35:13.000000Z",
                "updated_at": "2020-05-06T22:35:13.000000Z"
            },
            {
                "id": 269,
                "guid": "269",
                "name": "Lincomycin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other lincosamide antibacterials (e.g., clindamycin)",
                "interactions": "In vitro antibacterial antagonistic effects with erythromycin (avoid coadministration)",
                "adverse_effects": "Superinfections (e.g., methicillin-resistant staphylococci) have been reported in association with treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T22:37:26.000000Z",
                "updated_at": "2020-05-06T22:37:26.000000Z"
            },
            {
                "id": 270,
                "guid": "270",
                "name": "Lisinopril",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "ACE inhibitors are teratogens and are contraindicated during pregnancy",
                "contraindications": "Hypersensitivity to the drug and/or to other ACE inhibitors\nPregnancy",
                "interactions": "Additive effects with other vasodilators (e.g., other ACE inhibitors, nitrates, hydralazine) and/or drugs that decrease intravascular volume (diuretics)",
                "adverse_effects": "Poorly described in veterinary medicine\nHypovolemia and azotemia could be expected with overdoses or when the drug is given to very debilitated (e.g., dehydrated, anorectic) patients",
                "deleted_at": null,
                "created_at": "2020-05-06T22:38:05.000000Z",
                "updated_at": "2020-05-06T22:38:05.000000Z"
            },
            {
                "id": 271,
                "guid": "271",
                "name": "Lithium carbonate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "0.5-1.5 mmol/L is an extrapolated therapeutic range, but dogs may develop signs of toxicosis, without convincing benefit, even within this range",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Seizures, severe acute hepatic injury, and severe erythrocytosis (hematocrit >70%) in individual dog cases, where signs begin with lithium treatment and do not recur after discontinuation",
                "deleted_at": null,
                "created_at": "2020-05-06T22:38:50.000000Z",
                "updated_at": "2020-05-06T22:38:50.000000Z"
            },
            {
                "id": 272,
                "guid": "272",
                "name": "Lobaplatin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Likely fetotoxic (class effect)",
                "contraindications": "Hypersensitivity to the drug\nLeukopenia\nPregnancy",
                "interactions": "Additive myelosuppressant effects possible with other drugs, particularly other antineoplastic chemotherapeutics",
                "adverse_effects": "Neutropenia, thrombocytopenia common 7-10 days after treatment, self-resolving\nNausea/vomiting",
                "deleted_at": null,
                "created_at": "2020-05-06T22:40:24.000000Z",
                "updated_at": "2020-05-06T22:40:24.000000Z"
            },
            {
                "id": 273,
                "guid": "273",
                "name": "Lomustine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Lithium (thought to reduce/prevent thrombocytopenia) instead has been shown to fail to do so, and to confer additional adverse effects, in dogs[1]; dexamethasone also is not protective of myelotoxicosis in dogs[2]",
                "teratogenicity": "Teratogenic/fetotoxic",
                "contraindications": "Hypersensitivity to the drug\nLeukopenia\nPregnancy",
                "interactions": "Additive myelosuppressant and/or GI adverse effects possible with other drugs, particularly other antineoplastic chemotherapeutics",
                "adverse_effects": "Mild to severe neutropenia (potentially followed by thrombocytopenia) in most dogs (88%) and in >99% of dogs receiving 60 mg/m²\n29% incidence of mild hepatotoxicosis (increased liver enzymes, generally without overt clinical signs) during treatment\nMinimal renal effect (10% occurrence of mild azotemia)\nAdverse gastrointestinal tract effects",
                "deleted_at": null,
                "created_at": "2020-05-06T22:40:56.000000Z",
                "updated_at": "2020-05-06T22:40:56.000000Z"
            },
            {
                "id": 274,
                "guid": "274",
                "name": "Loperamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Naloxone",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nABCB1 mutation\nGastrointestinal tract obstruction\nFunctional ileus\nDiarrhea that is beneficial (e.g., expulsion of toxin)",
                "interactions": "Additive effects with other opioid drugs",
                "adverse_effects": "Signs of central nervous system dysfunction in ABCB1-mutant dogs\nVomiting recorded in one dog receiving 0.1 mg/kg PO q 8h for 2 days, leading to discontinuation of the drug",
                "deleted_at": null,
                "created_at": "2020-05-06T22:43:19.000000Z",
                "updated_at": "2020-05-06T22:43:19.000000Z"
            },
            {
                "id": 275,
                "guid": "275",
                "name": "Lorazepam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Flumazenil",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nExcessive sedation",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T22:44:27.000000Z",
                "updated_at": "2020-05-06T22:44:27.000000Z"
            },
            {
                "id": 276,
                "guid": "276",
                "name": "Lufenuron",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T22:45:27.000000Z",
                "updated_at": "2020-05-06T22:45:27.000000Z"
            },
            {
                "id": 277,
                "guid": "277",
                "name": "Lysine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T22:46:57.000000Z",
                "updated_at": "2020-05-06T22:46:57.000000Z"
            },
            {
                "id": 278,
                "guid": "278",
                "name": "Magnesium sulfate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Typical normal reference ranges for serum magnesium: dog total serum Mg = 0.7-1.35 mmol/L (1.4-2.7 mEq/L);dog ionized serum Mg = 0.26-0.41 mmol/L (0.52-0.82 mEq/L);cat total serum Mg = 0.8-1.2 mmol/L (1.6-2.4 mEq/L);cat ionized serum Mg = 0.47-0.63 mmol/L (0.96-1.26 mEq/L)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation\nHypermagnesemia\nHyperkalemia if concurrent hypomagnesemia is not documented\nSevere renal disease (avoid, or modify dosage, since elimination is via renal excretion)",
                "interactions": "Enhances efficacy of potassium supplementation (potassium retention) in hypokalemia",
                "adverse_effects": "Dosage miscalculations are well-recognized (due to potentially confusing units and dosages)\nCareful calculation and independent checking of dosages is essential to prevent life-threatening hypermagnesemia",
                "deleted_at": null,
                "created_at": "2020-05-06T22:47:41.000000Z",
                "updated_at": "2020-05-06T22:47:41.000000Z"
            },
            {
                "id": 279,
                "guid": "279",
                "name": "Mannitol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nIntravascular volume overload\nAnuria",
                "interactions": "Additive diuretic effects expected with other diuretics (e.g., furosemide)",
                "adverse_effects": "Expansion of circulating plasma volume may be excessive in patients with pre-existing heart disease and/or oliguria/anuria, leading to pulmonary edema (which could be difficult/impossible to eliminate in cases of anuria)",
                "deleted_at": null,
                "created_at": "2020-05-06T22:49:02.000000Z",
                "updated_at": "2020-05-06T22:49:02.000000Z"
            },
            {
                "id": 280,
                "guid": "280",
                "name": "Marbofloxacin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fluoroquinolones are generally not recommended in pregnancy (cartilage effects)",
                "contraindications": "Hypersensitivity to the drug or to other fluoroquinolones\nAge < 6 months (<18 months in growing dogs) - possible class effects",
                "interactions": "Possibility of class effects (fluoroquinolones): reduction in elimination of cyclosporine, flunixin, and theophylline, potentially increasing the serum levels of these drugs to clinically significant (toxic) levels\nIon-containing gastric protectants (e.g., calcium carbonate) or gastric protectants (e.g., sucralfate) may reduce absorption",
                "adverse_effects": "Seemingly much lower risk of retinotoxicity in cats compared to enrofloxacin\nArthrotoxicity possible in growing dogs and cats\nCaution in epileptic patients because of possible CNS stimulatory effects of fluoroquinolone antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-06T22:51:06.000000Z",
                "updated_at": "2020-05-06T22:51:06.000000Z"
            },
            {
                "id": 281,
                "guid": "281",
                "name": "Maropitant",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nYoung age (bone marrow hypoplasia in puppies < 11 weeks old, but not in puppies ≥ 16 weeks old)\nIngestion of toxic substance\nGastrointestinal obstruction and/or perforation",
                "interactions": null,
                "adverse_effects": "Local discomfort/pain at injection site is reported (4% of dogs in 1 series)",
                "deleted_at": null,
                "created_at": "2020-05-06T22:53:16.000000Z",
                "updated_at": "2020-05-06T22:53:16.000000Z"
            },
            {
                "id": 282,
                "guid": "282",
                "name": "Medium-chain triglycerides",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": null,
                "adverse_effects": "Diarrhea, poor taste",
                "deleted_at": null,
                "created_at": "2020-05-06T22:55:08.000000Z",
                "updated_at": "2020-05-06T22:55:08.000000Z"
            },
            {
                "id": 283,
                "guid": "283",
                "name": "Medroxyprogesterone acetate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nIntact female with history of pyometra\nHistory of mammary masses/neoplasia",
                "interactions": null,
                "adverse_effects": "Mammary gland tumors (benign and malignant), ovarian cysts, and cystic endometrial hyperplasia/pyometra complex all possible, with increasing risk arising from longer duration of usage\nAdrenocortical suppression is possible with long-term use",
                "deleted_at": null,
                "created_at": "2020-05-06T22:56:12.000000Z",
                "updated_at": "2020-05-06T22:56:12.000000Z"
            },
            {
                "id": 284,
                "guid": "284",
                "name": "Megestrol acetate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "No adverse effects noted on pregnant dogs when used as prescribed",
                "contraindications": "Hypersensitivity to the drug\nIntact female with history of pyometra\nHistory of mammary masses/neoplasia",
                "interactions": null,
                "adverse_effects": "Pyometra (3/389), mammary fibroadenomatous hyperplasia, reduction in sperm count and motility, increased appetite, personality changes and depression, adrenal suppression, glucose intolerance",
                "deleted_at": null,
                "created_at": "2020-05-06T22:57:33.000000Z",
                "updated_at": "2020-05-06T22:57:33.000000Z"
            },
            {
                "id": 285,
                "guid": "285",
                "name": "Meglumine antimoniate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Local inflammation (cellulitis if SC, phlebitis if IV) in 7% of treated dogs\nNonspecific signs (e.g., gastrointestinal signs [12%], lethargy [2.5%]) may or may not be related to treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T22:58:53.000000Z",
                "updated_at": "2020-05-06T22:58:53.000000Z"
            },
            {
                "id": 286,
                "guid": "286",
                "name": "Melarsomine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nSevere heartworm disease causing signs of right heart failure/caval syndrome (surgical removal is required)",
                "interactions": null,
                "adverse_effects": "Local pain/inflammation 3-7 days after injection with or without sterile abscess formation, in minority of dogs (not a painful injection at the time of administration)\nGeneral heartworm adulticide complications can include acute pneumonitis (3-10 days after treatment), renal effects (renal tubular effects uncommon, may compound glomerulonephritis from the disease)\nMassive heartworm embolization in dogs with heavy worm burdens not confined by their owners during the 8-week period following the first injection",
                "deleted_at": null,
                "created_at": "2020-05-06T22:59:40.000000Z",
                "updated_at": "2020-05-06T22:59:40.000000Z"
            },
            {
                "id": 287,
                "guid": "287",
                "name": "Melatonin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "Mean serum concentration in dogs receiving 1-1.3 mg/kg PO is 216 pg/mL 8h after oral dosage (not clinically important because not measured routinely)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T23:00:11.000000Z",
                "updated_at": "2020-05-06T23:00:11.000000Z"
            },
            {
                "id": 288,
                "guid": "288",
                "name": "Meloxicam",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Labeled for use in cats 16 weeks of age or older",
                "contraindications": "Hypersensitivity to the drug\nErosive gastrointestinal disease",
                "interactions": "Additive adverse gastrointestinal +/- renal effects with other nonsteroidal anti-inflammatories and with glucocorticoids - reduce risk by avoiding coadministration/overlap with these drugs, and ensuring animal is well-hydrated and not anorexic",
                "adverse_effects": "Occasional vomiting, loose feces, and melena (e.g., acute gastrointestinal signs in 4% of treated cats)\nInjection site sarcoma with injectable form in a 12.5 year-old cat that had gone unvaccinated for > 12 years",
                "deleted_at": null,
                "created_at": "2020-05-06T23:01:16.000000Z",
                "updated_at": "2020-05-06T23:01:16.000000Z"
            },
            {
                "id": 289,
                "guid": "289",
                "name": "Melphalan",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic and embryolethal",
                "contraindications": "Hypersensitivity to the drug\nLeukopenia (unless due to neoplastic myelophthisic disease)\nPregnancy\nLoss of efficacy",
                "interactions": "Additive myelotoxic effects possible with other antineoplastic drugs, particularly other alkylating agents",
                "adverse_effects": "Neutropenia, adverse gastrointestinal/general malaise effects possible, carcinogenesis possible",
                "deleted_at": null,
                "created_at": "2020-05-06T23:03:45.000000Z",
                "updated_at": "2020-05-06T23:03:45.000000Z"
            },
            {
                "id": 290,
                "guid": "290",
                "name": "Meperidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Additive depressive effects of central nervous system if coadministered with opioids, other narcotics, antihistamines",
                "adverse_effects": "50% incidence of post-op vomiting when administered just before or during surgery\nGeneral CNS excitement\nHypotension possible in dogs and cats\nIleus",
                "deleted_at": null,
                "created_at": "2020-05-06T23:05:33.000000Z",
                "updated_at": "2020-05-06T23:05:33.000000Z"
            },
            {
                "id": 291,
                "guid": "291",
                "name": "Meropenem",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other beta-lactam antibacterials",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T23:06:42.000000Z",
                "updated_at": "2020-05-06T23:06:42.000000Z"
            },
            {
                "id": 292,
                "guid": "292",
                "name": "Mesalamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Additive effects possible with other nonsteroidal anti-inflammatories and corticosteroids",
                "adverse_effects": "Keratoconjunctivitis sicca (more female than male)",
                "deleted_at": null,
                "created_at": "2020-05-06T23:07:11.000000Z",
                "updated_at": "2020-05-06T23:07:11.000000Z"
            },
            {
                "id": 293,
                "guid": "293",
                "name": "Methadone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Avoid in cesarean section (administration to dam causes respiratory depression in neonates);excreted in lactation (human milk/plasma ration of 0.8)",
                "contraindications": "Hypersensitivity to the drug and/or to other opiate drugs\nExcessive sedation or excessively deep plane of anesthesia\nIleus\nRespiratory depression\nObstructive airway disease\nCesarean section\nHypotension/shock\nSevere hepatic impairment (may precipitate hepatic encephalopathy)",
                "interactions": "Enhanced central nervous system depression with monoamine oxidase inhibitors (e.g., selegiline) and/or other central nervous system depressant - avoid coadministration\nIncreased serum methadone levels possible with P-glycoprotein inhibition (e.g., ABCB1 mutation) or hepatic CYP3A4 inhibitors (fluoxetine, clarithromycin, erythromycin, azole antifungal drugs), whereas decreased methadone levels are possible with hepatic CYP3A4-enzyme induction (e.g., avoid cotreatment with barbiturates, spironolactone, dexamethasone)",
                "adverse_effects": "Nausea\nVomiting\nConstipation\nRespiratory depression\nApnea, shock and cardiac arrest can occur\nToxic dosages are highly variable\nDose-related histamine releasing properties may lead to urticaria and pruritus\nIncrease in intracranial pressure",
                "deleted_at": null,
                "created_at": "2020-05-06T23:08:26.000000Z",
                "updated_at": "2020-05-06T23:08:26.000000Z"
            },
            {
                "id": 294,
                "guid": "294",
                "name": "Methazolamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Potentially fetotoxic",
                "contraindications": "Hypersensitivity to the drug\nAcidosis\nFeline species",
                "interactions": "Diuretics (may potentiate hypovolemia/dehydration, hyponatremia, hypokalemia)",
                "adverse_effects": "Mentation and metabolic changes in cats are prohibitive",
                "deleted_at": null,
                "created_at": "2020-05-06T23:09:32.000000Z",
                "updated_at": "2020-05-06T23:09:32.000000Z"
            },
            {
                "id": 295,
                "guid": "295",
                "name": "Methimazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Target range for serum thyroxine concentrations during ongoing methimazole treatment = 0.5-4 µg/dL (i.e., reference interval/euthyroid normal range) together with improvement and resolution of associated clinical signs",
                "reversal_agent": "Levothyroxine",
                "teratogenicity": "Potentially fetotoxic (fetal hypothyroidism) and can reduce thyroid function in nurslings",
                "contraindications": "Hypersensitivity to the drug\nHypothyroidism\nPregnancy",
                "interactions": "Transition from hyperthyroidism to euthyroidism can be expected to reduce elimination of other drugs, particularly those that are renally excreted (with some specific exceptions, e.g., the beta-blocker in cats, which has a shorter duration of effect in euthyroidism than in hyperthyroidism)",
                "adverse_effects": "Numerous and well-recognized, including: reduction in glomerular filtration rate revealing previously occult chronic kidney disease\nHepatopathy/hepatic lipidosis\nLeukopenia or other myelotoxic effects\nVomiting and inappetence\nIntense facial pruritus leading to self-inflicted facial excoriations/injuries\nEssentially all of which can be ended by reducing or discontinuing methimazole treatment",
                "deleted_at": null,
                "created_at": "2020-05-06T23:10:03.000000Z",
                "updated_at": "2020-05-06T23:10:03.000000Z"
            },
            {
                "id": 296,
                "guid": "296",
                "name": "Methionine, DL-",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product\nAcidosis",
                "interactions": "Urinary pH changes may alter the excretion of quinidine and the effectiveness or erythromycin and aminoglycoside antibacterials within the urinary tract",
                "adverse_effects": "Hemolytic anemia in cats (at therapeutic dosages)\nVomiting, ataxia, seizures with massive overdose in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T23:11:18.000000Z",
                "updated_at": "2020-05-06T23:11:18.000000Z"
            },
            {
                "id": 297,
                "guid": "297",
                "name": "Methionine, s-adenosyl",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "30 ng/mL (range: 21-38 ng/mL) in healthy cats without treatment;209-238 ng/mL 12h post-dose after 1-4 months of treatment in otherwise healthy cats;not routinely measured in practice",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T23:11:55.000000Z",
                "updated_at": "2020-05-06T23:11:55.000000Z"
            },
            {
                "id": 298,
                "guid": "298",
                "name": "Methocarbamol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nRenal impairment",
                "interactions": "Additive effects with other CNS depressants (e.g., barbiturates, benzodiazepines)\nWith anticholinesterase agents for myasthenia gravis: methocarbamol may inhibit the effect of pyridostigmine bromide",
                "adverse_effects": "Apnea, especially if coadministered IV with a barbiturate (e.g., phenobarbital)\nCNS depressant effects possible (e.g., drowsiness, and dizziness in humans)",
                "deleted_at": null,
                "created_at": "2020-05-06T23:13:27.000000Z",
                "updated_at": "2020-05-06T23:13:27.000000Z"
            },
            {
                "id": 299,
                "guid": "299",
                "name": "Methotrexate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Leucovorin (calcium folinate)",
                "teratogenicity": "Highly teratogenic;folate deficiency implicated in neural tube, conotruncal cardiovascular birth defects (drug is a folic acid antagonist)",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": "Nonsteroidal anti-inflammatory drugs and sulfa antibacterials can increase serum methotrexate levels, causing severe toxicosis\nPenicillins may reduce the renal clearance of methotrexate, predisposing to toxicosis\nVitamin preparations containing folate/folic acid/vitamin B9 may decrease response to methotrexate\nSulfonamide antibacterials may potentiate folic acid depletion and risk blood dyscrasias",
                "adverse_effects": "GI toxicosis, vomiting, diarrhea and weight loss occur with moderate frequency in treated dogs and cats, particularly with high dosages and/or debilitated patients",
                "deleted_at": null,
                "created_at": "2020-05-06T23:15:23.000000Z",
                "updated_at": "2020-05-06T23:15:23.000000Z"
            },
            {
                "id": 300,
                "guid": "300",
                "name": "Methylene blue, new",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": "Based on human experience, coadministration with selective serotonin reuptake-inhibiting drugs (e.g. fluoxetine [Prozac]) is not recommended",
                "adverse_effects": "Heinz body hemolytic anemia",
                "deleted_at": null,
                "created_at": "2020-05-06T23:17:07.000000Z",
                "updated_at": "2020-05-06T23:17:07.000000Z"
            },
            {
                "id": 301,
                "guid": "301",
                "name": "Methylphenidate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Possible teratogen - avoid in pregnancy",
                "contraindications": "Hypersensitivity to the drug\nMarked anxiety, tension or agitation\nGlaucoma\nDecompensated and/or severe arterial hypertension",
                "interactions": "Interacts with/potentiates monoamine oxidase inhibitors (e.g., selegiline) - avoid coadministration, and allow washout period if switching form one to the other\nadditive effects with vasopressors and may negate the effects of antihypertensive drugs (e.g., amlodipine)\nInhibits metabolism of coumarin anticoagulants, anticonvulsants and some antidepressants (potentially raising their plasma concentrations to harmful levels)",
                "adverse_effects": "Restlessness, vocalizing, and circling, generalized tremors, agitation, mydriasis, tachycardia, tachypnea, and hypertension possible",
                "deleted_at": null,
                "created_at": "2020-05-06T23:18:11.000000Z",
                "updated_at": "2020-05-06T23:18:11.000000Z"
            },
            {
                "id": 302,
                "guid": "302",
                "name": "Methylprednisolone",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound\nHyperadrenocorticism\nDiabetes mellitus\nCaution with cardiomyopathy patients (possibility of triggering pulmonary edema)",
                "interactions": "Additive effect (both therapeutic and adverse) with other corticosteroids\nShould not be coadministered with nonsteroidal anti-inflammatory drugs (gastric ulceration/perforation)\nCumulative effects with other immunosuppressants (e.g., cyclosporine)",
                "adverse_effects": "Insulin antagonism/diabetes mellitus\nIatrogenic congestive heart failure in cats with pre-existing heart disease\nObesity (due to polyphagia - may become detrimental and/or life-threatening with respiratory or orthopedic disorders)\nDecreased immune function\nSoft tissue fragility (especially skin) with chronic use\nIatrogenic hyperadrenocorticism possible with chronic use but rare in cats compared to dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T23:19:09.000000Z",
                "updated_at": "2020-05-06T23:19:09.000000Z"
            },
            {
                "id": 303,
                "guid": "303",
                "name": "Methylprednisolone acetate",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Potential abortefacient, teratogen",
                "contraindications": "Hypersensitivity to the compound\nHyperadrenocorticism\nDiabetes mellitus\nCaution with cardiomyopathy patients (possibility of triggering pulmonary edema)",
                "interactions": "Additive effect (both therapeutic and adverse) with other corticosteroids\nShould not be coadministered with nonsteroidal anti-inflammatory drugs (gastric ulceration/perforation)\nCumulative effects with other immunosuppressants (e.g., cyclosporine)",
                "adverse_effects": "Iatrogenic hyperadrenocorticism with chronic use\nAdrenal gland suppression, causing hypoadrenocorticism if stopped abruptly after long-term use\nInsulin antagonism/diabetes mellitus\nIatrogenic congestive heart failure in cats with pre-existing heart disease\nObesity (due to polyphagia - may become detrimental and/or life-threatening with respiratory or orthopedic disorders)\nDecreased immune function\nSoft tissue fragility (especially skin) with chronic use\nPolyuria, polydipsia (50% of treated dogs), panting (frequent in treated dogs) are common side-effects\nSubconjunctival injections of this medication are associated with granuloma formation at the site of injection in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T23:19:46.000000Z",
                "updated_at": "2020-05-06T23:19:46.000000Z"
            },
            {
                "id": 304,
                "guid": "304",
                "name": "Methylprednisolone sodium succinate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Potential abortefacient, teratogen",
                "contraindications": "Hypersensitivity to the compound\nPre-existing gastrointestinal bleeding",
                "interactions": "Cumulative effect (both therapeutic and adverse) with other corticosteroids\nShould not be coadministered with nonsteroidal anti-inflammatory drugs (gastric ulceration/perforation)\nCumulative effects with other immunosuppressants (e.g., cyclosporine)",
                "adverse_effects": "Gastrointestinal bleeding occurs in 90% of dogs treated with 1-2 doses",
                "deleted_at": null,
                "created_at": "2020-05-06T23:22:18.000000Z",
                "updated_at": "2020-05-06T23:22:18.000000Z"
            },
            {
                "id": 305,
                "guid": "305",
                "name": "Methyltestosterone",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Endocrine effects on the fetus are possible",
                "contraindications": "Hypersensitivity to the compound\nPre-existing prostatic disease",
                "interactions": null,
                "adverse_effects": "Hepatotoxicosis, decreased sperm count",
                "deleted_at": null,
                "created_at": "2020-05-06T23:24:06.000000Z",
                "updated_at": "2020-05-06T23:24:06.000000Z"
            },
            {
                "id": 306,
                "guid": "306",
                "name": "Metoclopramide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastrointestinal tract obstruction (like all promotility drugs)\nSeizure disorders (can aggravate/trigger, by crossing blood-brain barrier)",
                "interactions": "Incompatible (in vitro in injectable form) with ampicillin, cephalosporins, and all other beta-lactam antibacterials, erythromycin, and sodium bicarbonate, i.e., use different IV access for injection, or flush IV line thoroughly between drugs\npharmacokinetically, minimal increase in cephalexin uptake, no effect on amoxicillin, cyclosporine\nMay increase risk of serotonin syndrome\nhigher dosage (1 mg/kg) in cats shortens the time to onset of xylazine-induced sedation by approximately 20%",
                "adverse_effects": "Central nervous system effects may produce transient signs of neurologic dysfunction in patients with pre-existing central nervous system disease and/or when combined with other drugs that cause changes in mentation",
                "deleted_at": null,
                "created_at": "2020-05-06T23:24:46.000000Z",
                "updated_at": "2020-05-06T23:24:46.000000Z"
            },
            {
                "id": 307,
                "guid": "307",
                "name": "Metoprolol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dobutamine, isoproterenol",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nOvert/acute congestive heart failure\nBradycardia\nHypotension\nSinus tachycardia in a patient with systemic signs (metoprolol is contraindicated as monotherapy), because sinus tachycardia in a patient with systemic signs can exists in response to a primary cause (hypovolemia, systemic inflammation, anemia, etc.) and suppression of sinus tachycardia with a beta-blocker, without correcting of the primary cause, can cause hemodynamic collapse and cardiac arrest",
                "interactions": "Additive effects with other beta-blockers\nDrug-induced bradycardia could be harmful in patients receiving antihypertensive medications (e.g., amlodipine), causing hypotension\nPoorly regulated/excessive diuretics (e.g., furosemide), causing hypotension\nPoorly regulated/inadequate diuretics (e.g., furosemide), causing iatrogenic congestive heart failure\nOther drugs that have heart rate lowering and/or parasympathetic effects (e.g., opioids), causing excessive bradycardia",
                "adverse_effects": "In dogs receiving metoprolol for naturally-occurring heart disease, syncope (5%), congestive heart failure (2.5%), diarrhea (2.5%), and weakness, lethargy, inappetence, alopecia, and aggression (each 1%) have been attributed to treatment with metoprolol (no placebo controls for comparison, however)",
                "deleted_at": null,
                "created_at": "2020-05-06T23:26:12.000000Z",
                "updated_at": "2020-05-06T23:26:12.000000Z"
            },
            {
                "id": 308,
                "guid": "308",
                "name": "Metronidazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Diazepam (marked improvement from neurotoxicosis, mechanism unknown)",
                "teratogenicity": "Causes chromosome breaks in host (cats)",
                "contraindications": "Hypersensitivity to the drug\nSevere liver failure",
                "interactions": null,
                "adverse_effects": "Neurotoxicosis (vestibular signs or more generalized intracranial signs, e.g., seizures), reversible with discontinuation of metronidazole and supportive care if needed\nSuperinfection of gastrointestinal tract is possible\nHas been associated with cases of bone marrow necrosis in dogs\nConfirmed genotoxicosis (DNA damage) at standard dosages in cats",
                "deleted_at": null,
                "created_at": "2020-05-06T23:28:03.000000Z",
                "updated_at": "2020-05-06T23:28:03.000000Z"
            },
            {
                "id": 309,
                "guid": "309",
                "name": "Mexiletine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Additive effects with other Class I antiarrhythmics (e.g., lidocaine, tocainide), which therefore should not be coadministered with mexiletine",
                "adverse_effects": "Neurotoxicosis manifesting as ataxia, lethargy/mental dullness, and ultimately seizures, can occur with high dosages and/or inability to eliminate the drug normally, and can be reversed with discontinuation/dosage reduction in most cases\nTransient vomiting, diarrhea, inappetence possible",
                "deleted_at": null,
                "created_at": "2020-05-06T23:31:22.000000Z",
                "updated_at": "2020-05-06T23:31:22.000000Z"
            },
            {
                "id": 310,
                "guid": "310",
                "name": "Mibolerone",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogen",
                "contraindications": "Hypersensitivity to the drug\nPregnancy intended to reach term\nPerianal adenoma (or other androgen-dependent diseases)",
                "interactions": null,
                "adverse_effects": "Masculinization of female offspring\nCase report of ovarian fibroma\nAnecdotal reports of hepatotoxicosis in dogs and cats, thyrotoxicosis in cats\nPreferable to avoid in younger bitches (<8 months) since endocrine effects may accelerate epiphyseal closure",
                "deleted_at": null,
                "created_at": "2020-05-06T23:31:47.000000Z",
                "updated_at": "2020-05-06T23:31:47.000000Z"
            },
            {
                "id": 311,
                "guid": "311",
                "name": "Midazolam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Flumazenil (limited efficacy[1]); propofol may control midazolam-associated paradoxical hyperexcitability in the cat[2]",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other benzodiazepines",
                "interactions": "Additive effects with any other CNS depressant (e.g., other benzodiazepines [diazepam, oxazepam])",
                "adverse_effects": "Paradoxical hyperexcitability\nHypotension with IV bolus administration with ketamine in dogs (has been fatal)",
                "deleted_at": null,
                "created_at": "2020-05-06T23:32:39.000000Z",
                "updated_at": "2020-05-06T23:32:39.000000Z"
            },
            {
                "id": 312,
                "guid": "312",
                "name": "Mifepristone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Absolutely contraindicated in pregnancy intended to progress to term;risk of abortion if handled by pregnant women",
                "contraindications": "Hypersensitivity to the drug\nPregnancy intended to proceed to term",
                "interactions": "Dexamethasone, phenobarbital may lower serum mifepristone concentrations whereas erythromycin and azole antifungals may increase serum mifepristone concentrations (clinical importance uncertain)",
                "adverse_effects": "Abortefacient",
                "deleted_at": null,
                "created_at": "2020-05-06T23:34:58.000000Z",
                "updated_at": "2020-05-06T23:34:58.000000Z"
            },
            {
                "id": 313,
                "guid": "313",
                "name": "Milbemycin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Central nervous system adverse effects much less likely than with ivermectin, but still possible with off-label high dosages (e.g., for demodicosis)",
                "deleted_at": null,
                "created_at": "2020-05-06T23:35:47.000000Z",
                "updated_at": "2020-05-06T23:35:47.000000Z"
            },
            {
                "id": 314,
                "guid": "314",
                "name": "Mirtazapine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Risk of serotonin syndrome (hyperactivity, seizures, etc.) if combined with behavior-modifying drugs (e.g., tricyclic antidepressants, serotonin reuptake inhibitors)",
                "adverse_effects": "Behavioral changes (increased vocalization, physical activity/movement) may be excessive in some cats, e.g., receiving higher dosages than 1.88 mg/CAT",
                "deleted_at": null,
                "created_at": "2020-05-06T23:38:24.000000Z",
                "updated_at": "2020-05-06T23:38:24.000000Z"
            },
            {
                "id": 315,
                "guid": "315",
                "name": "Misoprostol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Abortefacient",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": null,
                "adverse_effects": "Diarrhea is common (especially at higher dosages) and self-limiting with discontinuation of misoprostol",
                "deleted_at": null,
                "created_at": "2020-05-06T23:39:04.000000Z",
                "updated_at": "2020-05-06T23:39:04.000000Z"
            },
            {
                "id": 316,
                "guid": "316",
                "name": "Mitoxantrone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic/fetotoxic",
                "contraindications": "Hypersensitivity to the drug\nLeukopenia\nPregnancy",
                "interactions": "Additive myelosuppressive effects possible with other antineoplastic drugs",
                "adverse_effects": "Myelosuppression (neutropenia in 50% of treated dogs at 6.1 +/- 0.6 mg/m² dosage), typically peaks around 7 days after administration\nVesicant (extravasation injury risk)\nIn cats, vomiting, depression, cardiomyopathy causing congestive heart failure, and seizures have been associated with mitoxantrone in certain cases",
                "deleted_at": null,
                "created_at": "2020-05-06T23:40:34.000000Z",
                "updated_at": "2020-05-06T23:40:34.000000Z"
            },
            {
                "id": 317,
                "guid": "317",
                "name": "Morphine sulfate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "30 +/- 2 ng/mL in dogs receiving 0.12 mg/kg/h IV CRI, associated with adequate analgesia (pain score: 4.4 on scale of zero [none] to 27 [severe];≤ 6 considered appropriate);not routinely measured in practice, however",
                "reversal_agent": "Naloxone; partial reversal with butorphanol administration",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other opiates\nHyperthermia\nIntolerance to common adverse effects (e.g., panting, hyperresponsiveness to sound)\nRespiratory depression\nPre-exisiting dysphoria or disorders where dysphoria may be detrimental (central nervous system disorders, disorders requiring the animal to remain immobilized) if evidence of dysphoria has emerged during previous hydromorphone treatment",
                "interactions": "Additive effects with other opiates and/or central nervous system depressants",
                "adverse_effects": "Bradycardia, vomiting, ileus, and other vagally-mediated autonomic effects are expected\nPanting (cats and dogs)\nHyperresponsiveness to sound, even very mild sound in some dogs/cats\nParadoxical excitement in cats may be overemphasized and is based on very high dosages (e.g., 20 mg/kg) given to cats experimentally >50 years ago\nMild hyperthermia is also expected with treatment in cats, whereas mild hypothermia occurs in dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T23:42:25.000000Z",
                "updated_at": "2020-05-06T23:42:25.000000Z"
            },
            {
                "id": 318,
                "guid": "318",
                "name": "Moxifloxacin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other fluoroquinolones\nImpaired vision (cats)\nGrowing puppies\nCaution/relative contraindication in patients with seizure disorders, since fluoroquinolones may lower the seizure threshold",
                "interactions": "Class effects possible: inhibition of cytochrome P450 (CYP-450) hepatic enzymes, increasing serum concentrations +/- duration of activity of many drugs (e.g., theophylline)\nAbsorption reduced by concurrent sucralfate (stagger doses)",
                "adverse_effects": "Arthropathy in growing kittens and puppies receiving ≥ 30 mg/kg/day and retinopathy in dogs receiving ≥ 60 mg/kg/day, similar to other fluoroquinolones\nProlongation of the QT interval on experimental canine electrocardiograms is reported, but clinical significance in dogs (and cats) is unknown",
                "deleted_at": null,
                "created_at": "2020-05-06T23:44:50.000000Z",
                "updated_at": "2020-05-06T23:44:50.000000Z"
            },
            {
                "id": 319,
                "guid": "319",
                "name": "Mycophenolate mofetil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Abortefacient and teratogenic",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": "Gastric acid-reducing drugs (e.g., omeprazole) may significantly reduce the bioavailability of mycophenolate\nfluoroquinolone antibacterials may reduce mycophenolate serum levels (both phenomena poorly explored in veterinary medicine, simply extrapolated from human medicine)",
                "adverse_effects": "Diarrhea is reported anecdotally in some treated dogs",
                "deleted_at": null,
                "created_at": "2020-05-06T23:45:26.000000Z",
                "updated_at": "2020-05-06T23:45:26.000000Z"
            },
            {
                "id": 320,
                "guid": "320",
                "name": "Naloxone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nDesired opiate effect",
                "interactions": "Reverses all opiate drugs",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T23:47:01.000000Z",
                "updated_at": "2020-05-06T23:47:01.000000Z"
            },
            {
                "id": 321,
                "guid": "321",
                "name": "Naproxen",
                "formulation_species_id": 0,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": null,
                "interactions": null,
                "adverse_effects": "Severe gastric ulceration and perforation",
                "deleted_at": null,
                "created_at": "2020-05-06T23:48:19.000000Z",
                "updated_at": "2020-05-06T23:48:19.000000Z"
            },
            {
                "id": 322,
                "guid": "322",
                "name": "Neostigmine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Pralidoxime; atropine or glycopyrrolate (to reverse muscarinic, but not neuromuscular, signs)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastrointestinal or urinary tract obstruction",
                "interactions": "Aminoglycosides may enhance myasthenic signs, requiring a higher dosage of neostigmine (or whenever possible, triggering a switch to a different class of antibacterial)",
                "adverse_effects": "Cholinergic crisis (muscarinic signs [salivation, defecation] progressing to nicotinic signs [weakness, tachypnea] reported in 1 dog given 0.04 mg/kg SC\nHigh-dosage IV injection (0.1 mg/kg) in neuromuscularly blockaded dogs produces salivation, increased bronchial secretions, bradycardia, and transient second-degree atrioventricular block",
                "deleted_at": null,
                "created_at": "2020-05-06T23:48:56.000000Z",
                "updated_at": "2020-05-06T23:48:56.000000Z"
            },
            {
                "id": 323,
                "guid": "323",
                "name": "Niacinamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": null,
                "adverse_effects": "Sporadic reports in dogs of anorexia, increase in seizure frequency if pre-existing seizure disorder",
                "deleted_at": null,
                "created_at": "2020-05-06T23:50:55.000000Z",
                "updated_at": "2020-05-06T23:50:55.000000Z"
            },
            {
                "id": 324,
                "guid": "324",
                "name": "Nifedipine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nLack of efficacy (e.g., feline urethral obstruction)\nHypotension",
                "interactions": "Additive hypotensive effects possible with other antihypertensive drugs (e.g., amlodipine) or with drugs that have a recognized vasodilating effect (e.g., acepromazine)",
                "adverse_effects": "Hypotension",
                "deleted_at": null,
                "created_at": "2020-05-06T23:52:47.000000Z",
                "updated_at": "2020-05-06T23:52:47.000000Z"
            },
            {
                "id": 325,
                "guid": "325",
                "name": "Nitenpyram",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T23:53:53.000000Z",
                "updated_at": "2020-05-06T23:53:53.000000Z"
            },
            {
                "id": 326,
                "guid": "326",
                "name": "Nitroglycerin 2%",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "New methylene blue (methemoglobinemia - unlikely)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other nitrate drugs\nHypotension\nCyanosis/methemoglobinemia",
                "interactions": "Additive hypotensive effects with antihypertensives (e.g., amlodipine), diuretics (e.g., furosemide), and other vasodilators (e.g., ACE inhibitors, acepromazine, etc.)",
                "adverse_effects": "Hypotension",
                "deleted_at": null,
                "created_at": "2020-05-06T23:54:33.000000Z",
                "updated_at": "2020-05-06T23:54:33.000000Z"
            },
            {
                "id": 327,
                "guid": "327",
                "name": "Nitroprusside",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "New methylene blue (methemoglobinemia)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other nitrate drugs\nHypotension\nCyanosis/methemoglobinemia",
                "interactions": "Additive hypotensive effects with antihypertensives (e.g., amlodipine), diuretics (e.g., furosemide), and other vasodilators (e.g., ACE inhibitors, acepromazine, etc.)",
                "adverse_effects": "Hypotension",
                "deleted_at": null,
                "created_at": "2020-05-06T23:55:39.000000Z",
                "updated_at": "2020-05-06T23:55:39.000000Z"
            },
            {
                "id": 328,
                "guid": "328",
                "name": "Nizatidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other H2-receptor blockers\nGI tract obstruction",
                "interactions": "May alter absorption of drugs for which gastric pH is important regarding bioavailability (e.g., ketoconazole, ampicillin-class antibacterials, digoxin)\nSucralfate needs an acidic environment to disperse, so it should be given >30 minutes before nizatidine",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T23:56:49.000000Z",
                "updated_at": "2020-05-06T23:56:49.000000Z"
            },
            {
                "id": 329,
                "guid": "329",
                "name": "Norepinephrine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product\nSystemic hypertension and/or evidence of hypertensive target organ damage",
                "interactions": null,
                "adverse_effects": "Long-term corticosteroid excess/hyperadrenocorticism doubles magnitude of response to norepinephrine in dogs (caution is warranted)",
                "deleted_at": null,
                "created_at": "2020-05-06T23:57:30.000000Z",
                "updated_at": "2020-05-06T23:57:30.000000Z"
            },
            {
                "id": 330,
                "guid": "330",
                "name": "Norfloxacin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fluoroquinolones are generally not recommended in pregnancy (cartilage effects)",
                "contraindications": "Hypersensitivity to the drug or to other fluoroquinolones\nAge < 6 months (<18 months in growing dogs) - possible class effects",
                "interactions": "Possibility of class effects (fluoroquinolones): reduction in elimination of cyclosporine, flunixin, and theophylline, potentially increasing the serum levels of these drugs to clinically significant (toxic) levels\nIon-containing gastric protectants (e.g., calcium carbonate) or gastric protectants (e.g., sucralfate) may reduce absorption",
                "adverse_effects": "Retinotoxicity possible in cats\nArthrotoxicity possible in growing dogs and cats\nCaution in epileptic patients because of possible CNS stimulatory effects of fluoroquinolone antibacterials (seemingly more often than enrofloxacin and other fluoroquinolones)",
                "deleted_at": null,
                "created_at": "2020-05-06T23:58:09.000000Z",
                "updated_at": "2020-05-06T23:58:09.000000Z"
            },
            {
                "id": 331,
                "guid": "331",
                "name": "Nystatin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Very limited, if any, drug interactions of clinical significance because nystatin absorption from the gastrointestinal tract is negligible",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-06T23:59:17.000000Z",
                "updated_at": "2020-05-06T23:59:17.000000Z"
            },
            {
                "id": 332,
                "guid": "332",
                "name": "Octreotide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cyclosporine serum levels may decrease, and require monitoring +/- dosage adjustment as necessary, during octreotide treatment\nInsulin dosages may need to be adjusted in some diabetics, especially type II (e.g., cats) because octreotide inhibits insulin (and glucagon) secretion\nIncreases bioavailability of bromocriptine",
                "adverse_effects": "Anorexia possible\nGenerally appears very safe (e.g., octreotide *reduces* [paradoxical - opposite to effect in insulinoma] serum blood glucose concentration in healthy dogs but not below normal range)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:00:17.000000Z",
                "updated_at": "2020-05-07T00:00:17.000000Z"
            },
            {
                "id": 333,
                "guid": "333",
                "name": "Ofloxacin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fluoroquinolones are generally not recommended in pregnancy (cartilage effects)",
                "contraindications": "Hypersensitivity to the drug or to other fluoroquinolones\nAge < 6 months (<18 months in growing dogs) - possible class effects\nPregnancy\nSeizures",
                "interactions": "Systemic administration inhibits cytochrome P450 (CYP-450) hepatic enzymes, increasing serum concentrations +/- duration of activity of many drugs (e.g., theophylline)\nAbsorption reduced by concurrent sucralfate (stagger doses)",
                "adverse_effects": "5 mg/kg PO q 24h for 8 days shown to not be arthropathic in growing puppies, but 10 mg/kg and 20 mg/kg dosages cause arthropathy (20 mg/kg produces grossly visible lesions after 2 days)\nRetinotoxicity possible in cats\ncaution in epileptic patients because of possible CNS stimulatory effects of fluoroquinolone antibacterials",
                "deleted_at": null,
                "created_at": "2020-05-07T00:01:16.000000Z",
                "updated_at": "2020-05-07T00:01:16.000000Z"
            },
            {
                "id": 334,
                "guid": "334",
                "name": "Olsalazine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other salicylate drugs",
                "interactions": "May increase bleeding risk of anticoagulant drugs and antithrombotic drugs",
                "adverse_effects": "Diarrhea, skin rash possible (extrapolated from use in human medicine)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:02:12.000000Z",
                "updated_at": "2020-05-07T00:02:12.000000Z"
            },
            {
                "id": 335,
                "guid": "335",
                "name": "Omeprazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "May alter absorption of drugs for which gastric pH is important regarding bioavailability (e.g., ketoconazole, ampicillin-class antibacterials, digoxin)\nMay reduce serum concentrations of clopidogrel, and conversely may increase serum concentrations of warfarin\nMay increase serum concentrations of drugs metabolized by hepatic P450 enzyme systems (e.g., benzodiazepines, cyclosporine), tacrolimus, and methotrexate - all extrapolated from human medicine\nSucralfate needs an acidic environment to disperse, so it should be given >30 minutes before omeprazole",
                "adverse_effects": "Diarrhea reported in some dogs/cats",
                "deleted_at": null,
                "created_at": "2020-05-07T00:02:42.000000Z",
                "updated_at": "2020-05-07T00:02:42.000000Z"
            },
            {
                "id": 336,
                "guid": "336",
                "name": "Ondansetron",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nOral intoxication/ingestion of toxic substance\nGastrointestinal tract obstruction\nCo-treatment with apomorphine (causes profound hypotension and unconsciousness in humans)",
                "interactions": "Antagonistic to emetic drugs (apomorphine, ipecac, hydrogen peroxide, alpha-2 adrenergic agonists in cats)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T00:04:36.000000Z",
                "updated_at": "2020-05-07T00:04:36.000000Z"
            },
            {
                "id": 337,
                "guid": "337",
                "name": "o,p'DDD",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Target cortisol level with treatment: 1h- or 2h-post ACTH serum cortisol < 5 µg/dL, without clinical signs of hypoadrenocorticism/cortisol deficiency",
                "reversal_agent": "Corticosteroids +/- mineralocorticoid",
                "teratogenicity": "Teratogenic and fetotoxic",
                "contraindications": "Hypersensitivity to the drug\nHypoadrenocorticism/cortisol deficiency\nPregnancy",
                "interactions": "Opposite effects to glucocorticoids, but oral glucocorticoids may be prescribed as precaution during treatment (see Pearls)\nCotreatment with ketoconazole is contraindicated (see Pearls)",
                "adverse_effects": "Hypocortisolism/hypoadrenocorticism, acute hepatopathy",
                "deleted_at": null,
                "created_at": "2020-05-07T00:05:41.000000Z",
                "updated_at": "2020-05-07T00:05:41.000000Z"
            },
            {
                "id": 338,
                "guid": "338",
                "name": "Orbifloxacin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fluoroquinolones are generally not recommended in pregnancy (cartilage effects)",
                "contraindications": "Hypersensitivity to the drug or to other fluoroquinolones\nAge < 6 months (<18 months in growing dogs) - possible class effects\nPregnancy\nSeizure disorders",
                "interactions": "Possibility of class effects (fluoroquinolones): reduction in elimination of cyclosporine, flunixin, and theophylline, potentially increasing the serum levels of these drugs to clinically significant (toxic) levels\nIon-containing gastric protectants (e.g., calcium carbonate) or gastric protectants (e.g., sucralfate) may reduce absorption",
                "adverse_effects": "Retinal degeneration occurs in some cats receiving orbifloxacin and, as with many other fluoroquinolones, the incidence is low, is more likely to occur with higher dosages, and is unpredictable on an individual cat basis\nAdverse cutaneous reaction (erythema) documented in 1 dog, resolving 1 week after termination of orbifloxacin\nMay increase predilection to seizures (class effect)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:06:55.000000Z",
                "updated_at": "2020-05-07T00:06:55.000000Z"
            },
            {
                "id": 339,
                "guid": "339",
                "name": "Osaterone",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nActive breeding males when androgenic characteristics and sperm effects are desirable",
                "interactions": "May decrease serum cortisol concentrations (causing hypoadrenocorticism and/or altering ACTH stimulation test response in hyperadrenocorticism patients)",
                "adverse_effects": "Transient polyphagia (23% of dogs), transient behavior changes (9%)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:07:57.000000Z",
                "updated_at": "2020-05-07T00:07:57.000000Z"
            },
            {
                "id": 340,
                "guid": "340",
                "name": "Oseltamivir",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastrointestinal tract obstruction",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T00:08:28.000000Z",
                "updated_at": "2020-05-07T00:08:28.000000Z"
            },
            {
                "id": 341,
                "guid": "341",
                "name": "Oxazepam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other benzodiazepines",
                "interactions": "Additive effects with other CNS depressants",
                "adverse_effects": "In cats, 0.3-3 mg/kg IP significantly increases aggression compared to placebo injection",
                "deleted_at": null,
                "created_at": "2020-05-07T00:09:04.000000Z",
                "updated_at": "2020-05-07T00:09:04.000000Z"
            },
            {
                "id": 342,
                "guid": "342",
                "name": "Oxymorphone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Naloxone",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other opiates\nHyperthermia\nIntolerance to common adverse effects (e.g., panting, hyperresponsiveness to sound)\nRespiratory depression",
                "interactions": "Additive effects with other central nervous system depressants, e.g., benzodiazepines, phenothiazines, inhalant anesthetics, and other opiates",
                "adverse_effects": "Bradycardia, vomiting, ileus, and other vagally-mediated autonomic effects are expected\nPanting (cats and dogs)\nHyperresponsiveness to sound, even very mild sound in some dogs/cats\nParadoxical excitement in cats at 0.2 mg/kg IV is prohibitive\nMild hyper-/hypothermia possible",
                "deleted_at": null,
                "created_at": "2020-05-07T00:09:41.000000Z",
                "updated_at": "2020-05-07T00:09:41.000000Z"
            },
            {
                "id": 343,
                "guid": "343",
                "name": "Oxytetracycline",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Contraindicated in pregnancy due to calcium binding, leading to tooth enamel discoloration and bone alterations",
                "contraindications": "Hypersensitivity to the drug and/or to other tetracyclines\nPregnancy\nNeonatal life (bone/teeth effects as in utero)\nCaution if extensive kidney disease, potentially causing accumulation and toxicosis (route of elimination is renal excretion)",
                "interactions": "Cotreatment with methotrexate may increase serum methotrexate concentrations\nCotreatment with synthetic retinoids may cause severe central nervous system complications (both extrapolated from human medicine)\ncotreatment with calcium-/magnesium-containing compounds or supplements can inactivate oxytetracycline",
                "adverse_effects": "Esophageal stricture in cats given oral doses without water or food follow-through",
                "deleted_at": null,
                "created_at": "2020-05-07T00:11:33.000000Z",
                "updated_at": "2020-05-07T00:11:33.000000Z"
            },
            {
                "id": 344,
                "guid": "344",
                "name": "Oxytocin",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Tocolytic (labor-suppressing) drugs, e.g., terbutaline",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nMechanical dystocia/obstruction of the birth canal",
                "interactions": "Synergistic with calcium gluconate (and minimally effective or even ineffective if untreated hypocalcemia exists)",
                "adverse_effects": "Hypoxic puppies, stillbirths significantly more frequent with oxytocin monotherapy than when oxytocin is coadministered with slow IV calcium gluconate\n2.5% incidence of iatrogenic oxytocin excess (uterine spasm)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:12:46.000000Z",
                "updated_at": "2020-05-07T00:12:46.000000Z"
            },
            {
                "id": 345,
                "guid": "345",
                "name": "Paclitaxel, water-soluble micellar",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing neutropenia",
                "interactions": null,
                "adverse_effects": "High rate of neutropenia (82%, vs. 93% for high-dosage lomustine 70 mg/m²) and emesis (79%, vs. 51% for high-dosage lomustine)\nLow rate of hepatotoxicosis (2%, vs. 33% for high-dosage lomustine)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:14:01.000000Z",
                "updated_at": "2020-05-07T00:14:01.000000Z"
            },
            {
                "id": 346,
                "guid": "346",
                "name": "Pamidronate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic to fetal bone",
                "contraindications": "Hypersensitivity to the drug\nAdvanced kidney disease/oliguria/anuria\nPregnancy\nHypocalcemia",
                "interactions": "Additive nephrotoxic effects possible with aminoglycoside antibacterials and other potentially nephrotoxic drugs (avoid if possible)",
                "adverse_effects": "Nephotoxicosis possible (extrapolation from human medicine)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:14:28.000000Z",
                "updated_at": "2020-05-07T00:14:28.000000Z"
            },
            {
                "id": 347,
                "guid": "347",
                "name": "Pancreatic enzymes",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": null,
                "adverse_effects": "Gingival bleeding (dosage-dependent)\nPowder may generate dust that is irritating to the respiratory mucosa (nasal signs, asthmatic exacerbation)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:15:20.000000Z",
                "updated_at": "2020-05-07T00:15:20.000000Z"
            },
            {
                "id": 348,
                "guid": "348",
                "name": "Pantoprazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "May alter absorption of drugs for which gastric pH is important regarding bioavailability (e.g., ketoconazole, ampicillin-class antibacterials, digoxin)\nMay increase serum methotrexate concentrations\nSucralfate needs an acidic environment to disperse, so it should be given >30 minutes before pantoprazole",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T00:17:14.000000Z",
                "updated_at": "2020-05-07T00:17:14.000000Z"
            },
            {
                "id": 349,
                "guid": "349",
                "name": "Paromomycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Aminoglycoside class concern re. fetotoxicity",
                "contraindications": "Hypersensitivity to the drug\nGastrointestinal tract obstruction",
                "interactions": "Additive effects with other potentially nephrotoxic drugs (e.g., other aminoglycosides)",
                "adverse_effects": "Acute renal failure, deafness documented in treated cats (aminoglycoside class toxicity)\nSevere effects at accidental overdose levels (80 mg/kg): appetite loss, weight loss, loss of scent perception, acute dehydration, deafness, and keratitis",
                "deleted_at": null,
                "created_at": "2020-05-07T00:17:55.000000Z",
                "updated_at": "2020-05-07T00:17:55.000000Z"
            },
            {
                "id": 350,
                "guid": "350",
                "name": "Paroxetine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Increased risk of congenital cardiac malformations in children (extrapolated to small animal medicine)",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Avoid cotreatment with tramadol, tricyclic antidepressants, amitraz, monoamine oxidase inhibitors (e.g., selegiline) due to risk of serotonin syndrome (severe tachycardia, CNS hyperactivity, possibly seizures)\nAllow at least 2-week washout period after previous drug termination before starting paroxetine",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T00:19:07.000000Z",
                "updated_at": "2020-05-07T00:19:07.000000Z"
            },
            {
                "id": 351,
                "guid": "351",
                "name": "Penicillamine, D-",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogen (cleft palate, fetal resorption)",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": "Adverse reactions possible with concurrent administration of cytotoxic drugs, drugs with nephrotoxic potential (e.g., aminoglycoside antibacterials, phenylbutazone)",
                "adverse_effects": "Anecdotally reported vomiting in dogs\nLeukopenia, thrombocytopenia, and kidney injury (glomerular damage) are reported in some human patients (5-10%)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:19:42.000000Z",
                "updated_at": "2020-05-07T00:19:42.000000Z"
            },
            {
                "id": 352,
                "guid": "352",
                "name": "Penicillin G (Na or K)",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug (seemingly much less common in dogs and cats than in humans)",
                "interactions": "Will crystallize (and obstruct IV catheter) if coinjected with aminoglycosides, so flushing with an appropriate amount of sterile saline or other compatible solution is necessary between penicillin and aminoglycoside IV injections\nCoadministration with aminoglycosides also inactivates the antibacterial properties of both drugs\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)\nPossibility of adverse cardiac effects from interaction between potassium in KPen and CNS drugs that are part of general anesthesia",
                "adverse_effects": "Iatrogenic hyperkalemia/hypernatremia if high concentration is infused too quickly",
                "deleted_at": null,
                "created_at": "2020-05-07T00:20:48.000000Z",
                "updated_at": "2020-05-07T00:20:48.000000Z"
            },
            {
                "id": 353,
                "guid": "353",
                "name": "Penicillin G procaine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug (seemingly much less common in dogs and cats than in humans)",
                "interactions": "Avoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Injection is often uncomfortable, even painful if not warmed to body temperature before injection\nIf given IV instead of IM or SC, may or may not be fatal: muscle tremors, seizures, blindness, vocalization in some dogs, cardiac arrest in others",
                "deleted_at": null,
                "created_at": "2020-05-07T00:22:33.000000Z",
                "updated_at": "2020-05-07T00:22:33.000000Z"
            },
            {
                "id": 354,
                "guid": "354",
                "name": "Pentobarbital",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Activated charcoal given directly PO or via stomach tube: acts as \"carbon sink\" and adsorbs barbiturates even when the barbiturate was given IV",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nRespiratory depression\nDepressed mentation/unconsciousness if hazardous (e.g., risk of aspiration pneumonitis with unprotected airway)",
                "interactions": "Additive effects with other drugs that depress central nervous system function (e.g., benzodiazepines like diazepam, phenothiazines like acepromazine, opiates like hydromorphone, etc.)",
                "adverse_effects": "Respiratory depression, notably at higher dosages",
                "deleted_at": null,
                "created_at": "2020-05-07T00:24:11.000000Z",
                "updated_at": "2020-05-07T00:24:11.000000Z"
            },
            {
                "id": 355,
                "guid": "355",
                "name": "Pentosan polysulfate",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Vomiting (5-15 minutes after injection) can occur in some dogs\nLethargy (lasting up to 2 days) has been described in some dogs",
                "deleted_at": null,
                "created_at": "2020-05-07T00:26:21.000000Z",
                "updated_at": "2020-05-07T00:26:21.000000Z"
            },
            {
                "id": 356,
                "guid": "356",
                "name": "Pentoxifylline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "May confer added anticoagulation (caution re. warfarin, aspirin, etc.)\nIncreases serum concentrations of theophylline, potentially predisposing to toxicosis",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T00:27:05.000000Z",
                "updated_at": "2020-05-07T00:27:05.000000Z"
            },
            {
                "id": 357,
                "guid": "357",
                "name": "Phenobarbital",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "Optimal: 23-28 µg/mL (drawn >1 week after starting treatment, anytime during the day irrespective of when doses are given) is associated with elimination of seizures in dogs that respond to phenobarbital monotherapy;persistent seizures despite levels in this range (or higher) should prompt re-evaluation of etiology (is there an underlying cause of seizures that can be corrected?) and the possibility of adding a second anticonvulsant;levels > 40 µg/mL are considered toxic and warrant dosage reduction;< 15 µg/mL is considered subtherapeutic",
                "reversal_agent": "For acute overdoses, activated charcoal given directly PO or via stomach tube, including >12h after intoxication, binds the drug directly but also acts as a gastric \"phenobarbital sink\" and adsorbs phenobarbital from the circulation",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nRespiratory depression\nDepressed mentation/unconsciousness if hazardous (e.g., risk of aspiration pneumonitis with unprotected airway)\nHepatopathy",
                "interactions": "Corticosteroids mimic (and add to) the adverse effects of phenobarbital both clinically (polyuria, polydipsia, polyphagia, weight gain) and biochemically (serum liver enzyme elevations)\nAccelerates catabolism of many/most hepatically-metabolized drugs\nAdditive effect of central nervous system depression if coadministered with opiates, benzodiazepines, phenothiazines, antihistamines, or other barbiturates\nChloramphenicol inhibits phenobarbital metabolism, potentially leading to toxic levels of phenobarbital even at therapeutic dosages",
                "adverse_effects": "Hepatopathy is common and typically more severe with higher dosages and/or longer durations of treatment and/or pre-existing liver disease\nTherapeutic drug monitoring and serum liver enzyme monitoring are recommended, and an alternative should be sought if significant abnormalities occur\nPolyuria, polydipsia, polyphagia and weight gain occur very commonly and may become prohibitive",
                "deleted_at": null,
                "created_at": "2020-05-07T00:27:55.000000Z",
                "updated_at": "2020-05-07T00:27:55.000000Z"
            },
            {
                "id": 358,
                "guid": "358",
                "name": "Phenoxybenzamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension\nCardiomyopathy",
                "interactions": "Additive effects with other drugs that cause hypotension (e.g., acepromazine, amlodipine), which has caused hypotensive crises in cats",
                "adverse_effects": "Hypotension possible with standard dosages\nRisk of triggering iatrogenic congestive heart failure in cats with pre-existing cardiomyopathy\nLack of efficacy in targeted area in cats",
                "deleted_at": null,
                "created_at": "2020-05-07T00:30:28.000000Z",
                "updated_at": "2020-05-07T00:30:28.000000Z"
            },
            {
                "id": 359,
                "guid": "359",
                "name": "Phenylbutazone",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastrointestinal bleeding\nRenal insufficiency\nAnorexia",
                "interactions": "May increase bleeding risk if coadministered with warfarin, heparin, aspirin, or other anticoagulant/antiplatelet drugs\nMay increase risk of gastrointestinal ulceration if coadministered with glucocorticoids (significant risk) or other nonsteroidal anti-inflammatories\nMay increase risk of renal injury if coadministered with diuretics, aminoglycoside antibacterials, acepromazine, or any other drugs that have nephrotoxic or hypotensive potential",
                "adverse_effects": "Gastrointestinal ulceration, hemorrhage, and perforation have occurred in dogs, especially debilitated and/or dehydrated dogs\nRenal injury possible",
                "deleted_at": null,
                "created_at": "2020-05-07T00:31:43.000000Z",
                "updated_at": "2020-05-07T00:31:43.000000Z"
            },
            {
                "id": 360,
                "guid": "360",
                "name": "Phenylephrine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Phenothiazine tranquilizers (e.g., acepromazine) block alpha-1-mediated effects",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nSystemic hypertension\nRisk of target organ damage with systemic hypertension\nHypovolemic hypotension (need to restore intravascular volume before vasopressor administration)",
                "interactions": "Monoamine oxidase inhibitors (e.g., selegiline) markedly increase vasopressor effect (potentially causing critical systemic hypertension with standard dosages of phenylephrine). As a result, a lower dosage of phenylephrine (or an alternative drug) should be used in patients who are receiving these drugs\nTricyclic antidepressants (e.g., clomipramine, amitriptyline, etc.) may also produce this effect with phenylephrine",
                "adverse_effects": "Systemic hypertension with or without target organ damage",
                "deleted_at": null,
                "created_at": "2020-05-07T00:32:21.000000Z",
                "updated_at": "2020-05-07T00:32:21.000000Z"
            },
            {
                "id": 361,
                "guid": "361",
                "name": "Phenylpropanolamine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Phenothiazine tranquilizers (e.g., acepromazine) block alpha-1-mediated effects",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nCardiovascular, renal and/or systemic hypertensive disorders\nPrior evidence of intolerance (notably tachycardia in patients who have pre-existing heart disease)",
                "interactions": "Additive (beneficial) urinary tract effects with diethylsilbestrol and other estrogen derivatives\nAdditive autonomic effects with catecholamines (e.g., epinephrine), possibly methylxanthines (e.g., theophylline)",
                "adverse_effects": "Adrenergic excess occurs in some dogs and may be distressing and/or hazardous (warranting termination of treatment with this drug): tachycardia, anxiety, systemic hypertension\nConversely, overdosage was associated with lethargy in 1 dog",
                "deleted_at": null,
                "created_at": "2020-05-07T00:33:09.000000Z",
                "updated_at": "2020-05-07T00:33:09.000000Z"
            },
            {
                "id": 363,
                "guid": "363",
                "name": "Pimobendan",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nConcentric ventricular hypertrophy/ventricular thickening\nVentricular outflow obstruction (e.g., pulmonic or subaortic stenosis)",
                "interactions": "Does not decrease renin-angiotensin-aldosterone system activation and therefore cannot be considered a replacement for ACE inhibition[1]",
                "adverse_effects": "Evidence of harm in preclinical (\"murmur-only\") myxomatous mitral valve disease, with worsening/acceleration of disease associated with treatment\nCollapse in a cat with hypertrophic cardiomyopathy and systolic anterior motion of the mitral valve",
                "deleted_at": null,
                "created_at": "2020-05-07T00:35:25.000000Z",
                "updated_at": "2020-05-07T00:35:25.000000Z"
            },
            {
                "id": 364,
                "guid": "364",
                "name": "Piperacillin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other beta-lactam antibacterials (penicillins, cephalosporins)",
                "interactions": "Cannot be mixed or administered with aminoglycosides (piperacillin inactivates the aminoglycoside, and vice-versa)\nMay increase serum levels of methotrexate (risking toxicosis)\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Hepatotoxicosis possible in dogs receiving very high (supratherapeutic) dosages",
                "deleted_at": null,
                "created_at": "2020-05-07T00:37:16.000000Z",
                "updated_at": "2020-05-07T00:37:16.000000Z"
            },
            {
                "id": 365,
                "guid": "365",
                "name": "Piperacillin + tazobactam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other beta-lactam antibacterials (penicillins, cephalosporins)",
                "interactions": "Cannot be mixed or administered with aminoglycosides (piperacillin inactivates the aminoglycoside, and vice-versa)\nMay increase serum levels of methotrexate (risking toxicosis)\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "Hepatotoxicosis possible in dogs receiving very high (supratherapeutic) dosages",
                "deleted_at": null,
                "created_at": "2020-05-07T00:37:44.000000Z",
                "updated_at": "2020-05-07T00:37:44.000000Z"
            },
            {
                "id": 366,
                "guid": "366",
                "name": "Piperazine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Competing mechanism with pyrantel (do not coadminister piperazine and pyrantel - self-defeating)",
                "adverse_effects": "Neurologic signs possible at high therapeutic or supratherapeutic dosages",
                "deleted_at": null,
                "created_at": "2020-05-07T00:38:14.000000Z",
                "updated_at": "2020-05-07T00:38:14.000000Z"
            },
            {
                "id": 367,
                "guid": "367",
                "name": "Piroxicam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing gastrointestinal ulceration",
                "interactions": "Additive gastrointestinal ulcerogenic effect with corticosteroids or other nonsteroidal anti-inflammatories (avoid)\nPotentiation of nephrotoxicosis possible, especially with volume-depleting drugs (e.g., diuretics) in dehydrated/anorectic patients",
                "adverse_effects": "Gastrointestinal ulceration and associated signs and complication (the most common adverse effect) occurs in 100% of dogs receiving 1.5 mg/kg PO q 24 and has been fatal\nRisk is unacceptably high (i.e., piroxicam treatment needs to be stopped temporarily or permanently) when there is decreased appetite, dehydration, and/or poor renal function",
                "deleted_at": null,
                "created_at": "2020-05-07T00:40:37.000000Z",
                "updated_at": "2020-05-07T00:40:37.000000Z"
            },
            {
                "id": 368,
                "guid": "368",
                "name": "Potassium chloride",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Normal serum K+ = 4-5 mEq/L",
                "reversal_agent": "Calcium gluconate slow IV, insulin + dextrose, sodium bicarbonate",
                "teratogenicity": null,
                "contraindications": "Hyperkalemia\nAnuria\nUrinary tract rupture",
                "interactions": "Ongoing treatment with potassium-sparing diuretics (e.g., spironolactone) and/or ACE inhibitors (e.g., enalapril) may enhance potassium retention and favor hyperkalemia (caution)\nDextrose-containing fluids and/or bicarbonate-containing fluids may reduce serum potassium concentrations, predisposing to hypokalemia\nSeveral (dozens of) in vitro incompatibilities, justifying consultation with a pharmacist before adding drugs to infusions already supplemented with potassium chloride",
                "adverse_effects": "Hyperkalemia possible if incorrect dose and/or rate is applied, or if IV fluid bag is not agitated after injection of KCl into bag (KCl remains in bottom of bag and is infused virtually undiluted), risking cardiac arrhythmia/arrest",
                "deleted_at": null,
                "created_at": "2020-05-07T00:43:55.000000Z",
                "updated_at": "2020-05-07T00:43:55.000000Z"
            },
            {
                "id": 369,
                "guid": "369",
                "name": "Potassium citrate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Normal serum K+ = 4-5 mEq/L",
                "reversal_agent": "Calcium gluconate slow IV, insulin + dextrose, sodium bicarbonate (but hyperkalemia occurs very rarely with potassium citrate, barring oliguria/anuria or massive overdose)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound\nHyperkalemia\nStruvite urolithiasis\nMetabolic alkalosis",
                "interactions": "Increases renal excretion of phenobarbital by 17% (i.e., lowers plasma concentration), even though phenobarbital is a predominantly hepatically-metabolized drug[1]",
                "adverse_effects": "Hyperkalemia uncommon (severe overdosage)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:44:55.000000Z",
                "updated_at": "2020-05-07T00:44:55.000000Z"
            },
            {
                "id": 370,
                "guid": "370",
                "name": "Potassium gluconate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Normal serum K+ = 4-5 mEq/L",
                "reversal_agent": "Calcium gluconate slow IV, insulin + dextrose, sodium bicarbonate (but hyperkalemia occurs very rarely with potassium gluconate, barring oliguria/anuria or massive overdose)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound\nHyperkalemia",
                "interactions": null,
                "adverse_effects": "Hyperkalemia uncommon (severe overdosage)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:45:57.000000Z",
                "updated_at": "2020-05-07T00:45:57.000000Z"
            },
            {
                "id": 371,
                "guid": "371",
                "name": "Potassium phosphate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Normal serum K+ = 4-5 mEq/L",
                "reversal_agent": "Calcium gluconate slow IV, insulin + dextrose, sodium bicarbonate",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the compound\nHyperkalemia\nHyperphosphatemia",
                "interactions": "Avoid administering in calcium-containing IV fluids (e.g., lactated Ringer's solution) due to calcium-phosphorus binding\n0.9% NaCl, 0.45% NaCl + 2.5% dextrose, etc. are OK",
                "adverse_effects": "Hypocalcemia in up to 80% of treated cats (but only a minority show overt clinical signs attributable to hypocalcemia)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:46:50.000000Z",
                "updated_at": "2020-05-07T00:46:50.000000Z"
            },
            {
                "id": 372,
                "guid": "372",
                "name": "Pradofloxacin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fetotoxic potential",
                "contraindications": "Dogs\nHypersensitivity to the drug or to other fluoroquinolones\nAge < 6 months (<18 months in growing dogs) - possible class effects\nPregnancy\nSeizure disorders",
                "interactions": "Possibility of class effects (fluoroquinolones): reduction in elimination of cyclosporine, flunixin, and theophylline, potentially increasing the serum levels of these drugs to clinically significant (toxic) levels\nIon-containing gastric protectants (e.g., calcium carbonate) or gastric protectants (e.g., sucralfate) may reduce absorption",
                "adverse_effects": "Contraindicated in dogs due to myelotoxicosis\nMyelotoxicosis (reversible) in kittens treated for >7 days\nRetinal degeneration occurs in some cats receiving fluoroquinolones - the incidence is low, is best recognized in enrofloxacin (likely in pat due to its longer history of use and market reach), is more likely to occur with higher dosages, and is unpredictable on an individual cat basis -- similarly, arthrotoxicosis is documented as a class effect of fluoroquinolones in growing puppies and kittens\nMay increase predilection to seizures (class effect)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:47:55.000000Z",
                "updated_at": "2020-05-07T00:47:55.000000Z"
            },
            {
                "id": 373,
                "guid": "373",
                "name": "Pralidoxime",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nCarbamate toxicosis (e.g., aldicarb, carbaryl, etc.) because pralidoxime increases toxicity of carbamates",
                "interactions": null,
                "adverse_effects": "Immediate but temporary worsening of cholinergic signs (tachycardia, laryngospasm, etc.) may occur with IV route",
                "deleted_at": null,
                "created_at": "2020-05-07T00:48:47.000000Z",
                "updated_at": "2020-05-07T00:48:47.000000Z"
            },
            {
                "id": 374,
                "guid": "374",
                "name": "Praziquantel",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "P450 hepatic enzyme-inducing drugs, notably phenobarbital, rifampin, and dexamethasone, accelerate praziquantel metabolism (e.g., praziquantel serum levels are undetectable in some human patients receiving chronic rifampin therapy)\nConversely, P450 enzyme inhibitors (e.g., ketoconazole, itraconazole, erythromycin, cimetidine) reduce drug catabolism, increasing serum praziquantel levels",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T00:49:40.000000Z",
                "updated_at": "2020-05-07T00:49:40.000000Z"
            },
            {
                "id": 375,
                "guid": "375",
                "name": "Prazosin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Alpha-1 adrenergic agonists, other vasopressors",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nNarcolepsy/cataplexy (exacerbates events)\nPre-existing hypotension",
                "interactions": "Additive hypotensive effects with other vasodilators (hydralazine, ACE inhibitors, nitroglycerin/nitroprusside, acepromazine)\nCountereffect to vasopressors (e.g., phenylephrine)",
                "adverse_effects": "Hypotension",
                "deleted_at": null,
                "created_at": "2020-05-07T00:51:50.000000Z",
                "updated_at": "2020-05-07T00:51:50.000000Z"
            },
            {
                "id": 376,
                "guid": "376",
                "name": "Prednisone/prednisolone",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": "Normal serum cortisol concentration = 0.5-5.5 µg/dL;normal serum cortisol concentration 1-2h after ACTH injection = 5-17 µg/dL",
                "reversal_agent": null,
                "teratogenicity": "Potentially teratogenic and/or abortefacient",
                "contraindications": "Hypersensitivity to the preparation\nUncontrolled hyperadrenocorticism (spontaneous or iatrogenic)\nSuspected lymphoma, autoimmune diseases, and other corticosteroid-responsive disorders if cytologic and/or biopsy confirmation has not been obtained, because prednisolone obscures (or makes impossible) the final diagnosis\nUncontrolled infection\nLymphoma if protocol-based chemotherapy will be considered\nAdvanced heart disease (risk of iatrogenic congestive heart failure)",
                "interactions": "Additive immunosuppressant effects with other immune-suppressing drugs\nAdditive adverse hepatic effects, polyuria/polydipsia, and polyphagia with barbiturates (e.g., phenobarbital)\nAdditive gastrointestinal ulcerogenic effects with other glucocorticoids and/or with nonsteroidal anti-inflammatory drugs",
                "adverse_effects": "Numerous and more likely to occur with extended (weeks/months/years) use and/or high dosages. As a result, benefit-vs.-risk analysis is always warranted when considering treatment\nMost common adverse effects in dogs include iatrogenic hyperadrenocorticism (dogs > cats), vacuolar hepatopathy/hepatic lipidosis, obesity and associated respiratory and orthopedic disorders, nuisance clinical signs (e.g., polyuria, polydipsia, polyphagia [dogs > cats]), diabetes mellitus (cats > dogs), iatrogenic congestive heart failure (cats > dogs), gastrointestinal irritation/ulceration, induction of P-glycoprotein-associated resistance to antineoplastic drugs, masking of immune-mediated inflammation or lymphoma (creating diagnostic ambiguity), and opportunistic infection from immune suppression and/or connective tissue weakening",
                "deleted_at": null,
                "created_at": "2020-05-07T00:53:16.000000Z",
                "updated_at": "2020-05-07T00:53:16.000000Z"
            },
            {
                "id": 377,
                "guid": "377",
                "name": "Prednisolone sodium succinate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Normal serum cortisol concentration = 0.5-5.5 µg/dL;normal serum cortisol concentration 1-2h after ACTH injection = 5-17 µg/dL",
                "reversal_agent": null,
                "teratogenicity": "Potentially teratogenic and/or abortefacient",
                "contraindications": "Hypersensitivity to the preparation\nActive gastrointestinal bleeding\nLymphoma if protocol-based chemotherapy will be considered\nSuspected lymphoma, autoimmune diseases, and other corticosteroid-responsive disorders if cytologic and/or biopsy confirmation has not been obtained, because prednisolone obscures (or makes impossible) the final diagnosis\nPregnancy",
                "interactions": "Many glucocorticoid drug interactions possible, but given the urgent, single-use (usually) application of prednisolone sodium succinate, the interaction of greatest concern is with nonsteroidal anti-inflammatories and other glucocorticoids (gastric ulceration) ",
                "adverse_effects": "Many glucocorticoid adverse reactions possible, but given the urgent, single-use (usually) application of prednisolone sodium succinate, the interaction of greatest concern is with nonsteroidal anti-inflammatories and other glucocorticoids (gastric ulceration)\nPolyuria/polydipsia, obesity, diabetes mellitus, hepatopathy, and many other glucocorticoid adverse effects mainly occur with weeks/months of use and are not relevant for this formulation of prednisolone",
                "deleted_at": null,
                "created_at": "2020-05-07T00:57:00.000000Z",
                "updated_at": "2020-05-07T00:57:00.000000Z"
            },
            {
                "id": 378,
                "guid": "378",
                "name": "Pregabalin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Median trough plasma concentration during treatment = 7.3 µg/mL (range = 2-11 µg/mL);> 2.8 µg/mL is considered therapeutic range; for trough level, blood sample should be drawn immediately before administering next dose",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Especially in dogs concurrently receiving phenobarbital, bromide, or both, mild to marked sedation and/or ataxia can be expected in up to 90% of dogs (and a dosage reduction should be undertaken accordingly)",
                "deleted_at": null,
                "created_at": "2020-05-07T00:58:10.000000Z",
                "updated_at": "2020-05-07T00:58:10.000000Z"
            },
            {
                "id": 379,
                "guid": "379",
                "name": "Procainamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Controversial;both 20 µg/dL [1] and 10-fold higher level (note denominator): 25-48.5 µg/mL [2] have demonstrated therapeutic effect in dogs with cardiac arrhythmias, i.e., associated with significantly less arrhythmia during treatment",
                "reversal_agent": "Intravenous lipid, e.g., 20% lipid emulsion, could be expected to provide clinical benefit in cases of toxicosis",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPathologic bradycardia, notably 3rd degree (or high-grade 2nd degree) atrioventricular block where suppression of ventricular escape beats could favor ventricular asystole",
                "interactions": "Additive effects with other class I antiarrhythmics, especially class Ia drugs (e.g., quinidine), which should not be coadministered\nHypokalemia causes refractoriness to the drug's therapeutic (but not toxic) effects\ncoadministration with ranitidine causes increased serum procainamide levels",
                "adverse_effects": "Reports exist of antinuclear antibody formation, hepatopathy, myelotoxic effects, and other unconfirmed side-effects, in dogs",
                "deleted_at": null,
                "created_at": "2020-05-07T00:58:50.000000Z",
                "updated_at": "2020-05-07T00:58:50.000000Z"
            },
            {
                "id": 380,
                "guid": "380",
                "name": "Procarbazine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic/fetotoxic potential",
                "contraindications": "Hypersensitivity to the drug\nPre-existing myelosuppression (unless due to neoplastic myelophthisis/infiltration)",
                "interactions": "Additive myelosuppressive and/or gastrointestinal effects possible with other antineoplastic drugs",
                "adverse_effects": "Myelosuppression (e.g., 33% of dogs in 1 study) and gastroenteritis (e.g., 14% of dogs in 1 study)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:00:31.000000Z",
                "updated_at": "2020-05-07T01:00:31.000000Z"
            },
            {
                "id": 381,
                "guid": "381",
                "name": "Prochlorperazine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension/hypovolemia\nUnconsciousness",
                "interactions": "Additive sedative and vasodilatory effects with other CNS depressants and vasodilators, respectively",
                "adverse_effects": "Hypotension, sedation possible, especially in debilitated and/or older dogs",
                "deleted_at": null,
                "created_at": "2020-05-07T01:01:24.000000Z",
                "updated_at": "2020-05-07T01:01:24.000000Z"
            },
            {
                "id": 382,
                "guid": "382",
                "name": "Propantheline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Bethanechol",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastrointestinal obstruction/ileus\nGlaucoma\nUrinary tract obstruction\nMyasthenia gravis",
                "interactions": "Potentiation/additive anticholinergic effects possible with phenothiazines (e.g., acepromazine), antihistamines, tricyclic antidepressants (e.g., clomipramine), meperidine, atropine, glycopyrrolate\nIncrease in digoxin serum levels, and decrease in serum ketoconazole levels, possible",
                "adverse_effects": "Excessive anticholinergic effects: constipation, xerostomia (dry mouth), tachycardia, mydriasis",
                "deleted_at": null,
                "created_at": "2020-05-07T01:02:24.000000Z",
                "updated_at": "2020-05-07T01:02:24.000000Z"
            },
            {
                "id": 383,
                "guid": "383",
                "name": "Propofol",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Readily crosses placenta (fetal depression possible)",
                "contraindications": "Hypersensitivity to the product\nIncreased intraocular pressure",
                "interactions": "Additive apnea and immobilization effects when coadministered with other anesthetics and with barbiturates",
                "adverse_effects": "Apnea at induction (11% of dogs, and higher with rapid bolus, which should be avoided)\nVomiting (5%)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:03:05.000000Z",
                "updated_at": "2020-05-07T01:03:05.000000Z"
            },
            {
                "id": 384,
                "guid": "384",
                "name": "Propranolol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Isoproterenol, dobutamine",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nAsthma/airway disease\nSinus tachycardia in a patient with systemic signs (propranolol is contraindicated as monotherapy), because sinus tachycardia in a patient with systemic signs can exist in response to a primary cause (hypovolemia, systemic inflammation, anemia, etc.) and suppression of sinus tachycardia with a beta-blocker, without correcting of the primary cause, can cause hemodynamic collapse and cardiac arrest",
                "interactions": "Numerous (all extrapolated from human medicine) - propranolol blood levels are increased by coadministration of aminophylline, amiodarone, chlorpromazine, cimetidine, fluconazole, fluoxetine, imipramine, paroxetine, quinidine (3-fold increase in blood propranolol levels if coadministered), theophylline, and other hepatic P450 enzyme inhibitors or substrates\nPropranolol blood levels are reduced by phenobarbital, rifampin, and other inducers of hepatic P450 enzymes\ncoadministration of propranolol increases blood levels of diazepam, lidocaine, and warfarin",
                "adverse_effects": "Subjectively greater incidence of hepatopathy and general malaise (anorexia, lethargy - not necessarily related to bradycardia) with propranolol compared to other beta-blockers (e.g., atenolol), notably in cats\nHypotension may be severe",
                "deleted_at": null,
                "created_at": "2020-05-07T01:05:48.000000Z",
                "updated_at": "2020-05-07T01:05:48.000000Z"
            },
            {
                "id": 385,
                "guid": "385",
                "name": "Pseudoephedrine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Phenothiazine tranquilizers (e.g., acepromazine) block alpha-1-mediated effects",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nSystemic hypertension",
                "interactions": "Additive effects with other vasopressor drugs (e.g., phenylephrine) +/- with nonselective beta-blockers (e.g., propranolol)",
                "adverse_effects": "Panting, decreased appetite, and/or lethargy in 56% of dogs treated for 28 days",
                "deleted_at": null,
                "created_at": "2020-05-07T01:07:32.000000Z",
                "updated_at": "2020-05-07T01:07:32.000000Z"
            },
            {
                "id": 386,
                "guid": "386",
                "name": "Psyllium mucilloid",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product\nObstipation (ineffective during impaction)",
                "interactions": "If taken in excess, may bind and reduce the bioavailability of virtually any orally-administered drug (uncommon/rare)",
                "adverse_effects": "Loose feces possible",
                "deleted_at": null,
                "created_at": "2020-05-07T01:08:27.000000Z",
                "updated_at": "2020-05-07T01:08:27.000000Z"
            },
            {
                "id": 387,
                "guid": "387",
                "name": "Pyrantel pamoate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Competing mechanism with piperazine (do not coadminister piperazine and pyrantel - self-defeating)",
                "adverse_effects": "Very uncommon\nMassive worm kill in heavily burdened animal has caused GI tract obstruction",
                "deleted_at": null,
                "created_at": "2020-05-07T01:09:34.000000Z",
                "updated_at": "2020-05-07T01:09:34.000000Z"
            },
            {
                "id": 388,
                "guid": "388",
                "name": "Pyridostigmine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "For myasthenia gravis confirmation: antiacetylcholine receptor antibody titer >0.6 nmol/L (dog) or >0.3 nmol/L (cat) is consistent with myasthenia gravis",
                "reversal_agent": "Atropine (for muscarinic signs)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGI and/or urinary tract obstruction\nOrganophosphate toxicosis (pesticide) or exposure (e.g., flea collar)\nAsthma (due to increase in bronchial secretions)",
                "interactions": "Enhancement of effect of anticholinesterase glaucoma drugs (e.g., demecarium) and of bradycardia caused by opiates and barbiturates",
                "adverse_effects": "5-20 mg/kg q 24h consistently produces adverse effects (hypersalivation, muscle tremors, and severe vomiting and diarrhea) and has been fatal with 10-20 mg/kg q 24 h for 14 days\nPost-mortem exam reveals intestinal intussusception",
                "deleted_at": null,
                "created_at": "2020-05-07T01:11:42.000000Z",
                "updated_at": "2020-05-07T01:11:42.000000Z"
            },
            {
                "id": 389,
                "guid": "389",
                "name": "Pyrimethamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Leucovorin",
                "teratogenicity": "Folate deficiency implicated in neural tube, conotruncal cardiovascular birth defects (drug is a folic acid antagonist)",
                "contraindications": "Hypersensitivity to the drug\nMyelosuppression\nPregnancy",
                "interactions": "Additive myelosuppressant effects possible with antineoplastic chemotherapeutic drugs and/or other drugs with myelotoxic potential, especially methotrexate (added interaction of folic acid inhibition from both drugs, risking blood dyscrasias)\nOther folate antagonists (e.g., trimethoprim-potentiated sulfonamides) may heighten efficacy but also increase risk of toxicosis",
                "adverse_effects": "Myelotoxicosis possible (\"Bone marrow suppression may develop with prolonged use, corrected by adding folinic acid (5 mg/d) to the animal’s diet.\")",
                "deleted_at": null,
                "created_at": "2020-05-07T01:12:53.000000Z",
                "updated_at": "2020-05-07T01:12:53.000000Z"
            },
            {
                "id": 390,
                "guid": "390",
                "name": "Quinidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPathologic bradycardia, notably 3rd degree (or high-grade 2nd degree) atrioventricular block where suppression of ventricular escape beats could favor ventricular asystole",
                "interactions": "Increases digoxin serum levels, favoring digoxin toxicosis\nKetoconazole cotreatment raises plasma quinidine concentrations",
                "adverse_effects": "Proarrhythmia, notably unpredictable ventricular tachycardia +/- torsade de pointes (polymorphic ventricular tachycardia potentially causing cardiac arrest), extrapolated from human medicine\nIM injection is painful\nMechanism could conceivably alter bowel function",
                "deleted_at": null,
                "created_at": "2020-05-07T01:13:48.000000Z",
                "updated_at": "2020-05-07T01:13:48.000000Z"
            },
            {
                "id": 391,
                "guid": "391",
                "name": "Ramipril",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fetotoxic (renal effects on fetus, including fetal death) and therefore contraindicated in pregnancy",
                "contraindications": "Hypersensitivity to the drug and/or ACE inhibitors in general",
                "interactions": "Concurrent furosemide administration can increase risk of azotemia/oliguria (in which case the furosemide dosage should be reduced and/or the dietary salt intake reduced without impacting diet palatability)\nConcurrent spironolactone administration may predispose to hyperkalemia (low risk at therapeutic dosages with normal renal function)\nConcurrent administration of amlodipine or other antihypertensive may predispose to hypotension (low risk at therapeutic dosages)",
                "adverse_effects": "Adverse renal effects appear to be uncommon and mild in animals that have an adequate appetite, are adequately hydrated, and are receiving standard dosages of ACE inhibitor",
                "deleted_at": null,
                "created_at": "2020-05-07T01:15:08.000000Z",
                "updated_at": "2020-05-07T01:15:08.000000Z"
            },
            {
                "id": 392,
                "guid": "392",
                "name": "Ranitidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Coadministration with procainamide increases serum procainamide levels\nReduction in gastric pH may increase (e.g., midazolam) or decrease (e.g., ketoconazole) absorption of other drugs",
                "adverse_effects": "IV route is associated with nausea and hypotension in some dogs and cats",
                "deleted_at": null,
                "created_at": "2020-05-07T01:16:14.000000Z",
                "updated_at": "2020-05-07T01:16:14.000000Z"
            },
            {
                "id": 393,
                "guid": "393",
                "name": "Rifampin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Potent inducer of hepatic P450 enzyme systems, notoriously reduces serum/plasma levels of many drugs including anticonvulsants (e.g., phenobarbital), antiarrhythmics (e.g., mexiletine, quinidine), azole antifungals, benzodiazepines (e.g., diazepam), beta-blockers, calcium-channel blockers, cyclosporine, fluoroquinolone antibacterials (e.g., enrofloxacin), glucocorticoids, theophylline/aminophylline, tricyclic antidepressants (e.g., amitriptyline), and many more",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:17:37.000000Z",
                "updated_at": "2020-05-07T01:17:37.000000Z"
            },
            {
                "id": 394,
                "guid": "394",
                "name": "Robenacoxib",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastrointestinal ulceration",
                "interactions": "Additive gastrointestinal ulcerogenic effects expected if coadministered with other nonsteroidal anti-inflammatories and/or glucocorticoids",
                "adverse_effects": "Slightly higher rate of post-operative incisional complications (bleeding, infection)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:18:31.000000Z",
                "updated_at": "2020-05-07T01:18:31.000000Z"
            },
            {
                "id": 395,
                "guid": "395",
                "name": "Ronidazole",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Additive effects (including neurotoxic effects) would be expected if coadministered with metronidazole\nCaution is warranted with other potentially neurotoxic drugs",
                "adverse_effects": "Neurotoxicosis is a recognized and dosage-limiting adverse effect in cats",
                "deleted_at": null,
                "created_at": "2020-05-07T01:19:38.000000Z",
                "updated_at": "2020-05-07T01:19:38.000000Z"
            },
            {
                "id": 396,
                "guid": "396",
                "name": "Rutin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:20:18.000000Z",
                "updated_at": "2020-05-07T01:20:18.000000Z"
            },
            {
                "id": 397,
                "guid": "397",
                "name": "Salmeterol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Class effect: triggering of uterine contractions possible as effect of treatment",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Excessive beta-stimulation (sinus tachycardia, systemic hypertension) possible)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:21:15.000000Z",
                "updated_at": "2020-05-07T01:21:15.000000Z"
            },
            {
                "id": 398,
                "guid": "398",
                "name": "Selamectin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other avermectins",
                "interactions": null,
                "adverse_effects": "Vomiting, diarrhea reported sporadically when product is ingested\nTolerance unknown for high-dose protocol for demodicosis when administered to ABCB1-deficient dogs",
                "deleted_at": null,
                "created_at": "2020-05-07T01:21:55.000000Z",
                "updated_at": "2020-05-07T01:21:55.000000Z"
            },
            {
                "id": 399,
                "guid": "399",
                "name": "Selegiline",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Broadly, any drug that alters CNS function should be evaluated for compatibility with selegiline, including tricyclic antidepressants and selective serotonin reuptake inhibitors (risk of the serotonin syndrome - uncontrolled hyperactivity, tachycardia, mania), and opiates and barbiturates (enhanced CNS depression effect)\nBuspirone, dextroamphetamine, phenylephrine, and other vasopressors may trigger hypertensive crisis if coadministered with selegiline\nEffects (especially adverse effects) of topical amitraz can be extensively increased by selegiline treatment\nCoadministration with cyproheptadine can cause cholinergic crisis (tachycardia, mydriasis)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:24:27.000000Z",
                "updated_at": "2020-05-07T01:24:27.000000Z"
            },
            {
                "id": 400,
                "guid": "400",
                "name": "Sildenafil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension",
                "interactions": "Additive effects can cause hypotension during cotreatment with diuretics (e.g., furosemide) and other vasodilators (e.g., amlodipine, ACE inhibitors, nitrates)",
                "adverse_effects": "Hypotension possible if predisposition exists, or with overdose",
                "deleted_at": null,
                "created_at": "2020-05-07T01:25:50.000000Z",
                "updated_at": "2020-05-07T01:25:50.000000Z"
            },
            {
                "id": 401,
                "guid": "401",
                "name": "Silymarin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:27:01.000000Z",
                "updated_at": "2020-05-07T01:27:01.000000Z"
            },
            {
                "id": 402,
                "guid": "402",
                "name": "Sodium bicarbonate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "17-24 mEq/L (normal reference range)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation\nAlkalosis\nOngoing severe chloride loss\nAdministration of solution containing precipitates (bicarbonate may form precipitates if added to calcium-containing solution)",
                "interactions": "Incompatible in vitro: norepinephrine, dopamine, calcium-containing solutions",
                "adverse_effects": "Late-developing metabolic alkalosis (in patients with kidney disease/decreased glomerular filtration rate)\nIonized hypocalcemia\nIatrogenic congestive heart failure (due to sodium load, osmolality of NaHCO3: 2000 mOsm/L)\nAbolition of metabolic acidosis-driven hyperventilation (leading to paradoxic CNS acidosis)\nHypokalemia",
                "deleted_at": null,
                "created_at": "2020-05-07T01:28:31.000000Z",
                "updated_at": "2020-05-07T01:28:31.000000Z"
            },
            {
                "id": 403,
                "guid": "403",
                "name": "Sotalol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Isoproterenol, dobutamine",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nBradycardia\nHypotension",
                "interactions": "Additive effects with other bradycardia-inducing drugs, notably beta-adrenergic blockers and alpha-adrenergic agonists",
                "adverse_effects": "Bradycardia, hypotension possible if overdosage or if debilitated/frail patient",
                "deleted_at": null,
                "created_at": "2020-05-07T01:30:04.000000Z",
                "updated_at": "2020-05-07T01:30:04.000000Z"
            },
            {
                "id": 404,
                "guid": "404",
                "name": "Spinosad",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:31:20.000000Z",
                "updated_at": "2020-05-07T01:31:20.000000Z"
            },
            {
                "id": 405,
                "guid": "405",
                "name": "Spironolactone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Plasma canrenone (active metabolite) concentrations in dogs = 23-97 ng/mL at therapeutic dosages, but not associated with effective diuresis",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHyperkalemia\nHypoadrenocorticism",
                "interactions": "Additive potassium-conserving effects with ACE inhibitors may cause hyperkalemia (generally mild, possibly severe if kidney disease and/or debilitated, dehydrated patient)\nPositive interaction with most other diuretics (loop, thiazide), which are potassium-wasting, i.e., balanced potassium effects with coadministration of spironolactone",
                "adverse_effects": "Hyperkalemia possible, especially if kidney disease and/or debilitated, dehydrated patient\nSevere (treatment-terminating) ulcerative facial dermatitis in some cats\nMild azotemia can occur with any diuretic and is expected during treatment, whereas overtreatment could cause profound dehydration, hypovolemia, and hypotension, leading to intrinsic renal failure",
                "deleted_at": null,
                "created_at": "2020-05-07T01:32:02.000000Z",
                "updated_at": "2020-05-07T01:32:02.000000Z"
            },
            {
                "id": 406,
                "guid": "406",
                "name": "Stanozolol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Potentially fetotoxic",
                "contraindications": "Hypersensitivity to the drug\nTestosterone-mediated diseases (e.g., prostatic disease, perianal adenoma)\nPregnancy\nBreeding males\nLiver disease",
                "interactions": null,
                "adverse_effects": "Androgen/masculinizing effects (e.g., clitoral enlargement in females), adverse effects on sperm count possible, hepatotoxic in cats",
                "deleted_at": null,
                "created_at": "2020-05-07T01:33:18.000000Z",
                "updated_at": "2020-05-07T01:33:18.000000Z"
            },
            {
                "id": 407,
                "guid": "407",
                "name": "Stibogluconate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other antimony-based compounds",
                "interactions": "Cardiotoxic interaction when coadministered with amphotericin B (humans)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:33:54.000000Z",
                "updated_at": "2020-05-07T01:33:54.000000Z"
            },
            {
                "id": 408,
                "guid": "408",
                "name": "Streptokinase",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nNon-acute thrombosis (>12h since thrombus formation\nSome clinicians consider >8h post-thromboembolism to be a contraindication)\nActive bleeding",
                "interactions": "Additive effects with anticoagulants and antiplatelet drugs",
                "adverse_effects": "Reperfusion injury causing life-threatening hyperkalemia (35% of treated cats), hemorrhage (24% of treated cats) and risk of target organ damage",
                "deleted_at": null,
                "created_at": "2020-05-07T01:34:24.000000Z",
                "updated_at": "2020-05-07T01:34:24.000000Z"
            },
            {
                "id": 409,
                "guid": "409",
                "name": "Streptozotocin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nAzotemia/kidney disease",
                "interactions": "Additive effects with diazoxide, glucocorticoids, dextrose",
                "adverse_effects": "Acute kidney injury (uncommon with peri-treatment diuresis), liver enzyme elevations, vomiting (may be severe), diabetes mellitus with 5 or more doses (12% of dogs overall)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:35:11.000000Z",
                "updated_at": "2020-05-07T01:35:11.000000Z"
            },
            {
                "id": 410,
                "guid": "410",
                "name": "Succimer",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Since many heavy metals are excreted in milk, dams/queens receiving this drug should not nurse their puppies/kittens",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Does not interact with oral iron supplements",
                "adverse_effects": "Gastrointestinal signs reported in 20% of treated humans",
                "deleted_at": null,
                "created_at": "2020-05-07T01:35:59.000000Z",
                "updated_at": "2020-05-07T01:35:59.000000Z"
            },
            {
                "id": 411,
                "guid": "411",
                "name": "Sucralfate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Reduces absorption of several drugs, notably enrofloxacin and other fluoroquinolone antibacterials, cimetidine, digoxin, warfarin, and tetracycline\nRequires acidic environment to disperse (do not coadminister with gastric acid-reducing drugs, but stagger doses and administer sucralfate >30 minutes earlier)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:36:42.000000Z",
                "updated_at": "2020-05-07T01:36:42.000000Z"
            },
            {
                "id": 412,
                "guid": "412",
                "name": "Sulfadiazine + trimethoprim",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Folate (for hematologic adverse effects)",
                "teratogenicity": "Folate deficiency implicated in neural tube, conotruncal cardiovascular birth defects (drug is a folic acid antagonist)",
                "contraindications": "Hypersensitivity to the drug and/or to other sulfonamides\nHistory of immune-mediated adverse effects associated with prior treatment with this drug (e.g., polyarthritis, urticaria, bone marrow suppression)\nHepatopathy\nInadequate tear production\nBlood dyscrasias or bone marrow disorders other than antineoplastic chemotherapy-associated neutropenia",
                "interactions": "Additive effect of myelotoxicosis possible with antineoplastic chemotherapeutics\nAdditive effect of keratoconjunctivitis sicca possible with etodolac cotreatment\nAdditive hepatotoxic effect possible with phenobarbital, glucocorticoids, and many other drugs with hepatotoxic potential\nMay increase digoxin, procainamide, warfarin effects\nMay increase risk of nephrotoxicosis associated with cyclosporine and/or decrease serum cyclosporine levels",
                "adverse_effects": "Myelotoxicosis, especially at higher dosages and/or for prolonged treatment\nHepatotoxicosis (idiopathic hepatic necrosis)\nKeratoconjunctivitis sicca\nHypothyroidism (sulfa drugs inhibit thyroid peroxidase), especially at higher dosages\nDrug may precipitate in urine (ensure adequate hydration/fluid intake)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:38:28.000000Z",
                "updated_at": "2020-05-07T01:38:28.000000Z"
            },
            {
                "id": 413,
                "guid": "413",
                "name": "Sulfadimethoxine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Folate deficiency implicated in neural tube, conotruncal cardiovascular birth defects (drug is a folic acid antagonist)",
                "contraindications": "Hypersensitivity to the drug and/or to other sulfonamides\nHepatopathy\nInadequate tear production\nBlood dyscrasias or bone marrow disorders",
                "interactions": "Sulfa-class effects in dogs are possible, but less commonly reported for sulfadimethoxine than other drugs of this class\nAdditive effect of myelotoxicosis with antineoplastic chemotherapeutics\nAdditive effect of keratoconjunctivitis sicca with etodolac cotreatment\nAdditive hepatotoxic effect with phenobarbital, glucocorticoids, and many other drugs with hepatotoxic potential\nMay increase digoxin, procainamide, warfarin effects\nMay increase risk of nephrotoxicosis associated with cyclosporine and/or decrease serum cyclosporine levels",
                "adverse_effects": "Class effects (less common with sulfadimethoxine than with other sulfas): myelotoxicosis, especially at higher dosages and/or for prolonged treatment\nHepatotoxicosis (idiopathic hepatic necrosis)\nkeratoconjunctivitis sicca\nHypothyroidism (sulfa drugs inhibit thyroid peroxidase), especially at higher dosages\nSafety: 160 mg/kg PO q 24h for 13 weeks in dogs does not cause any signs of toxicosis",
                "deleted_at": null,
                "created_at": "2020-05-07T01:40:54.000000Z",
                "updated_at": "2020-05-07T01:40:54.000000Z"
            },
            {
                "id": 414,
                "guid": "414",
                "name": "Sulfadimethoxine + ormetoprim",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Folate deficiency implicated in neural tube, conotruncal cardiovascular birth defects (drug is a folic acid antagonist)",
                "contraindications": "Hypersensitivity to the drug and/or to other sulfonamides\nHistory of immune-mediated adverse effects associated with prior treatment with this drug (e.g., polyarthritis, urticaria, bone marrow suppression)\nHepatopathy\nInadequate tear production\nBlood dyscrasias or bone marrow disorders other than antineoplastic chemotherapy-associated neutropenia",
                "interactions": "Additive effect of myelotoxicosis possible with antineoplastic chemotherapeutics\nAdditive effect of keratoconjunctivitis sicca possible with etodolac cotreatment\nAdditive hepatotoxic effect possible with phenobarbital, glucocorticoids, and many other drugs with hepatotoxic potential\nMay increase digoxin, procainamide, warfarin effects\nMay increase risk of nephrotoxicosis associated with cyclosporine and/or decrease serum cyclosporine levels",
                "adverse_effects": "Class effects possible: myelotoxicosis, especially at higher dosages and/or for prolonged treatment\nHepatotoxicosis (idiopathic hepatic necrosis)\nKeratoconjunctivitis sicca\nHypothyroidism (sulfa drugs inhibit thyroid peroxidase), especially at higher dosages",
                "deleted_at": null,
                "created_at": "2020-05-07T01:41:46.000000Z",
                "updated_at": "2020-05-07T01:41:46.000000Z"
            },
            {
                "id": 415,
                "guid": "415",
                "name": "Sulfamethoxazole + trimethoprim",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Folate deficiency implicated in neural tube, conotruncal cardiovascular birth defects (drug is a folic acid antagonist)",
                "contraindications": "Hypersensitivity to the drug and/or to other sulfonamides\nHistory of immune-mediated adverse effects associated with prior treatment with this drug (e.g., polyarthritis, urticaria, bone marrow suppression)\nHepatopathy\nInadequate tear production\nBlood dyscrasias or bone marrow disorders other than antineoplastic chemotherapy-associated neutropenia",
                "interactions": "Additive effect of myelotoxicosis possible with antineoplastic chemotherapeutics\nAdditive effect of keratoconjunctivitis sicca possible with etodolac cotreatment\nAdditive hepatotoxic effect possible with phenobarbital, glucocorticoids, and many other drugs with hepatotoxic potential\nMay increase digoxin, procainamide, warfarin effects\nMay increase risk of nephrotoxicosis associated with cyclosporine and/or decrease serum cyclosporine levels",
                "adverse_effects": "Hypothyroidism (sulfa drugs inhibit thyroid peroxidase), especially at higher dosages\nOther class effects possible: myelotoxicosis, especially at higher dosages and/or for prolonged treatment\nKepatotoxicosis (idiopathic hepatic necrosis)\nKeratoconjunctivitis sicca",
                "deleted_at": null,
                "created_at": "2020-05-07T01:42:29.000000Z",
                "updated_at": "2020-05-07T01:42:29.000000Z"
            },
            {
                "id": 416,
                "guid": "416",
                "name": "Tacrolimus",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Not routinely measured clinically except for organ transplant recipients;median level: 4.5 ng/mL (but up to 27 ng/mL) in dogs receiving topical tacrolimus on damaged, atopic skin[1] and from undetectable to 10.7 ng/mL when applied to the nasal planum of dogs with cutaneous lupus erythematosus[2];increased risk of toxicosis at >20 ng/mL;target levels for systemic immunosuppression post-transplantation: 5-10 ng/mL [3]",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Nephrotoxic effects possible (caution with, or avoid, cotreatment with drugs that have nephrotoxic potential, e.g., cyclosporine, aminoglycoside antibacterials, amphotericin B)\nDiltiazem, azole antifungals, and macrolide antibacterials (e.g., azithromycin, clarithromycin, erythromycin) may increase serum tacrolimus levels\nPhenobarbital, rifampin, and other hepatic P450-inducing drugs may decrease serum tacrolimus levels",
                "adverse_effects": "Topical irritation has occurred in some dogs (can be difficult to differentiate from disease process/lesions)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:43:49.000000Z",
                "updated_at": "2020-05-07T01:43:49.000000Z"
            },
            {
                "id": 417,
                "guid": "417",
                "name": "Tadalafil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension",
                "interactions": "Additive effects can cause hypotension during cotreatment with diuretics (e.g., furosemide) and other vasodilators (e.g., amlodipine, ACE inhibitors)",
                "adverse_effects": "Hypotension possible if predisposition exists, or with overdose",
                "deleted_at": null,
                "created_at": "2020-05-07T01:46:06.000000Z",
                "updated_at": "2020-05-07T01:46:06.000000Z"
            },
            {
                "id": 418,
                "guid": "418",
                "name": "Tamsulosin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Vasopressors",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension",
                "interactions": "Despite urogenital tropism, caution is warranted when cotreating with diuretics (e.g., furosemide) and other vasodilators (e.g., amlodipine, ACE inhibitors) due to potential for hypotension\nCotreatment with cimetidine may increase tamsulosin plasma concentrations",
                "adverse_effects": "Lower urinary tract obstruction can be life-threatening and generally requires procedural/surgical intervention, not administration of drugs that can cause urethral relaxation\nDrug may act on region of prostate that is not clinically relevant (e.g., postprostatic urethra, if this is the location of obstruction)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:46:37.000000Z",
                "updated_at": "2020-05-07T01:46:37.000000Z"
            },
            {
                "id": 419,
                "guid": "419",
                "name": "Taurine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation",
                "interactions": null,
                "adverse_effects": "None known",
                "deleted_at": null,
                "created_at": "2020-05-07T01:47:26.000000Z",
                "updated_at": "2020-05-07T01:47:26.000000Z"
            },
            {
                "id": 420,
                "guid": "420",
                "name": "Terbinafine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Coadministered fluconazole or ketoconazole (both hepatic P450 inhibitors) may significantly increase terbinafine serum concentrations, risking toxicosis\nTerbinafine is a hepatic P450 enzyme inhibitor, potentially increasing circulating blood levels of several behavioral drugs (tricyclic antidepressants, selective serotonin reuptake inhibitors), beta-adrenergic blockers, and certain monoamine oxidase inhibitors\nIncreases elimination of cyclosporine by 15% whereas cyclosporine does not influence clearance of terbinafine",
                "adverse_effects": "20% incidence of periocular swelling, chemosis, and conjunctival erythema in dogs, beginning 8h after dosing and resolving spontaneously after drug cessation in 24–36h\nAcute vomiting within 60 minutes of dosing can occur in some cats, requiring termination of treatment\nHepatotoxicosis, lymphopenia, exacerbation of systemic lupus erythematosus in humans",
                "deleted_at": null,
                "created_at": "2020-05-07T01:48:22.000000Z",
                "updated_at": "2020-05-07T01:48:22.000000Z"
            },
            {
                "id": 421,
                "guid": "421",
                "name": "Terbutaline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Beta-adrenergic blockers (e.g., IV propranolol)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nUse with caution (avoid triggering sympathetic surge/tachycardia) if hyperthyroidism, cardiomyopathy, systemic hypertension and/or seizures exist\nNot for extended tocolysis/delay of parturition",
                "interactions": "Antagonism of beta-blockers\nIncreases potassium wasting, enhancing hypokalemia caused by diuretics (e.g., furosemide)",
                "adverse_effects": "Tachycardia",
                "deleted_at": null,
                "created_at": "2020-05-07T01:50:03.000000Z",
                "updated_at": "2020-05-07T01:50:03.000000Z"
            },
            {
                "id": 422,
                "guid": "422",
                "name": "Testosterone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic/fetotoxic",
                "contraindications": "Hypersensitivity to the drug\nTestosterone-mediated diseases (e.g., prostatic disease, perianal adenoma)\nPregnancy",
                "interactions": "Cotreatment with glucocorticoids may enhance fluid retention (caution regarding heart diseases, systemic hypertension)",
                "adverse_effects": "Androgen/masculinizing effects (e.g., clitoral enlargement in females), adverse effects on sperm count possible",
                "deleted_at": null,
                "created_at": "2020-05-07T01:51:38.000000Z",
                "updated_at": "2020-05-07T01:51:38.000000Z"
            },
            {
                "id": 423,
                "guid": "423",
                "name": "Tetracycline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Contraindicated in all pregnant dams and queens due to dental (discoloration) and osseous (altered bone growth) effects on the fetus, unless indication is life-threatening disorder in the dam",
                "contraindications": "Hypersensitivity to the drug or to tetracyclines in general",
                "interactions": "Absorption is impaired by calcium-, aluminum-, and bismuth-containing compounds (e.g., several laxative and antacid solutions)",
                "adverse_effects": "Gastrointestinal signs (vomiting, inappetence, diarrhea) occur in some in dogs and cats\nWell-recognized risk of esophagitis (tablet is retained in esophagus) in cats and small dogs, so each oral dose should be followed by several mL of water or a morsel of food",
                "deleted_at": null,
                "created_at": "2020-05-07T01:53:27.000000Z",
                "updated_at": "2020-05-07T01:53:27.000000Z"
            },
            {
                "id": 424,
                "guid": "424",
                "name": "Theophylline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "10-20 µg/mL (55-165 µmol/L), which should be attainable in dogs receiving 10 mg/kg PO q 12h and cats receiving 25 mg/kg PO q 24h (sustained-/extended-release);if subtherapeutic in dogs, the dosage may be increased to 15 mg/kg, with heightened monitoring for side-effects",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other methylxanthines\nConditions where tachycardia and CNS stimulation could be detrimental (e.g., advanced heart disease and/or systemic hypertension, hyperthyroidism)",
                "interactions": "Many drugs increase plasma theophylline levels, potentially causing theophylline toxicosis, notably including: fluoroquinolone antibacterials (enrofloxacin, ciprofloxacin, etc.), diltiazem, fluconazole, macrolide antibacterials (azithromycin, clarithromycin, erythromycin, etc.), methotrexate, mexiletine, propranolol, pentoxiphylline, selective serotonin-reuptake inhibitors (e.g., fluoxetine), and thiabendazole\nConversely, barbiturates (e.g., phenobarbital) decrease plasma theophylline concentrations, potentially to subtherapeutic levels\nTheophylline increases the plasma concentrations of digoxin, thiazide diuretics, many nephrotoxic drugs, and many sympathomimetic amines, whereas it decreases the therapeutic effect of warfarin-based anticoagulants and allopurinol",
                "adverse_effects": "Agitation, excitement, polyuria/polydipsia, tachycardia, seizures",
                "deleted_at": null,
                "created_at": "2020-05-07T01:54:56.000000Z",
                "updated_at": "2020-05-07T01:54:56.000000Z"
            },
            {
                "id": 425,
                "guid": "425",
                "name": "Thiabendazole",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Class effect: teratogenic potential",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Competitive interaction with methylxanthines (aminophylline, theophylline), potentially increasing serum levels",
                "adverse_effects": "Inappetence in 50% of long-term orally-treated dogs\nVomiting or diarrhea in 25% of long-term orally-treated dogs\nCutaneous drug eruption possible",
                "deleted_at": null,
                "created_at": "2020-05-07T01:57:02.000000Z",
                "updated_at": "2020-05-07T01:57:02.000000Z"
            },
            {
                "id": 426,
                "guid": "426",
                "name": "Thiamine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Normal range in cats (whole blood): 4.2-5.6 µg/dL;clinically deficient cats have been recorded to have levels ranging from undetectable up to 1 µg/dL",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation",
                "interactions": "Protect from light due to photodegradation",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T01:58:22.000000Z",
                "updated_at": "2020-05-07T01:58:22.000000Z"
            },
            {
                "id": 427,
                "guid": "427",
                "name": "Thiopental",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nUnconsciousness",
                "interactions": "Additive CNS depressant effects with other anesthetic agents, sedative, and tranquilizer",
                "adverse_effects": "Proarrhythmic, especially when there is pre-existing structural heart disease, vesicant (may cause extravasation injury if seep from vein)",
                "deleted_at": null,
                "created_at": "2020-05-07T01:59:18.000000Z",
                "updated_at": "2020-05-07T01:59:18.000000Z"
            },
            {
                "id": 428,
                "guid": "428",
                "name": "Thyrotropin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Serum T4 levels consistent with hypothyroidism: pre TSH (baseline) < 1 µg/dL, post TSH <1.5 µg/dL;serum T4 levels consistent with euthyroidism: pre TSH (baseline) >1.5 µg/dL, post TSH > 3 µg/dL",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHyperthyroidism",
                "interactions": null,
                "adverse_effects": "Anaphylaxis occurs rarely",
                "deleted_at": null,
                "created_at": "2020-05-07T02:00:39.000000Z",
                "updated_at": "2020-05-07T02:00:39.000000Z"
            },
            {
                "id": 429,
                "guid": "429",
                "name": "Ticarcillin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other penicillins",
                "interactions": "May increase serum methotrexate levels (to potentially toxic levels) if coadministered\nAvoid mixing with aminoglycoside antibacterials, which inactivate ticarcillin (and vice-versa) in vitro\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "IM injections are painful to many dogs\nAntithrombotic effects at very high dosages (can surpass antithrombotic effects of aspirin)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:01:37.000000Z",
                "updated_at": "2020-05-07T02:01:37.000000Z"
            },
            {
                "id": 430,
                "guid": "430",
                "name": "Ticarcillin + clavulanate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other beta-lactams (penicillins, cephalosporins)",
                "interactions": "May increase serum methotrexate levels (to potentially toxic levels) if coadministered\nAvoid mixing with aminoglycoside antibacterials, which inactivate ticarcillin (and vice-versa) in vitro\nAvoid coadministration with doxycycline, because doxycycline reduces cell protein synthesis required for formation of cell walls, the substrate on which penicillins act (i.e., coadministration predisposes to treatment failure)",
                "adverse_effects": "IM injections are painful to many dogs\nAntithrombotic effects at very high dosages (can surpass antithrombotic effects of aspirin)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:02:33.000000Z",
                "updated_at": "2020-05-07T02:02:33.000000Z"
            },
            {
                "id": 431,
                "guid": "431",
                "name": "Tiletamine + zolazepam",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Flumazenil (for zolazepam component)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug combination or its components\nSeizures (tiletamine component may trigger/exacerbate)",
                "interactions": "Additive effects with other dissociative anesthetics (e.g., ketamine) and/or other benzodiazepines (e.g., diazepam)\nAdditive effects with sedative, tranquilizers, other anesthetics\nAdditive effects with other tachycardia-inducing drugs",
                "adverse_effects": "IM injection is painful\nCaution in patients with heart disease (tachycardia induced by tiletamine), kidney disease (tiletamine requires renal excretion), and liver disease (zolazepam requires hepatic metabolism)\nApnea (70 seconds in 1 dog, beginning 1 minute after IV injection) has been documented, indicating the need to be prepared for endotracheal intubation",
                "deleted_at": null,
                "created_at": "2020-05-07T02:03:07.000000Z",
                "updated_at": "2020-05-07T02:03:07.000000Z"
            },
            {
                "id": 432,
                "guid": "432",
                "name": "Tilmicosin",
                "formulation_species_id": 0,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Dobutamine; possibly calcium salts (calcium-channel blockade implicated in toxicity)",
                "teratogenicity": null,
                "contraindications": "Contraindicated in small animal practice",
                "interactions": null,
                "adverse_effects": "Cardiotoxicosis\nA single IV dose of 2.5-5 mg/kg produces severe, acute decrease in ventricular inotropic force within 10 min of injection in dogs",
                "deleted_at": null,
                "created_at": "2020-05-07T02:04:50.000000Z",
                "updated_at": "2020-05-07T02:04:50.000000Z"
            },
            {
                "id": 433,
                "guid": "433",
                "name": "Tobramycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "5-10 µg/mL (peak; desired trough concentrations approach zero, as with all aminoglycosides)",
                "reversal_agent": null,
                "teratogenicity": "Fetotoxic potential (otic, renal)",
                "contraindications": "Hypersensitivity to the drug\nOliguria/anuria\nHypovolemia/dehydration\nPre-existing hearing loss",
                "interactions": "Inactivated in vitro by penicillins (do not coadminister), though penicillins and other beta-actams have a complementary spectrum to aminoglycosides and are a good addition if administered separately\nAdditive nephrotoxic effects possible with other aminoglycosides, amphotericin B\nAdditive ototoxic effects possible with other aminoglycosides",
                "adverse_effects": "Nephrotoxicosis (well-recognized for aminoglycosides) and ototoxicosis (may be subtle and/or difficult to recognize in animals, especially at early stages) are main complications in humans\nFor ototoxicosis, tobramycin is more likely to cause auditory damage than vestibular damage",
                "deleted_at": null,
                "created_at": "2020-05-07T02:05:06.000000Z",
                "updated_at": "2020-05-07T02:05:06.000000Z"
            },
            {
                "id": 434,
                "guid": "434",
                "name": "Tocainide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Therapeutic: 4-9 mg/L; increased incidence of toxicosis with levels >10 mg/L",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Additive effects with other class I antiarrhythmics (e.g., mexiletine, quinidine), which should not be coadministered\nAdditive nephrotoxic effects possible with long-term treatment and coadministration of aminoglycoside antibacterials, amphotericin B, and others (avoid)",
                "adverse_effects": "Acute anorexia, vomiting, diarrhea in 25% of dogs (dosage-independent, but blood concentration-dependent)\nLong-term treatment (>4 months) causes varying degrees of nephrotoxicosis in 50% of dogs (initially, polyuria and polydipsia, followed 1-2 weeks later by azotemia - all reversible with drug discontinuation) and corneal endothelial dystrophy (producing visual impairment despite discontinuation of the drug) in 25% of dogs",
                "deleted_at": null,
                "created_at": "2020-05-07T02:06:23.000000Z",
                "updated_at": "2020-05-07T02:06:23.000000Z"
            },
            {
                "id": 435,
                "guid": "435",
                "name": "Toceranib",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fetotoxic (embryolethal, due at least partly to antiangiogenic properties)",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": null,
                "adverse_effects": "Gastrointestinal toxicosis (vomiting, diarrhea, inappetence) is extremely common, reaching 100% prevalence in some studies (though placebo-treated dogs in the same period have a prevalence of 30% for the same signs, likely due to GI ulceration from histamine in mast cells)\nGI hemorrhage is possible, including gastric perforation\nNasal depigmentation and blanching of the haircoat occurs in a small proportion of dogs\nThromboembolic disease appears more often during treatment in a minority of dogs, including pulmonary thromboembolism and/or disseminated intravascular coagulation (mechanism unproven)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:07:03.000000Z",
                "updated_at": "2020-05-07T02:07:03.000000Z"
            },
            {
                "id": 436,
                "guid": "436",
                "name": "Tolfenamic acid",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastric erosion/ulceration\nDehydration/hypovolemia\nCaution if kidney disease",
                "interactions": "Additive effects with other nonsteroidal anti-inflammatories and/or glucocorticoids, none of which should be coadministered with tolfenamic acid\nPotential for heightened, additive nephrotoxic effects if coadministered with aminoglycoside antibacterials or other drugs known to carry a risk of nephrotoxicosis",
                "adverse_effects": "Class effects: potential for gastrointestinal erosion, ulceration, or perforation\nMay cause renal tubular damage (both types of adverse effects are more likely in debilitated animals, with higher dosages, or both)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:07:57.000000Z",
                "updated_at": "2020-05-07T02:07:57.000000Z"
            },
            {
                "id": 437,
                "guid": "437",
                "name": "Toltrazuril",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T02:09:12.000000Z",
                "updated_at": "2020-05-07T02:09:12.000000Z"
            },
            {
                "id": 438,
                "guid": "438",
                "name": "Torsemide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypovolemia",
                "interactions": "Cumulative effect with other diuretics (reducing circulating plasma volume)\nMay potentiate potassium and magnesium wasting if cotreatment with certain additional diuretics (e.g., thiazides) or this effect may be offset by potassium-sparing diuretics (e.g., spironolactone)\nHypokalemia caused by torsemide could potentiate digoxin toxicosis\nMay enhance nephrotoxicosis and/or ototoxicosis of aminoglycoside antibacterials, platinum-based antineoplastics, or both",
                "adverse_effects": "Mild azotemia is common and expected during treatment, whereas overtreatment can cause profound dehydration, hypovolemia, and hypotension, leading to intrinsic renal failure\nHypokalemia, hypomagnesemia, and metabolic alkalosis are common and should be adjusted by assessing whether the severity of fluid retention (past or present) requires the current dosage of torsemide, and decreasing the dosage if it is not",
                "deleted_at": null,
                "created_at": "2020-05-07T02:09:58.000000Z",
                "updated_at": "2020-05-07T02:09:58.000000Z"
            },
            {
                "id": 439,
                "guid": "439",
                "name": "Tramadol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Maximum plasma [tramadol], [O-desmethyltramadol], [N-desmethyltramadol], and [N,O-didesmethyltramadol] = 215.7, 5.7, 379.1, and 2372 ng/mL, respectively (questionable clinical relevance, as rarely measured)",
                "reversal_agent": "Naloxone reverses respiratory depression[1] but not antitussive effects[2] in cats",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nAll opiates: ileus, pneumonia (productive cough), respiratory depression",
                "interactions": "Additive effects possible with other opiates, sedatives, and tranquilizers (caution if coadministering, or choose other class of drug as substitute)",
                "adverse_effects": "Mydriasis, sedation, hypersalivation possible in individual cats\nRespiratory depression possible, especially with very high dosages",
                "deleted_at": null,
                "created_at": "2020-05-07T02:10:57.000000Z",
                "updated_at": "2020-05-07T02:10:57.000000Z"
            },
            {
                "id": 440,
                "guid": "440",
                "name": "Tranexamic acid",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nThromboembolic disease",
                "interactions": "Antagonist effects to anticoagulants (e.g., heparin, warfarin), antiplatelet drugs (e.g., aspirin, clopidogrel), and thrombolytic (e.g., streptokinase)",
                "adverse_effects": "Retinotoxicosis documented in dogs, cats, and humans (dose-dependent severity)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:14:22.000000Z",
                "updated_at": "2020-05-07T02:14:22.000000Z"
            },
            {
                "id": 441,
                "guid": "441",
                "name": "Triamcinolone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Potential abortefacient, teratogen",
                "contraindications": "Hypersensitivity to the compound\nHyperadrenocorticism\nDiabetes mellitus\nCaution with cardiomyopathy patients (possibility of triggering pulmonary edema)",
                "interactions": "Additive effect (both therapeutic and adverse) with other corticosteroids\nShould not be coadministered with nonsteroidal anti-inflammatory drugs (gastric ulceration/perforation)\nCumulative effects with other immunosuppressants (e.g., cyclosporine)",
                "adverse_effects": "Iatrogenic hyperadrenocorticism with chronic use\nAdrenocortical atrophy with prolonged use, requiring taper rather than abrupt cessation\nInsulin antagonism/diabetes mellitus\nIatrogenic congestive heart failure in cats with pre-existing heart disease\nObesity (due to polyphagia - may become detrimental and/or life-threatening with respiratory or orthopedic disorders)\nDecreased immune function\nSoft tissue fragility (especially skin) with chronic use\nPolyuria, polydipsia (50% of treated dogs), panting (frequent in treated dogs) are common side-effects",
                "deleted_at": null,
                "created_at": "2020-05-07T02:15:08.000000Z",
                "updated_at": "2020-05-07T02:15:08.000000Z"
            },
            {
                "id": 442,
                "guid": "442",
                "name": "Trilostane",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Desirable basal cortisol concentrations = 1.3-2.9 µg/dL.  Basal cortisol ≥ 1.3 µg/dL identifies that trilostane's effects are not excessive (similar to ACTH stimulation testing, but requiring only 1 blood sample and no ACTH injection), and basal cortisol concentration ≤ 2.9 µg/dL correctly excludes insufficient trilostane effect (poor control)[1]",
                "reversal_agent": "Glucocorticoids",
                "teratogenicity": "Fetotoxic",
                "contraindications": "Hypersensitivity to the drug\nPregnancy\nHypoadrenocorticism",
                "interactions": "Antagonist effect of glucocorticoids",
                "adverse_effects": "Rare adrenal necrosis reported\nMixed renal effects of well-controlled hyperadrenocorticism\nWith excess, may suppress both glucocorticoid and mineralocorticoid activity (vs. ketoconazole, for example)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:16:25.000000Z",
                "updated_at": "2020-05-07T02:16:25.000000Z"
            },
            {
                "id": 443,
                "guid": "443",
                "name": "Tylosin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T02:18:12.000000Z",
                "updated_at": "2020-05-07T02:18:12.000000Z"
            },
            {
                "id": 444,
                "guid": "444",
                "name": "Ursodeoxycholic acid",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Not detectable in clinically significant amounts (see Pearls)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nBiliary tract obstruction",
                "interactions": "May increase bioavailability of cyclosporine and vitamin E",
                "adverse_effects": "Gallbladder rupture possible if fixed obstruction to gallbladder outflow exists",
                "deleted_at": null,
                "created_at": "2020-05-07T02:19:30.000000Z",
                "updated_at": "2020-05-07T02:19:30.000000Z"
            },
            {
                "id": 445,
                "guid": "445",
                "name": "Valacyclovir",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "All administration to cats is contraindicated",
                "interactions": null,
                "adverse_effects": "Coagulative necrosis of the renal tubular epithelium, centrilobular atrophy and hepatic necrosis, and severe bone marrow depression occur with treatment at standard dosages\nAt 60 mg/kg PO: lethargy, dehydration and neutropenia occur, and feline herpesvirus-1 replication is not suppressed",
                "deleted_at": null,
                "created_at": "2020-05-07T02:21:28.000000Z",
                "updated_at": "2020-05-07T02:21:28.000000Z"
            },
            {
                "id": 446,
                "guid": "446",
                "name": "Vancomycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Trough levels > 5-15 µg/ml have been recommended",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nAdvanced kidney disease, particularly in hypovolemic/hypotensive patient",
                "interactions": "Aminoglycoside antibacterials, amphotericin B, and any other drugs with nephrotoxic potential should be administered carefully (if at all), with accrued monitoring of renal function\nCoadministration with anesthetics has triggered hypersensitivity reactions in human patients",
                "adverse_effects": "Nephrotoxic potential, especially in hypovolemic/dehydrated/debilitated patients",
                "deleted_at": null,
                "created_at": "2020-05-07T02:21:47.000000Z",
                "updated_at": "2020-05-07T02:21:47.000000Z"
            },
            {
                "id": 447,
                "guid": "447",
                "name": "Vasopressin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nSystemic hypertension\nCaution if bradycardia (further reflex slowing of heart rate with vasoconstriction)",
                "interactions": "Additive effects with other vasopressors (e.g., phenylephrine), which could cause systemic hypertensive target organ damage if not controlled\nOpposite effects to diuretics",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T02:22:50.000000Z",
                "updated_at": "2020-05-07T02:22:50.000000Z"
            },
            {
                "id": 448,
                "guid": "448",
                "name": "Verapamil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "+/- atropine, +/- epinephrine (for severe bradycardia, but resolution is often spontaneous and rapid)",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension\nBradycardia\nEpilepsy (increased severity in one study when used as add-on treatment)",
                "interactions": "Additive effects with other bradycardia-inducing drugs (e.g., beta-blockers, digoxin, diltiazem)",
                "adverse_effects": "Hypotension and collapse/pre-arrest if excessive IV administration",
                "deleted_at": null,
                "created_at": "2020-05-07T02:23:49.000000Z",
                "updated_at": "2020-05-07T02:23:49.000000Z"
            },
            {
                "id": 449,
                "guid": "449",
                "name": "Vinblastine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing neutropenia",
                "interactions": "Additive effects with other potentially neutropenia-inducing drugs (avoid coadministration if possible, including many antineoplastic chemotherapeutics)",
                "adverse_effects": "Neutropenia and associated fever in 13% of dogs treated with this dosage, including 4% fatalities\nVesicant (extravasation during injection causes extensive sloughing/necrosis)\nGI adverse effects mild and reversible",
                "deleted_at": null,
                "created_at": "2020-05-07T02:25:45.000000Z",
                "updated_at": "2020-05-07T02:25:45.000000Z"
            },
            {
                "id": 450,
                "guid": "450",
                "name": "Vincristine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other vinca alkaloids\nInability to establish venous access",
                "interactions": null,
                "adverse_effects": "Neurotoxicosis (50 µg/kg IV q 4 days is neurotoxic in cats)\nVesicant (extravasation during injection causes extensive sloughing/necrosis)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:26:59.000000Z",
                "updated_at": "2020-05-07T02:26:59.000000Z"
            },
            {
                "id": 451,
                "guid": "451",
                "name": "Vitamin E",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation",
                "interactions": null,
                "adverse_effects": "Overdosage can cause hepatic dysfunction (lipid-soluble vitamin)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:29:03.000000Z",
                "updated_at": "2020-05-07T02:29:03.000000Z"
            },
            {
                "id": 452,
                "guid": "452",
                "name": "Vitamin K1",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the product",
                "interactions": "Reverses effect of warfarin and warfarin-based anticoagulants",
                "adverse_effects": "Risk of anaphylaxis if administered IV and of hematoma if administered IM\nGive SC (small-gauge needle) or PO",
                "deleted_at": null,
                "created_at": "2020-05-07T02:30:40.000000Z",
                "updated_at": "2020-05-07T02:30:40.000000Z"
            },
            {
                "id": 453,
                "guid": "453",
                "name": "Voriconazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Potential for hepatotoxic effects (monitor liver enzymes)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:32:15.000000Z",
                "updated_at": "2020-05-07T02:32:15.000000Z"
            },
            {
                "id": 454,
                "guid": "454",
                "name": "Warfarin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Prothrombin time (PT) should be 1.5-2.5 times upper limit of reference range for optimal anticoagulation",
                "reversal_agent": "Vitamin K1",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nActive bleeding\nPhysically vigorous lifestyle (e.g., outdoor cat)\nInconsistent owner compliance",
                "interactions": "Numerous (plasma protein-bound)",
                "adverse_effects": "Excessive bleeding, which typically manifests as lethargy, GI bleeding (suspected but only seldom produces melena at the time of presentation for signs of bleeding), epistaxis, or pulmonary hemorrhage (dyspnea)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:33:00.000000Z",
                "updated_at": "2020-05-07T02:33:00.000000Z"
            },
            {
                "id": 455,
                "guid": "455",
                "name": "Xylazine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Yohimbine, atipamezole, tolazoline",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nSystemic hypertension\nPre-existing bradycardia\nPre-existing dilated cardiomyopathy or valvular heart disease",
                "interactions": "Additive effects with other alpha-2 adrenergic agonists and vasopressors in general\nAdditive effects with CNS depressant drugs",
                "adverse_effects": "Vomiting (vast majority of cats)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:33:56.000000Z",
                "updated_at": "2020-05-07T02:33:56.000000Z"
            },
            {
                "id": 456,
                "guid": "456",
                "name": "Yohimbine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nXylazine sedation that is intended to continue",
                "interactions": null,
                "adverse_effects": "Transient CNS stimulation possible",
                "deleted_at": null,
                "created_at": "2020-05-07T02:35:56.000000Z",
                "updated_at": "2020-05-07T02:35:56.000000Z"
            },
            {
                "id": 457,
                "guid": "457",
                "name": "Zafirlukast",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T02:36:56.000000Z",
                "updated_at": "2020-05-07T02:36:56.000000Z"
            },
            {
                "id": 458,
                "guid": "458",
                "name": "Zidovudine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Neutropenia, gastrointestinal signs, marked bone marrow hypercellularity possible (splenic extramedullary hematopoiesis, >15 mg/kg)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:37:38.000000Z",
                "updated_at": "2020-05-07T02:37:38.000000Z"
            },
            {
                "id": 459,
                "guid": "459",
                "name": "Zinc gluconate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Normal blood zinc concentrations: 0.8-2 ppm",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation",
                "interactions": "Binds copper",
                "adverse_effects": "Nausea, inappetence possible",
                "deleted_at": null,
                "created_at": "2020-05-07T02:38:27.000000Z",
                "updated_at": "2020-05-07T02:38:27.000000Z"
            },
            {
                "id": 460,
                "guid": "460",
                "name": "Zinc methionine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Normal blood zinc concentrations: 0.8-2 ppm",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation",
                "interactions": "Binds copper",
                "adverse_effects": "Nausea, inappetence possible",
                "deleted_at": null,
                "created_at": "2020-05-07T02:39:07.000000Z",
                "updated_at": "2020-05-07T02:39:07.000000Z"
            },
            {
                "id": 461,
                "guid": "461",
                "name": "Zinc sulfate",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Normal blood zinc concentrations: 0.8-2 ppm",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the preparation",
                "interactions": "Binds copper",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T02:39:45.000000Z",
                "updated_at": "2020-05-07T02:39:45.000000Z"
            },
            {
                "id": 462,
                "guid": "462",
                "name": "Zonisamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "10-40 µg/mL",
                "reversal_agent": null,
                "teratogenicity": "Recognized teratogen in dogs",
                "contraindications": "Hypersensitivity to the drug\nSubdued states of consciousness\nPre-existing liver disease",
                "interactions": null,
                "adverse_effects": "Acute hepatopathy reported in a dog\nAnorexia, diarrhea, vomiting, somnolence, locomotor ataxia reported in a cat",
                "deleted_at": null,
                "created_at": "2020-05-07T02:40:30.000000Z",
                "updated_at": "2020-05-07T02:40:30.000000Z"
            },
            {
                "id": 463,
                "guid": "463",
                "name": "Docetaxel",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "238+/- 160 ng/mL reported in dogs, but without clear correlation to clinical effect",
                "reversal_agent": null,
                "teratogenicity": "Contraindicated in pregnancy (class effect)",
                "contraindications": "Hypersensitivity to the drug\nNeutropenia",
                "interactions": "Hepatic P450 enzyme inhibitors can decrease docetaxel clearance and increase toxicity\n loperamide should not be used as an antidiarrheal treatment in patients receiving docetaxel\n corticosteroids and non-steroidal anti-inflammatories should be discontinued 1 week prior to oral docetaxel chemotherapy",
                "adverse_effects": "Moderate to severe GI toxicosis is very common, is dose-limiting, and often requires hospitalization\nHypersensitivity to carrier solution (polysorbate-80) possible with parenteral form",
                "deleted_at": null,
                "created_at": "2020-05-07T02:41:00.000000Z",
                "updated_at": "2020-05-07T02:41:00.000000Z"
            },
            {
                "id": 464,
                "guid": "464",
                "name": "Endotoxin antiserum",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or related compounds",
                "interactions": null,
                "adverse_effects": "Hypersensitivity possible, even on first administration",
                "deleted_at": null,
                "created_at": "2020-05-07T02:41:44.000000Z",
                "updated_at": "2020-05-07T02:41:44.000000Z"
            },
            {
                "id": 465,
                "guid": "465",
                "name": "Epsiprantel",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Theoretical possibility of intestinal obstruction with rapid death of heavy worm burden (appears clinically rare/very unlikely)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:42:07.000000Z",
                "updated_at": "2020-05-07T02:42:07.000000Z"
            },
            {
                "id": 466,
                "guid": "466",
                "name": "Etomidate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGlaucoma",
                "interactions": null,
                "adverse_effects": "Hypersalivation and vomiting are common in both dogs and cats, and routine premedication may reduce the incidence\nAdrenocortical suppression (mild) for 2-6h after administration",
                "deleted_at": null,
                "created_at": "2020-05-07T02:43:48.000000Z",
                "updated_at": "2020-05-07T02:43:48.000000Z"
            },
            {
                "id": 467,
                "guid": "467",
                "name": "Flecainide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Plasma concentration of 1.7 + 0.3 mg/L is associated with conversion of atrial fibrillation to sinus rhythm in experimental dogs",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Cumulative effects (both therapeutic and toxic) expected if co-treatment with other class I antiarrhythmics (e.g., lidocaine, mexiletine, tocainide)",
                "adverse_effects": "Proarrhythmic effect, especially in dogs with pre-existing myocardial ischemia/infarction\nMyocardial depression (decreased systolic function) when given at 0.3 mg/kg followed by 0.03 mg/kg/min",
                "deleted_at": null,
                "created_at": "2020-05-07T02:45:01.000000Z",
                "updated_at": "2020-05-07T02:45:01.000000Z"
            },
            {
                "id": 468,
                "guid": "468",
                "name": "Flumethasone",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Abortefacient - do not use in pregnant animals if pregnancy is intended to reach term",
                "contraindications": "Hypersensitivity to the preparation\nPregnancy\nChronic use is contraindicated in animals with uncontrolled hyperadrenocorticism or other signs of untreated glucocorticoid excess",
                "interactions": "Do not coadminister with nonsteroidal anti-inflammatory drugs",
                "adverse_effects": "Gastrointestinal ulceration, polyphagia leading to weight gain, polyuria/polydipsia, immunosuppression, liver enzyme elevation/steroid hepatopathy, insulin antagonism in cats, causing persistent glucosuria",
                "deleted_at": null,
                "created_at": "2020-05-07T02:45:57.000000Z",
                "updated_at": "2020-05-07T02:45:57.000000Z"
            },
            {
                "id": 469,
                "guid": "469",
                "name": "Hyoscyamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "If severe overdose: atenolol or propranolol",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nTachycardia\nIleus\nGI, urinary, or genital tract obstruction",
                "interactions": "Additive effects with other anticholinergics (e.g., atropine, propantheline) and with antispasmodics (e.g., loperamide)",
                "adverse_effects": "Ileus\nXerostomia (dry mouth)\nTachycardia\nUrinary retention (very rare at therapeutic dosages)",
                "deleted_at": null,
                "created_at": "2020-05-07T02:46:39.000000Z",
                "updated_at": "2020-05-07T02:46:39.000000Z"
            },
            {
                "id": 470,
                "guid": "470",
                "name": "Iopanoic acid",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Levothyroxine",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to iodine-based compunds in general\nHypothyroidism",
                "interactions": "Could interfere with radioiodine uptake, so allow washout period before radioiodine treatment",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T02:47:47.000000Z",
                "updated_at": "2020-05-07T02:47:47.000000Z"
            },
            {
                "id": 471,
                "guid": "471",
                "name": "Ipodate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Levothyroxine",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or to iodine-based compunds in general\nHypothyroidism",
                "interactions": "Could interfere with radioiodine uptake, so allow washout period before radioiodine treatment",
                "adverse_effects": "Interference with thyroid hormones when used as a radiographic contrast agent.",
                "deleted_at": null,
                "created_at": "2020-05-07T02:48:13.000000Z",
                "updated_at": "2020-05-07T02:48:13.000000Z"
            },
            {
                "id": 472,
                "guid": "472",
                "name": "Ipronidazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Nitroimidazoles are potential mutagens/carcinogens/teratogens\\nThis drug should be avoided in pregnant bitches during the first half of gestation.",
                "contraindications": "Hypersensitivity to the compound",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T02:49:11.000000Z",
                "updated_at": "2020-05-07T02:49:11.000000Z"
            },
            {
                "id": 473,
                "guid": "473",
                "name": "Kanamycin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug and/or to other aminoglycosides",
                "interactions": null,
                "adverse_effects": "Ototoxicosis, nephrotoxicosis if administered systemically",
                "deleted_at": null,
                "created_at": "2020-05-07T02:49:43.000000Z",
                "updated_at": "2020-05-07T02:49:43.000000Z"
            },
            {
                "id": 474,
                "guid": "474",
                "name": "Lansoprazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Proton-pump inhibitors are renowned inhibitors of metabolism of many drugs, could interfere with elimination of concurrently administered medication\n pharmacist consultation is warranted",
                "adverse_effects": "Vomiting, diarrhea, flatulence, mild anorexia possible",
                "deleted_at": null,
                "created_at": "2020-05-07T02:50:38.000000Z",
                "updated_at": "2020-05-07T02:50:38.000000Z"
            },
            {
                "id": 475,
                "guid": "475",
                "name": "Lipid emulsion",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug or compound\nHyperlipidemia",
                "interactions": null,
                "adverse_effects": "Extravasation may lead to painful swelling\nFat embolism possible with excessively rapid IV administration",
                "deleted_at": null,
                "created_at": "2020-05-07T02:52:10.000000Z",
                "updated_at": "2020-05-07T02:52:10.000000Z"
            },
            {
                "id": 476,
                "guid": "476",
                "name": "Meclizine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nMicturition disorders",
                "interactions": null,
                "adverse_effects": "Potentially anticholinergic effects (tachycardia, xerostomia/dry mouth, etc.), sedation",
                "deleted_at": null,
                "created_at": "2020-05-07T02:55:06.000000Z",
                "updated_at": "2020-05-07T02:55:06.000000Z"
            },
            {
                "id": 477,
                "guid": "477",
                "name": "Memantine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nDrugs or diet that make urine alkaline (can reduce drug elimination by 80% in humans, potentially causing toxicosis)",
                "interactions": null,
                "adverse_effects": "Increased frequency of urination has been reported in dogs",
                "deleted_at": null,
                "created_at": "2020-05-07T02:56:11.000000Z",
                "updated_at": "2020-05-07T02:56:11.000000Z"
            },
            {
                "id": 478,
                "guid": "478",
                "name": "Metyrapone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Prednisolone or other glucocorticoid",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoadrenocorticism\nRelative or absolute adrenal insufficiency",
                "interactions": null,
                "adverse_effects": "Dose-dependent gastrointestinal toxicity (don’t exceed 70 mg/kg)\nHypocortisolemia, increased endogenous ACTH levels resulting in loss of adrenal blockade possible",
                "deleted_at": null,
                "created_at": "2020-05-07T02:56:58.000000Z",
                "updated_at": "2020-05-07T02:56:58.000000Z"
            },
            {
                "id": 479,
                "guid": "479",
                "name": "Miltefosine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Fetal death and teratogenicity has occurred in animals receiving miltefosine.",
                "contraindications": null,
                "interactions": null,
                "adverse_effects": "Vomiting, diarrhea",
                "deleted_at": null,
                "created_at": "2020-05-07T02:57:44.000000Z",
                "updated_at": "2020-05-07T02:57:44.000000Z"
            },
            {
                "id": 480,
                "guid": "480",
                "name": "Mosapride",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nGastric outflow obstruction",
                "interactions": "Aditive effect with other prokinetics (e.g., erythromycin, nizatidine)",
                "adverse_effects": "Safe when given to dogs at 2 mg/kg PO q 24 h for 1 week",
                "deleted_at": null,
                "created_at": "2020-05-07T02:58:26.000000Z",
                "updated_at": "2020-05-07T02:58:26.000000Z"
            },
            {
                "id": 481,
                "guid": "481",
                "name": "Naltrexone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nConcurrent treatment with beta-adrenergic blockers or corticosteroids, due to the potential for the induction of cardiac arrhythmias",
                "interactions": null,
                "adverse_effects": "Drowsiness, withdrawal from owner in 10% of dogs\nAt higher dosages (2 mg/kg PO q 6 h), intense generalized pruritus can develop, resolving with dosage reduction\nAt excessively high dosages, it depresses cardiac function",
                "deleted_at": null,
                "created_at": "2020-05-07T02:59:21.000000Z",
                "updated_at": "2020-05-07T02:59:21.000000Z"
            },
            {
                "id": 482,
                "guid": "482",
                "name": "Oclacitinib",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nPre-existing lymphopenia/circulating cytopenias may be a relative contraindication",
                "interactions": null,
                "adverse_effects": "Transient anorexia recorded in some dogs\nSlight weight gain possible over time\nHealthy dogs receiving 3-5 times the prescribed dosage develop interdigital furunculosis/cysts and decreased lymphocyte counts in blood and lymphoid tissues (nodes, spleen, etc.)",
                "deleted_at": null,
                "created_at": "2020-05-07T03:00:24.000000Z",
                "updated_at": "2020-05-07T03:00:24.000000Z"
            },
            {
                "id": 483,
                "guid": "483",
                "name": "Oxybutynin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nUrethral obstruction",
                "interactions": null,
                "adverse_effects": "Dose-dependent tachycardia, urine retention, and constipation possible, as with other anticholinergics",
                "deleted_at": null,
                "created_at": "2020-05-07T03:00:58.000000Z",
                "updated_at": "2020-05-07T03:00:58.000000Z"
            },
            {
                "id": 484,
                "guid": "484",
                "name": "Pancuronium",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Neostigmine 0.04 mg/kg and atropine 0.04 mg/kg, both IV, can reverse pancuronium-induced neuromuscular blockade\\nEdrophonium 10 mcg/kg IV, given three times over 1-1.5 minutes effectively antagonizes pancuronium with or without enhancement from lidocaine or verapamil",
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypoventilation\nHypoxemia\nHypercapnia\nLiver disease\nKidney disease",
                "interactions": "Many drugs which can be used concurrently during the procedure could increase depth/duration of pancuronium activity (e.g., aminoglycoside antibacterials\n induction agents - propofol, ketamine\n inhalation anesthetics\n sedatives/tranquilizers - benzodiazepines)",
                "adverse_effects": "Hypoventilation, respiratory acidosis resulting in the need for ventilatory support\nMyocardial depression at higher dosages",
                "deleted_at": null,
                "created_at": "2020-05-07T03:02:14.000000Z",
                "updated_at": "2020-05-07T03:02:14.000000Z"
            },
            {
                "id": 485,
                "guid": "485",
                "name": "Phentolamine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": "Vasoconstrictors (e.g., dopamine, phenylephrine)",
                "teratogenicity": null,
                "contraindications": "Caution in neonates (bradycardia), which is not seen in adult dogs",
                "interactions": "Additive effects with other intraoperative antihypertensive drugs (e.g., nitroprusside) and/ordrugs that decrease cardiac output (e.g., esmolol)",
                "adverse_effects": "Hypotension, reflex tachycardia",
                "deleted_at": null,
                "created_at": "2020-05-07T03:03:20.000000Z",
                "updated_at": "2020-05-07T03:03:20.000000Z"
            },
            {
                "id": 486,
                "guid": "486",
                "name": "Plasminogen activator inhibitor",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypercoagulable states",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T03:03:52.000000Z",
                "updated_at": "2020-05-07T03:03:52.000000Z"
            },
            {
                "id": 487,
                "guid": "487",
                "name": "Primaquine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Vomiting occurs with PO dosing. May be fatal with dosages >1 mg/kg (>2 mg/kg has caused 100% mortality in cats)",
                "deleted_at": null,
                "created_at": "2020-05-07T03:04:16.000000Z",
                "updated_at": "2020-05-07T03:04:16.000000Z"
            },
            {
                "id": 488,
                "guid": "488",
                "name": "Teicoplanin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T03:04:51.000000Z",
                "updated_at": "2020-05-07T03:04:51.000000Z"
            },
            {
                "id": 489,
                "guid": "489",
                "name": "Telmisartan",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Contraindicated in pregnancy and lactation",
                "contraindications": "Hypersensitivity to the drug\nHypotension",
                "interactions": null,
                "adverse_effects": "Regurgitation, vomiting, diarrhea/soft stool reported",
                "deleted_at": null,
                "created_at": "2020-05-07T03:05:32.000000Z",
                "updated_at": "2020-05-07T03:05:32.000000Z"
            },
            {
                "id": 490,
                "guid": "490",
                "name": "Tepoxalin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Not to be combined with corticosteroids or other non-steroidal anti-inflammatories",
                "adverse_effects": "Increased serum creatinine concentration, collapse, increase in liver enzymes, vomiting and diarrhea, hematochezia, gastrointestinal ulceration/perforation have been documented in dogs\nThe prevalence of adverse effects (notably vomiting) in cats is 8.8% based on a retrospective study",
                "deleted_at": null,
                "created_at": "2020-05-07T03:06:09.000000Z",
                "updated_at": "2020-05-07T03:06:09.000000Z"
            },
            {
                "id": 491,
                "guid": "491",
                "name": "Thyrotropin-releasing hormone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Panting, vomiting, salivation, and defecation\nAt TRH dosages >1 mg/kg, side effects include urination, defecation, salivation, vomiting, miosis, tachypnea and tachycardia.",
                "deleted_at": null,
                "created_at": "2020-05-07T03:07:26.000000Z",
                "updated_at": "2020-05-07T03:07:26.000000Z"
            },
            {
                "id": 492,
                "guid": "492",
                "name": "Trazodone",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "If IV route: tachycardia, behavioral changes.",
                "deleted_at": null,
                "created_at": "2020-05-07T03:09:07.000000Z",
                "updated_at": "2020-05-07T03:09:07.000000Z"
            },
            {
                "id": 493,
                "guid": "493",
                "name": "Deslorelin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug \n Breeding stud intended to mate",
                "interactions": "",
                "adverse_effects": "Infantilism of external genitalia is common when administered to prepubertal females, predispose to vaginitis or perivulvar dermatitis. Case report of follicular cysts and prolonged estrus in an adult female dog\nOocyst recovery is significantly reduced with dslorelin treatment in cats",
                "deleted_at": null,
                "created_at": "2020-05-07T03:10:22.000000Z",
                "updated_at": "2020-11-08T19:34:23.000000Z"
            },
            {
                "id": 494,
                "guid": "494",
                "name": "Esomeprazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "Can alter efficacy of drugs that require an acidic gastric pH to function (e.g., sucralfate)",
                "adverse_effects": "No significant difference in fecal consistency in treated dogs vs. placebo",
                "deleted_at": null,
                "created_at": "2020-05-07T03:12:29.000000Z",
                "updated_at": "2020-11-11T18:44:40.000000Z"
            },
            {
                "id": 495,
                "guid": "495",
                "name": "Flucytosine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Teratogenic",
                "contraindications": "Hypersensitivity to the drug\nPregnancy",
                "interactions": null,
                "adverse_effects": "Cutaneous or mucocutaneous drug eruptions are sufficiently serious to require end of treatment and are extremely common (88% of treated dogs)\nMyelotoxic\nGI tract toxicosis",
                "deleted_at": null,
                "created_at": "2020-05-07T03:13:20.000000Z",
                "updated_at": "2020-05-07T03:13:20.000000Z"
            },
            {
                "id": 496,
                "guid": "496",
                "name": "Irbesartan",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Minimum effective plasma concentration in otherwise healthy dogs is theorized to be 550-800 ng/mL (24195292)",
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nHypotension",
                "interactions": null,
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T03:14:35.000000Z",
                "updated_at": "2020-05-07T03:14:35.000000Z"
            },
            {
                "id": 497,
                "guid": "497",
                "name": "Linezolid",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Occasional vomiting and anorexia reported",
                "deleted_at": null,
                "created_at": "2020-05-07T03:15:16.000000Z",
                "updated_at": "2020-05-07T03:15:16.000000Z"
            },
            {
                "id": 498,
                "guid": "498",
                "name": "Mebendazole",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "As a class, some benzimidazoles are considered to have teratogenic potential",
                "contraindications": "Hypersensitivity to the drug\nLiver disease\nPossibly Dachshund breed",
                "interactions": null,
                "adverse_effects": "Hepatotoxicosis (anorexia, depression, vomiting, hemorrhagic diarrhea, icterus, elevated liver enzymes, and hepatic necrosis) has been reported in dogs following mebendazole treatment\nIdiosyncratic reaction is possible because some toxicologic studies with dosages over 100 times greater than the standard dosage have not produced any toxic effects\nSafety studies have been done on this drug and even when used at 110 times the therapeutic dose, no evidence of adverse effects were noted (including hepatic dysfunction).",
                "deleted_at": null,
                "created_at": "2020-05-07T03:16:16.000000Z",
                "updated_at": "2020-05-07T03:16:16.000000Z"
            },
            {
                "id": 499,
                "guid": "499",
                "name": "Methenamine",
                "formulation_species_id": 3,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug\nKidney disease/uremia",
                "interactions": "Avoid co-treatment with sulfonamide drugs (precipitate in urine)",
                "adverse_effects": null,
                "deleted_at": null,
                "created_at": "2020-05-07T03:19:46.000000Z",
                "updated_at": "2020-05-07T03:19:46.000000Z"
            },
            {
                "id": 500,
                "guid": "500",
                "name": "Neomycin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "Fecal neomycin concentration >100 mcg/g corresponds to serum levels 5-8 mcg/mL",
                "reversal_agent": null,
                "teratogenicity": "Use with caution in postpartum animals and animals with calcium depletion, as neomycin increases urinary calcium excretion.",
                "contraindications": "Hypersensitivity to the drug or to other aminoglycosides\nPre-existing hearing impairment or kidney disease",
                "interactions": null,
                "adverse_effects": "Ototoxicity (cochleotoxicity) and nephrotoxicity are well-know and are prohibitive: parenteral administration is absolutely contraindicated",
                "deleted_at": null,
                "created_at": "2020-05-07T03:20:55.000000Z",
                "updated_at": "2020-05-07T03:20:55.000000Z"
            },
            {
                "id": 501,
                "guid": "501",
                "name": "Thioguanine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": "Potential teratogen, mutagen, and carcinogen, as with many antineoplastics",
                "contraindications": "Hypersensitivity to the drug\nCytopenias",
                "interactions": null,
                "adverse_effects": "Myelotoxicosis and severe immunosuppression, cytopenias and secondary infections that have been fatal\nDevelopment of resistance to thioguanine is possible",
                "deleted_at": null,
                "created_at": "2020-05-07T03:22:57.000000Z",
                "updated_at": "2020-05-07T03:22:57.000000Z"
            },
            {
                "id": 502,
                "guid": "502",
                "name": "Trovafloxacin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": null,
                "reversal_agent": null,
                "teratogenicity": null,
                "contraindications": "Hypersensitivity to the drug",
                "interactions": null,
                "adverse_effects": "Hepatotoxicosis\nPossibility of in utero cartilage damage, feline retinopathy (fluoroquinolone class effect) but no conclusive data",
                "deleted_at": null,
                "created_at": "2020-05-07T03:23:56.000000Z",
                "updated_at": "2020-05-07T03:23:56.000000Z"
            },
            {
                "id": 503,
                "guid": null,
                "name": "2-mercaptopropionylglycine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Pre-existing methemoglobinemia\n blood dyscrasias (agranulocytosis, anemia, thromboocytopenia)\n hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Single cases of transient reversible hepatopathy and thrombocytopenia reported\nCutaneous reactions (rash, pruritus), fever, and lupus-like signs reported in some humans\nGiven the possibility of causing methemoglobinemia, use in cats or in any individual at risk of methemoglobinemia is not supported.",
                "deleted_at": null,
                "created_at": "2020-10-30T19:33:08.000000Z",
                "updated_at": "2020-10-30T19:33:08.000000Z"
            },
            {
                "id": 504,
                "guid": null,
                "name": "ACTH gel - depot formulation",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-10-30T19:41:08.000000Z",
                "updated_at": "2020-10-30T19:41:08.000000Z"
            },
            {
                "id": 505,
                "guid": null,
                "name": "Adenosine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Bradycardia (second- or third-degree AV block, sinus node dysfunction/sick sinus syndrome)        \n         hypersensitivity to the product",
                "interactions": "Methylxanthines (e.g., theophylline, aminophylline) are antagonistic, requiring higher dosages of adenosine\r\n dipyridamole is synergistic, requiring lower dosages of adenosine",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-10-30T19:50:18.000000Z",
                "updated_at": "2020-10-30T20:27:23.000000Z"
            },
            {
                "id": 507,
                "guid": null,
                "name": "Afoxolaner",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n relative contraindication in patients with epilepsy (role of GABA?)",
                "interactions": "Other drugs affecting GABAergic systems, e.g., ivermectin and other macrolides, fipronil (Frontline), etc.\n if using afoxolaner, avoid high-dosage ivermectin (e.g.,when treating demodicosis) or wean off ivermectin entirely before starting afoxolaner",
                "adverse_effects": "Single anecdotal reports of seizures in dogs known to have a previous history of seizures\n Afoxolaner given up to 31.5 mg/kg PO q 2-4 weeks X 4 months to 8-week-old puppies produced no identifiable adverse effects\n Afoxolaner given up to 25 mg/kg + milbemycin given up to 5 mg/kg PO q 2-4 weeks X 4 months to 8-week-old puppies produced no identifiable adverse effects",
                "deleted_at": null,
                "created_at": "2020-10-30T20:32:59.000000Z",
                "updated_at": "2020-10-30T20:32:59.000000Z"
            },
            {
                "id": 508,
                "guid": null,
                "name": "Ambroxol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n elimination in humans is both GI and renal, so some caution should be exercised in patients with hepatic and/or renal dysfunction",
                "interactions": "",
                "adverse_effects": "Mild GI adverse effects documented occasionally in human patients",
                "deleted_at": null,
                "created_at": "2020-10-31T18:18:17.000000Z",
                "updated_at": "2020-10-31T18:18:17.000000Z"
            },
            {
                "id": 509,
                "guid": null,
                "name": "Apixaban",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Frozen or fresh frozen plasma",
                "teratogenicity": "",
                "contraindications": "Bleeding disorder or hypocoagulable state\n hypersensitivity to the product",
                "interactions": "Additive effects with antiplatelet drugs (e.g., asprin, clopidogrel) or other anticoagulants (e.g., warfarin, heparin)",
                "adverse_effects": "Excessive bleeding possible based on mechanism of action, but safety profile not yet studied in large numbers of dogs or cats",
                "deleted_at": null,
                "created_at": "2020-10-31T18:20:29.000000Z",
                "updated_at": "2020-10-31T18:20:29.000000Z"
            },
            {
                "id": 510,
                "guid": null,
                "name": "Artemisinin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Mechanism of action implies substantial teratogenic risk\n not recommended during pregnancy or lactation",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-10-31T18:22:19.000000Z",
                "updated_at": "2020-10-31T18:22:19.000000Z"
            },
            {
                "id": 511,
                "guid": null,
                "name": "Bezafibrate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Not advised during pregnancy (humans)",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "By extrapolation from humans: enhances effect of some anticoagulants, may interact with cyclosporine in a way that causes kidney injury",
                "adverse_effects": "None noted: on the contrary, alanine aminotransferase (ALT) concentrations have decreased during treatment in dogs",
                "deleted_at": null,
                "created_at": "2020-10-31T18:24:08.000000Z",
                "updated_at": "2020-10-31T18:24:08.000000Z"
            },
            {
                "id": 512,
                "guid": null,
                "name": "Capromorelin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "In treated dogs versus placebo controls: hypersalivation (2.3% vs 0%), polydipsia (4.1% vs. 1.4%), and increased blood urea nitrogen (4.1% vs. 2.7%) \n\r\n \n Treated dogs have higher growth hormone and insulin growth factor-1 levels\n therefore, this drug should probably be avoided in acromegalic dogs",
                "deleted_at": null,
                "created_at": "2020-10-31T18:25:07.000000Z",
                "updated_at": "2020-10-31T18:25:07.000000Z"
            },
            {
                "id": 514,
                "guid": null,
                "name": "Diatrizoate meglumine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Absolute contraindications include hypersensitivity to this class of contrast agents or iodine-containing products, myelography (life-threatening or fatal CNS effects), and any application that risks aspiration (severe/fatal pneumonitis)",
                "interactions": "",
                "adverse_effects": "Accidental intrathecal administration can be fatal, or can cause tonic-clonic muscle spasms (3 hours post-administration), generalized seizure activity resistant to anticonvulsants, and respiratory arrest, which could respond to mechanical ventilation (26 hours in 1 case) and tetraparesis X 20 days.\nNegative cardiovascular effects after routine IV administration in dogs can include vasodilation, myocardial depression, and cardiac arrhythmias",
                "deleted_at": null,
                "created_at": "2020-10-31T18:39:35.000000Z",
                "updated_at": "2020-10-31T18:39:35.000000Z"
            },
            {
                "id": 515,
                "guid": null,
                "name": "Diclazuril",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product",
                "interactions": "",
                "adverse_effects": "Uncontrolled/unmonitored supplementation may lead to an excess of vitamin D effects, including irreversible soft tissue mineralization",
                "deleted_at": null,
                "created_at": "2020-10-31T19:12:34.000000Z",
                "updated_at": "2020-10-31T19:12:34.000000Z"
            },
            {
                "id": 516,
                "guid": null,
                "name": "Fenofibrate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n hypolipidemia\n nephrolithiasis",
                "interactions": "",
                "adverse_effects": "Nephrolithiasis has occurred in some dogs receiving bezafibrate\n significant increase in both hepatic carcinomas and pancreatic carcinomas occurred in rats receiving 6 times the maximum recommended dosage",
                "deleted_at": null,
                "created_at": "2020-11-03T15:11:32.000000Z",
                "updated_at": "2020-11-03T15:11:32.000000Z"
            },
            {
                "id": 517,
                "guid": null,
                "name": "Fenoldopam",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n systemic hypertension",
                "interactions": "Additive effect with dopamine",
                "adverse_effects": "Hypotension noted in 7% and 23% of treated dogs and cats, respectively",
                "deleted_at": null,
                "created_at": "2020-11-03T15:13:16.000000Z",
                "updated_at": "2020-11-03T15:13:16.000000Z"
            },
            {
                "id": 518,
                "guid": null,
                "name": "Ferric cyanoferrate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product\n relative contraindication in cats (cyanide content)",
                "interactions": "",
                "adverse_effects": "Cyanide-based drug\n monitor for associated adverse effects (e.g., metabolic acidosis with high blood lactate concentration, increased respiratory effort without cyanosis and no other inciting cause identified)",
                "deleted_at": null,
                "created_at": "2020-11-03T15:14:06.000000Z",
                "updated_at": "2020-11-03T15:14:06.000000Z"
            },
            {
                "id": 519,
                "guid": null,
                "name": "Fluralaner",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product\n relative contraindication in patients with epilepsy (role of GABA?)",
                "interactions": "Other drugs affecting GABAergic systems, e.g., ivermectin and other macrolides, fipronil (Frontline), etc.\n if using fluralaner, avoid high-dosage ivermectin (e.g.,when treating demodicosis) or wean off ivermectin entirely before starting fluralaner",
                "adverse_effects": "Clinical toxicology study in 8 week-old puppies evaluating safety of fluralaner oral chews at 2-11 times the labeled dosage (56-280 mg/kg PO q 2 months X 3 doses) found no clinically relevant side effects on growth, physical variables, clinical pathology variables, or tissues examined histologically.\n\r\nWell-tolerated with no adverse side effects up to 28 days in MDR1(-/-) Collies when administered orally once at 3x highest expected clinical dose (168 mg/kg)\n Concurrent treatment of dogs with fluralaner (Bravecto) and deltamethrin (Scalibor protectorband) has been well-tolerated with no adverse side effects up to 24 weeks.\r\n\n Concurrent treatment of dogs with fluralaner (Bravecto) and milbemycin oxime/praziquantel has been well-tolerated with no adverse side effects up to 28 days.\n Concurrent treatment of cats with fluralaner (Bravecto) and epimoside/praziquantel has been well-tolerated with no adverse side effects up to 28 days.",
                "deleted_at": null,
                "created_at": "2020-11-03T15:32:27.000000Z",
                "updated_at": "2020-11-03T15:32:27.000000Z"
            },
            {
                "id": 520,
                "guid": null,
                "name": "Gemfibrozil",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Teratological studies in rats and rabbits demonstrate no adverse effects on litter or fetal parameters",
                "contraindications": "Hypersensitivity to the drug\n hypolipidemia",
                "interactions": "",
                "adverse_effects": "Well-tolerated by dogs receiving 150 mg/kg PO q 24h X 12 months\n variable histological liver abnormalities (centrolobular atrophy) noted in some dogs receiving 300  mg/kg daily for 12 months\n\r\n Acute toxicity studies indicate minimal hazard from acute overdose",
                "deleted_at": null,
                "created_at": "2020-11-03T15:54:06.000000Z",
                "updated_at": "2020-11-03T15:54:06.000000Z"
            },
            {
                "id": 521,
                "guid": null,
                "name": "Grapiprant",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n possibly pre-existing gastrointestinal disease (see Adverse effects)",
                "interactions": "Avoid using concurrently with glucocorticoids or other NSAIDs",
                "adverse_effects": "Vomiting 3X more frequent in grapiprant-treated dogs (17%) compared to placebo-treated controls (6.3%) over 1 month's time\n long-term effects unclear\n\r\n In healthy dogs, high dosage of grapiprant  (up to 50 mg/kg) was associated with minor drug-related changes in serum total protein and albumin (differences resolved following discontinuation of drug), no drug-related gross or microscopic pathological changes except mild mucosal regeneration in the ileum of one dog",
                "deleted_at": null,
                "created_at": "2020-11-03T15:55:28.000000Z",
                "updated_at": "2020-11-03T15:55:28.000000Z"
            },
            {
                "id": 522,
                "guid": null,
                "name": "Imepitoin",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n severe impairment of hepatic, renal, or cardiovascular function",
                "interactions": "Likely additive CNS depression if combined with other anticonvulsants, with tranquilizers, with general anesthetics, etc., especially those acting at GABAergic sites",
                "adverse_effects": "86% of dogs receiving 30 mg/kg PO q 12h have shown adverse side effects, mainly CNS (ataxia, disorientation, restlessness) and GI (vomiting, inappetence) and mainly in the first week, subsiding spontaneously: no hepatic enzyme elevation or evidence of organ damage observed over 6 month period\n\r\n In dogs, no-observed-event-level (NOEL) at 90 mg/kg PO q 12h for 26 weeks\n mild and transient side effects observed at 150 mg/kg PO q 12h including relaxed nictitating membranes, vomiting, salivation, lacrimation, eye dryness, eye discharges, ataxia, loss of righting reflex, intermittent tremors, lethargy, nystagmus\n imepitoin not associated with significant changes in serum biochemical parameters\n\r\n One canine cutaneous adverse event reported: erythema and exfoliation on lips, ears, abdomen, and small erosions and depigmentation of oral mucosa, lip folds,  philtrum - complete resolution of lesions after discontinuation of imepitoin and treatment with low-dose prednisolone X 4 weeks\n\r\n Well-tolerated in cats, with no serious adverse effects at dosages up to 80 mg/kg for 30 days\n most common side-effects include mild and transient lethargy, vomiting, and inappetence",
                "deleted_at": null,
                "created_at": "2020-11-03T16:00:28.000000Z",
                "updated_at": "2020-11-03T16:00:28.000000Z"
            },
            {
                "id": 523,
                "guid": null,
                "name": "Iohexol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product or to other iodinated compounds\n hemodynamic instability\n caution with advanced kidney dysfunction",
                "interactions": "",
                "adverse_effects": "Case report of asystole occurring during iohexol myelography in a dog\n return of normal sinus rhythm coincident with glycopyrrolate treatment and spontaneous loss of drug effect\n No adverse side effects observed during or after IV infusion of iohexol for GFR estimation\n Better side-effect profile and higher-quality images for angiography compared to diatrizoate meglumine",
                "deleted_at": null,
                "created_at": "2020-11-03T16:03:40.000000Z",
                "updated_at": "2020-11-03T16:03:40.000000Z"
            },
            {
                "id": 524,
                "guid": null,
                "name": "Lokivetmab",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product",
                "interactions": "",
                "adverse_effects": "Blinded, randomized, controlled trial evaluating short-term safety in 245 dogs (clinical population) reported no immediate hypersensitivity reactions, no difference in frequency and type of adverse events in placebo vs lokivetmab groups except for pruritus being less frequent in lokivetmab group, and no clinically relevant differences in clinical pathology results in placebo vs lokivetmab groups\n treatment-induced immunogenicity was found in 2.5% of dogs treated with lokivetmab.",
                "deleted_at": null,
                "created_at": "2020-11-03T16:09:23.000000Z",
                "updated_at": "2020-11-03T16:09:23.000000Z"
            },
            {
                "id": 525,
                "guid": null,
                "name": "Mitratapide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Contraindicated in pregnancy and in dogs less than 18 months of age",
                "contraindications": "Hypersensitivity to the drug\n liver dysfunction\n obesity that is caused by an underlying illness (e.g., hypothyroidism)\n related drug (dirlotapide) is contraindicated in cats with hepatic lipidosis suggesting that mechanistically mitratapide should be as well",
                "interactions": "",
                "adverse_effects": "Potential side-effects include vomiting, diarrhea, anorexia, lethargy, and changes in biochemistry parameters (serum protein, calcium, potassium, ALP, ALT) which are typically mild and transient\n in a study involving 19 obese dogs treated with mitratapide in a clinical settings, no side-effects were observed",
                "deleted_at": null,
                "created_at": "2020-11-03T16:11:35.000000Z",
                "updated_at": "2020-11-03T16:11:35.000000Z"
            },
            {
                "id": 526,
                "guid": null,
                "name": "Nandrolone decanoate",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n liver dysfunction\n obesity that is caused by an underlying illness (e.g., hypothyroidism)\n related drug (dirlotapide) is contraindicated in cats with hepatic lipidosis suggesting that mechanistically mitratapide should be as well",
                "interactions": "",
                "adverse_effects": "Potential side-effects include vomiting, diarrhea, anorexia, lethargy, and changes in biochemistry parameters (serum protein, calcium, potassium, ALP, ALT) which are typically mild and transient\n in a study involving 19 obese dogs treated with mitratapide in a clinical settings, no side-effects were observed",
                "deleted_at": null,
                "created_at": "2020-11-03T16:33:24.000000Z",
                "updated_at": "2020-11-03T16:33:24.000000Z"
            },
            {
                "id": 527,
                "guid": null,
                "name": "Nifurtimox",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Other nitrofuran-class drugs are recognized teratogens, so this may apply to nifurtimox as well",
                "contraindications": "Hypersensitivity to the drug\n pre-existing arrhythmogenic heart disorders",
                "interactions": "",
                "adverse_effects": "Acute myocarditis associated with rapid parasite kill\n corticosteroid appears to modulate",
                "deleted_at": null,
                "created_at": "2020-11-03T16:34:20.000000Z",
                "updated_at": "2020-11-03T16:34:20.000000Z"
            },
            {
                "id": 528,
                "guid": null,
                "name": "Nifurtimox",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Other nitrofuran-class drugs are recognized teratogens, so this may apply to nifurtimox as well",
                "contraindications": "Hypersensitivity to the drug\n pre-existing arrhythmogenic heart disorders",
                "interactions": "",
                "adverse_effects": "Acute myocarditis associated with rapid parasite kill\n corticosteroid appears to modulate",
                "deleted_at": null,
                "created_at": "2020-11-03T16:34:56.000000Z",
                "updated_at": "2020-11-03T16:34:56.000000Z"
            },
            {
                "id": 530,
                "guid": null,
                "name": "Physostigmine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "Atropine reverses physostigmine",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n asthma\n cardiovascular disease\n GI or urinary tract obstruction",
                "interactions": "",
                "adverse_effects": "\"Tremulouness\" (ataxia, tremor) noted with 0.05 mg/kg IV dosage in Dobermans\n anticholinergic syndrome a possible adverse effect (anxiety, tachycardia, hyperthermia, mydriasis, seizures). Cholinergic crisis possible if administered too rapidly: bradycardia, hypersalivation.\n\"Tremulouness\" (ataxia, tremor) noted with 0.05 mg/kg IV dosage in Dobermans\n anticholinergic syndrome a possible adverse effect (anxiety, tachycardia, hyperthermia, mydriasis, seizures). Cholinergic crisis possible if administered too rapidly: bradycardia, hypersalivation.",
                "deleted_at": null,
                "created_at": "2020-11-03T16:37:57.000000Z",
                "updated_at": "2020-11-03T16:37:57.000000Z"
            },
            {
                "id": 531,
                "guid": null,
                "name": "Polyethylene glycol (PEG)",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "GI perforation\n GI obstruction\n ileus\n hypersenstivity to the product",
                "interactions": "Can potentiate electrolyte loss in patients receiving diuretics or with preexisting electrolyte abnormalities (e.g., hypokalemia in anorectic cats)\n absorption of drugs coadministered with PEG may be altered due to faster GI tract elimination",
                "adverse_effects": "6% of dogs receiving PEG for colonoscopy preparation have gastric distension and discomfort resulting in vomiting or regurgitation\n aspiration of PEG can be life-threatening\nCats treated for constipation can have diarrhea if the dosage is excessive\n mild hyperkalemia possible",
                "deleted_at": null,
                "created_at": "2020-11-03T17:07:59.000000Z",
                "updated_at": "2020-11-03T17:07:59.000000Z"
            },
            {
                "id": 532,
                "guid": null,
                "name": "Polynuclear ferric-starch saccharose complex",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product\n hypophosphatemia",
                "interactions": "",
                "adverse_effects": "Decreased appetite with treatment (but no measurable effect on body weight in healthy experimental cats, and decreased appetite greater with positive control alternative treatment, Renalzin/Lantharenol)",
                "deleted_at": null,
                "created_at": "2020-11-03T17:09:16.000000Z",
                "updated_at": "2020-11-03T17:09:16.000000Z"
            },
            {
                "id": 533,
                "guid": null,
                "name": "Ponazuril",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the product or to other drugs in its class",
                "interactions": "",
                "adverse_effects": "Oronasal mucocutaneous ulcerations and dermatitis noted in small proportion of treated horses",
                "deleted_at": null,
                "created_at": "2020-11-03T17:10:32.000000Z",
                "updated_at": "2020-11-03T17:10:32.000000Z"
            },
            {
                "id": 534,
                "guid": null,
                "name": "Posaconazol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to related antifungals",
                "interactions": "Cimetidine, digoxin, esomeprazole, metoclopramide",
                "adverse_effects": "In dogs, no clinically relevant adverse events or increases in serum liver enzyme activities have been reported during treatment with posaconazole for either sinonasal or disseminated aspergillosis\n In cats, potential adverse reactions of erythema and pruritus of the pinnae and superficial excoriation of the skin in the left temporal region from self-trauma associated with rubbing",
                "deleted_at": null,
                "created_at": "2020-11-03T17:13:56.000000Z",
                "updated_at": "2020-11-03T17:13:56.000000Z"
            },
            {
                "id": 535,
                "guid": null,
                "name": "Prucalopride",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Gastrointestinal tract obstruction\n hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "In dogs, no adverse events reported in 5 experimental dogs treated with prucalopride. In humans, headache, nausea, diarrhea, and abdominal pain are reported in >10% of individuals taking prucalopride",
                "deleted_at": null,
                "created_at": "2020-11-03T17:14:55.000000Z",
                "updated_at": "2020-11-03T17:14:55.000000Z"
            },
            {
                "id": 536,
                "guid": null,
                "name": "Rabacfosadine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Teratogenic: should not be administered during pregnancy",
                "contraindications": "Interstitial pulmonary fibrosis (IPF)\n West Highland white terrier breed (due to predisposition to IPF)\n hypersensitivity to the drug\n neutropenia",
                "interactions": "",
                "adverse_effects": "At least 1 adverse effect noted in every dog in 2 studies of standard dosages of rabacfosadine (most of these being transient and reversible with delay or discontinuation of the drug): anorexia, vomiting, lethargy, anemia, neutropenia, thrombocytopenia, increased liver enzyme concentrations, otitis externa, cuaneous ulcerations, excoriations\n irreversible pulmonary fibrosis identified in some dogs (severity significant: led to euthanasia).",
                "deleted_at": null,
                "created_at": "2020-11-03T17:16:19.000000Z",
                "updated_at": "2020-11-03T17:16:19.000000Z"
            },
            {
                "id": 537,
                "guid": null,
                "name": "Rifaximin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-11-03T17:17:31.000000Z",
                "updated_at": "2020-11-03T17:17:31.000000Z"
            },
            {
                "id": 538,
                "guid": null,
                "name": "Rivaroxaban",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Anti-factor-Xa concentrations can be used to confirm anticoagulant effect",
                "reversal_agent": "Plasma transfusion",
                "teratogenicity": "Not recommended for pregnant dams due to risk of bleeding",
                "contraindications": "Hypersensitivity to the product\n bleeding disorders",
                "interactions": "Cumulative effect with antiplatelet drugs or other anticoagulants - coadminister with caution and consideration of risk versus benefit",
                "adverse_effects": "No bleeding-associated complications noted to date, but broader use of this drug in large numbers of canine patients is necessary to clarify safety profile",
                "deleted_at": null,
                "created_at": "2020-11-03T17:18:17.000000Z",
                "updated_at": "2020-11-03T17:18:17.000000Z"
            },
            {
                "id": 539,
                "guid": null,
                "name": "Secnidazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Mechanism of action (disruption of DNA) raises possibility of teratogenicity, carcinogenesis as in related compounds, e.g., metronidazole",
                "contraindications": "Hypersensitivity to the drug or related compounds (e.g., metronidazole)",
                "interactions": "",
                "adverse_effects": "Hypersalivation in >83% of treated cats immediately after drug administration, self-resolving after 3-5 min\n rare mild to moderate increase in liver enzyme concentrations possible (ALT, GGT)",
                "deleted_at": null,
                "created_at": "2020-11-03T17:19:42.000000Z",
                "updated_at": "2020-11-03T17:19:42.000000Z"
            },
            {
                "id": 540,
                "guid": null,
                "name": "Secnidazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Mechanism of action (disruption of DNA) raises possibility of teratogenicity, carcinogenesis as in related compounds, e.g., metronidazole",
                "contraindications": "Hypersensitivity to the drug or related compounds (e.g., metronidazole)",
                "interactions": "",
                "adverse_effects": "Hypersalivation in >83% of treated cats immediately after drug administration, self-resolving after 3-5 min\n rare mild to moderate increase in liver enzyme concentrations possible (ALT, GGT)",
                "deleted_at": null,
                "created_at": "2020-11-03T17:20:05.000000Z",
                "updated_at": "2020-11-03T17:20:05.000000Z"
            },
            {
                "id": 541,
                "guid": null,
                "name": "Secnidazole",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Mechanism of action (disruption of DNA) raises possibility of teratogenicity, carcinogenesis as in related compounds, e.g., metronidazole",
                "contraindications": "Hypersensitivity to the drug or related compounds (e.g., metronidazole)",
                "interactions": "",
                "adverse_effects": "Hypersalivation in >83% of treated cats immediately after drug administration, self-resolving after 3-5 min\n rare mild to moderate increase in liver enzyme concentrations possible (ALT, GGT)",
                "deleted_at": null,
                "created_at": "2020-11-03T17:20:25.000000Z",
                "updated_at": "2020-11-03T17:20:25.000000Z"
            },
            {
                "id": 542,
                "guid": null,
                "name": "Sertraline",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the compound",
                "interactions": "Numerous. Cannot be combined with monoamine oxidase (MAO) inhibitors like selegeline, insecticides in flea/tick collars (specifically amitraz) or newer appetite stimulants (e.g., mirtazapine), and should be avoided or used only with caution with other serotoninergic drugs (tramadol, most tricyclic antidepressants, fentanyl, St. John's wort)\n increases plasma diazepam concentrations\n cimetidine increases plasma sertraline concentrations\n increases antiplatelet effects of aspirin and other NSAIDs.",
                "adverse_effects": "Rare possibility of development of serotonin syndrome (extreme agitation, hyperthermia, coma)",
                "deleted_at": null,
                "created_at": "2020-11-03T17:22:07.000000Z",
                "updated_at": "2020-11-03T17:22:07.000000Z"
            },
            {
                "id": 543,
                "guid": null,
                "name": "Spectinomycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other macrolides",
                "interactions": "",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-11-03T19:17:27.000000Z",
                "updated_at": "2020-11-03T19:17:27.000000Z"
            },
            {
                "id": 544,
                "guid": null,
                "name": "Spiramycin",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug or to other macrolides",
                "interactions": "",
                "adverse_effects": "Dermatologic reaction (acute generalized exanthematous pustulosis) reported in humans",
                "deleted_at": null,
                "created_at": "2020-11-03T19:19:33.000000Z",
                "updated_at": "2020-11-03T19:19:33.000000Z"
            },
            {
                "id": 545,
                "guid": null,
                "name": "Sulfaguanidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n porphyria\n blood disorders",
                "interactions": "Methotrexate, phenytoin\n positive (synergistic treatment effect) and negative (potential folic acid depletion) interaction expected with trimethoprim and related compounds",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-11-03T19:25:23.000000Z",
                "updated_at": "2020-11-03T19:25:23.000000Z"
            },
            {
                "id": 546,
                "guid": null,
                "name": "Sulfaguanidine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n porphyria\n blood disorders",
                "interactions": "Methotrexate, phenytoin\n positive (synergistic treatment effect) and negative (potential folic acid depletion) interaction expected with trimethoprim and related compounds",
                "adverse_effects": "",
                "deleted_at": null,
                "created_at": "2020-11-03T19:26:22.000000Z",
                "updated_at": "2020-11-03T19:26:22.000000Z"
            },
            {
                "id": 547,
                "guid": null,
                "name": "Tissue plasminogen activor (tPA)",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Bleeding tendency\n active bleeding\n hypersensitivity to the drug",
                "interactions": "Additive effects with anticoagulants (e.g., warfarin, heparin) and antiplatelet drugs (e.g., aspirin, clopidogrel)",
                "adverse_effects": "Dogs: mild ecchymoses on skin (inguinal area, elbow) 3 days after several doses of tPA were administered\n ecchymoses resolved within 2 weeks\n Dogs: hemorrhage at sites of jugular catheter and esophagostomy tube within 30 minutes of tPA administration in 1 case report\n total blood loss 40-80 mL per series of doses\n hemorrhage resolved spontaneously within 90 minutes after last dose\n Cats: adverse side effects occurred in 11/11 cats following administration of tPA for aortic thromboembolism including azotemia (5/11), neurological signs (5/11), cardiac arrhythmias (5/11), hyperkalemia (4/11), acidosis (2/11), and sudden death (1/11) in one case series\n some effects may have been due to the disease process, not the drug",
                "deleted_at": null,
                "created_at": "2020-11-03T19:29:15.000000Z",
                "updated_at": "2020-11-03T19:29:15.000000Z"
            },
            {
                "id": 548,
                "guid": null,
                "name": "Trientine",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "Recheck serum and hepatic [Cu] periodically -at least at 14-15 months of age and again at midlife- to monitor for iatrogenic Cu deficiency associated with long-term treatment",
                "reversal_agent": "",
                "teratogenicity": "Known teratogen in humans",
                "contraindications": "Hypersensitivity to the product\n copper deficiency (spontaneous or iatrogenic)",
                "interactions": "",
                "adverse_effects": "Long-term treatment (>8 years) in a Bedlington Terrier was associated with iatrogenic Cu deficiency: lethargy, vomiting, weight loss, PU/PD, and nonregenerative microcytic hypochromic anemia",
                "deleted_at": null,
                "created_at": "2020-11-03T19:30:45.000000Z",
                "updated_at": "2020-11-03T19:30:45.000000Z"
            },
            {
                "id": 549,
                "guid": null,
                "name": "Trimethobenzamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Potentially sedation, due to antihistaminergic activity",
                "deleted_at": null,
                "created_at": "2020-11-03T19:35:56.000000Z",
                "updated_at": "2020-11-03T19:35:56.000000Z"
            },
            {
                "id": 550,
                "guid": null,
                "name": "Trimethobenzamide",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug",
                "interactions": "",
                "adverse_effects": "Potentially sedation, due to antihistaminergic activity",
                "deleted_at": null,
                "created_at": "2020-11-03T19:36:40.000000Z",
                "updated_at": "2020-11-03T19:36:40.000000Z"
            },
            {
                "id": 551,
                "guid": null,
                "name": "Trimeprazine",
                "formulation_species_id": 2,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "",
                "contraindications": "Hypersensitivity to the drug\n glucocorticoid contraindications if administering the combination product",
                "interactions": "",
                "adverse_effects": "Like other older H1 histamine receptor antagonists, it crosses the blood-brain barrier and therefore could produce sedation and anticholinergic side-effects",
                "deleted_at": null,
                "created_at": "2020-11-03T20:25:39.000000Z",
                "updated_at": "2020-11-03T20:25:39.000000Z"
            },
            {
                "id": 552,
                "guid": null,
                "name": "Ergocalciferol",
                "formulation_species_id": 1,
                "notes": null,
                "target_serum_levels": "",
                "reversal_agent": "",
                "teratogenicity": "Significant negative fetal effects possible, contraindicating use in pregnancy unless lifesaving for the dam",
                "contraindications": "Hypersensitivity to the drug\n hypercalcemia",
                "interactions": "Additive effects with other vitamin D analogs\n enhances absorption of calcium-containing compounds (e.g., calcium carbonate)",
                "adverse_effects": "Uncontrolled/unmonitored supplementation may lead to an excess of vitamin D effects, including irreversible soft tissue mineralization",
                "deleted_at": null,
                "created_at": "2020-11-03T20:48:34.000000Z",
                "updated_at": "2020-11-03T20:48:34.000000Z"
            }
        ];


      let query2 = "INSERT INTO vdi_drugs (id, guid, name,formulation_species_id,notes,target_serum_levels,reversal_agent,contraindications,teratogenicity,interactions,adverse_effects,deleted_at,created_at,updated_at) VALUES";

    
      //alert(target.replace("'", "\\'"));
      
      for (let i = 0; i < drugs.length; ++i) {
            query2 = query2 + "('"
                  + drugs[i].id //id
                  + "','"
                  + drugs[i].guid
                  + "','"
                  + (drugs[i].name == null ? null : drugs[i].name.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + drugs[i].formulation_species_id
                  + "','"
                  + (drugs[i].notes == null ? null : drugs[i].notes.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + (drugs[i].target_serum_levels == null ? null : drugs[i].target_serum_levels.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + (drugs[i].reversal_agent == null ? null : drugs[i].reversal_agent.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + (drugs[i].teratogenicity == null ? null : drugs[i].teratogenicity.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + (drugs[i].contraindications == null ? null : drugs[i].contraindications.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + (drugs[i].interactions == null ? null : drugs[i].interactions.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + (drugs[i].adverse_effects == null ? null : drugs[i].adverse_effects.replace(/[`~!@#$^_?'"\\]/gi, '\\'))
                  + "','"
                  + drugs[i].deleted_at 
                  + "','"
                  + drugs[i].created_at 
                  + "','"
                  + drugs[i].updated_at 
                  + "')";
            if (i != drugs.length - 1) {
                  query2 = query2 + ",";
            }
      }
      query2 = query2 + ";";

      let insertedDrugs = await ExecuteQuery(query2, []);
      console.log('Charles Inserting VDI DRUGS!!.................................', insertedDrugs);
      console.log('....................................................................');

}
export const drugInsert = {
      insertDrugsToDatabaseAsync

}

